Medical Specialty Archives - Medical Conferences

Home > > Medical Specialty

Featured articles

Letter from the Editor

Editor

Prof. Marc P. Bonaca, University of Colorado, USA

Conference

ESC 2025

7 November 2025 15:03

DUAL-ACS: real-world study comparing 3-month vs 12-month DAPT in ACS

Presented By

Prof. David Newby, University of Edinburgh, UK

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:27

UEGW 2025 Highlights Podcast

Dr Kerem Balan , Hacettepe University, Ankara, Turkey

Conference

19 July 2023 15:43

Understanding the stresses and strains of being a doctor

Expert

Dr Steven Younger, Sutter Health, California Pacific Medical Center, CA, USA

18 July 2023 11:14

2023 New Year Ahead text with white blocks | Jernej Furman | Flickr

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Top 14 Medical Innovations for 2022

Expert

Dr Alex McDonald (Board member, Physician’s Weekly) and Dr Rachel Giles (Medical Science Officer, Medicom Medical Publishers)

25 January 2023 02:33

Cardiology

Letter from the Editor

Editor

Prof. Marc P. Bonaca, University of Colorado, USA

Conference

ESC 2025

7 November 2025 15:03

2025 ESC/EACTS guidelines for the management of valvular heart disease

Presented By

Dr Fabien Praz and Prof. Michael Borger , University of Bern, Switzerland and Heart Center of Leipzig, Germany

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:47

Novel ESC guidelines for the management of cardiovascular disease and pregnancy

Presented By

Prof. Julie de Backer and Prof. Kristina Hermann Haugaa , University of Ghent, Belgium and Oslo University Hospital Rikshospitalet, Norway

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:45

2025 ESC guidelines for the management of myocarditis and pericarditis

Presented By

Prof. Massimo Imazio and Prof. Jeanette Schulz-Menger, University Hospital Santa Maria della Misericordia, Italy and Charité University of Medicine Berlin, Germany

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:44

ESC clinical consensus statement on mental health and CVD

Presented By

Prof. Christi Deaton , University of Cambridge, UK

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:41

Focused update of the guidelines for the management of dyslipidaemias

Presented By

Dr Konstantinos Koskinas , Bern University Hospital, Switzerland

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:38

STRIDE: Functional improvements with semaglutide in PAD plus T2D, irrespective of sex

Presented By

Prof. Subodh Verma , University of Toronto, Canada

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:36

SWEDEPAD 1 and 2: Similar outcomes for drug-coated and uncoated devices in PAD

Presented By

Prof. Marten Falkenberg , University Hospital Gothenburg, Sweden

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:35

NEWTON-CABG: Aiming for improved SVG patency with PCSK9 inhibitors

Presented By

Dr Subodh Verma , University of Toronto, ON, Canada

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:33

Shaking the pillars of post-MI treatment

Presented By

Dr Xavier Rossello , Son Espases University Hospital, Spain

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:32

DUAL-ACS: real-world study comparing 3-month vs 12-month DAPT in ACS

Presented By

Prof. David Newby, University of Edinburgh, UK

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:27

NEO-MINDSET: Very early aspirin discontinuation after PCI for ACS fails to meet non-inferiority versus continued DAPT

Presented By

Dr Pedro Lemos , Hospital Israelita Albert Einstein, Brazil

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:23

ALONE-AF: Is it safe to discontinue oral anticoagulation in non-recurrent AF?

Presented By

Dr Boyoung Joung , Yonsei University College of Medicine, South Korea

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:22

TARGET-FIRST: PCI-treated patients after low-risk MI with infrequent events and similar outcomes with early aspirin discontinuation

Presented By

Prof. Giuseppe Tarantini , University of Padua, Italy

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:21

ODYSSEY-HCM: Mavacamten misses primary endpoint in non-obstructive HCM

Presented By

Dr Milind Desai , Cleveland Clinic, OH, USA

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:20

MAPLE-HCM: Aficamten meets efficacy endpoints in obstructive HCM

Presented By

Dr Pablo Garcia-Pavia , University Hospital Puerta de Hierro Majadahonda, Spain

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:19

POTCAST: Effective prevention of arrhythmias with targeted potassium intervention

Presented By

Dr Christian Jons, Rigshospitalet, Denmark

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:16

PREVENT-MINS: Ivabradine does not reduce MINS in non-cardiac surgery

Presented By

Prof. Wojciech Szczeklik , Jagiellonian University, Poland

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:14

DANCAVAS 2: Invitation to screening alone is not sufficient for outcome benefit

Presented By

Prof. Axel Diederichsen , University of Southern Denmark, Denmark

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:13

VICTORION confirms LDL-cholesterol-lowering potential of inclisiran

Presented By

Prof. Ulf Landmesser , Charité University of Medicine Berlin, Germany

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:12

VICTOR + VICTORIA: Vericiguat offers benefits to a broad spectrum of HFrEF patients

Presented By

Dr Faiez Zannad, University of Lorraine, France

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:11

Does in-hospital initiation of SGLT2 inhibitors reduce adverse events in HF?

Presented By

Dr David Berg , Brigham and Women's Hospital, MA, USA

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:09

DIGIT-HF: digitoxin efficacious in HFrEF

Presented By

Dr Udo Bavendiek , Hannover Medical School, Germany

Conference

ESC 2025

Type

Peer-reviewed article

7 November 2025 14:07

PARACHUTE-HF: positive trial result for sacubitril/valsartan in Chagasic HFrEF

Presented By

Dr Renato Lopes, Duke University, NC, USA

17 July 2025 14:08

SOGALDI-PEF: SGLT2 inhibitor plus MRA improves biomarker outcomes in HFp/mrEF

Presented By

Dr João Ferreira, University of Porto, Portugal

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 14:06

REDICAE: Diuretic withdrawal appears feasible in stable HFrEF

Presented By

Dr Jesus Torres Zamudio, Reina Sofia University Hospital, Spain

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 14:03

GLADIATOR: Anti-ulcer agent geranylgeranylacetone explored in HFpEF

Presented By

Dr Geert Voordes, University Medical Center Groningen, the Netherlands

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 14:01

High vs low positive end-expiratory pressure in IMV may impact survival

Presented By

Dr Min-Seok Kim, Asan Medical Centre, South Korea

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:59

PRAISE-HFrEF: Is it safe to use GLP1-receptor agonists in clinically severe HF?

Presented By

Dr Varun Sundaram, University Hospitals Harrington Heart & Vascular Institute, OH, USA

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:54

HELIOS-B: Health benefits of vutrisiran for ATTR-CM may increase over time

Presented By

Prof. Marianna Fontana, University College London, UK

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:53

EMPEROR-Preserved: Diastolic dysfunction might predict response to empagliflozin

Presented By

Dr Andrew Stewart Coats, Heart Research Institute, Australia

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:50

GALACTIC-HF: zooming in on efficacy data and subgroups

Presented By

Dr Kieran Docherty, University of Glasgow, UK

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:49

Novel HCM therapy shows potential

Presented By

Dr Anjali Owens, University of Pennsylvania, PA, USA

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:47

SEQUOIA-HCM: Aficamten effects consistent across regions

Presented By

Dr Caroline Coats, University of Glasgow, UK

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:40

Real-world eligibility for finerenone: insights from the FIDELITY pooled analysis

Presented By

Dr Alberto Esteban Fernandez, Severo Ochoa Hospital, Spain

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:36

FINEARTS-HF confirms: analysis suggests premature cessation of Finerenone is associated with risk and supports long-term treatment

Presented By

Dr Muthiah Vaduganathan, Brigham and Women’s Hospital, MA, USA

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:34

FIVE-STAR: Mechanistic effects of finerenone in T2D plus CKD unravelled

Presented By

Prof. Atsushi Tanaka, Saga University, Japan

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:32

FUTURE-HF: Novel IVC sensor may help control volume and improve function outcomes

Presented By

Dr Kevin Damman, University Medical Center Groningen, the Netherlands

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:27

C-MIC II: Cardiac microcurrent therapy in HFrEF

Presented By

Dr Stefan Anker, University Medicine Göttingen, Germany

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:24

Artificial intelligence in HF management

Presented By

Dr Mariell Jessup, University of Pennsylvania, PA, USA

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:23

Consistent results for nexiguran ziclumeran across wildtype and variant ATTR-CM

Presented By

Prof. Marianna Fontana, University College London, UK

Conference

HFA 2025

Type

Peer-reviewed article

17 July 2025 13:19

New gene therapy for HFrEF passes phase 1 testing

Presented By

Dr Roger Hajjar , Mass General Brigham, MA, USA

Presented By

Prof. William Herrington, University of Oxford, UK

Conference

ERA 2025

6 June 2025 10:43

HFA 2025 Highlights Podcast

Presented By

Dr. Rachel Giles, Robert van den Heuvel, Medicom

Conference

HFA 2025

4 June 2025 10:59

Letter from the Editor ACC 2025

Editor

Prof. Marc P. Bonaca, University of Colorado, USA

Conference

ACC 2025

22 May 2025 15:17

Potential benefit of autologous cell therapy in patients with ischaemic HFrEF?

Presented By

Prof. Amish Raval, University of Wisconsin – Madison, WI, USA

Trial

CardiAMP-HF

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:09

Restricting fluid in HF may not be necessary after all

Presented By

Dr Roland van Kimmenade, Radboud University Medical Center, the Netherlands

Trial

FRESH-UP

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:07

FAIR-HF2: The value of intravenous iron in patients with HF and iron deficiency

Presented By

Prof. Stefan Anker, Charité University, Germany

Trial

Phase 4, FAIR-HF2

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:04

MIGHTy-Heart: Can we improve transition-of-care in post-acute HF?

Presented By

Prof. Ruth Masterson Creber, Columbia University, NY, USA

Trial

MIGHTy-Heart

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:03

Dapagliflozin after TAVI reduces HF in elderly patients

Presented By

Dr Sergio Raposeiras-Roubín, Hospital Universitario Álvaro Cunqueiro de Vigo, Spain

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:01

Oral semaglutide reduces cardiovascular events in patients at high-risk with type 2 diabetes

Presented By

Prof. Darren McGuire, University of Texas, TX, USA

Trial

Phase 3, SOUL

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:46

STRIDE: Semaglutide improves function, symptoms, and outcomes in patients with peripheral artery disease and type 2 diabetes

Presented By

Prof. Marc P. Bonaca, University of Colorado, CO, USA

Trial

Phase 3, STRIDE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:42

Lorundrostat represents novel class of BP-lowering drugs

Presented By

Dr Luke Laffin, Cleveland Clinic, OH, USA

Trial

Phase 2, Advance-HTN

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:41

ALLEPRE: Long-term benefits of nurse-led secondary prevention programme for ACS

Presented By

Dr Giulia Magnani, University of Parma, Italy

Trial

ALLEPRE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:39

Can we manage INOCA in women with intensive medical therapy?

Presented By

Prof. Eileen Handberg, University of Florida, FL, USA

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:32

API-CAT: Encouraging results for extended reduced-dose apixaban in cancer-related VTE

Presented By

Prof. Isabelle Mahé, Université Paris Cité, France

Trial

Phase 3, API-CAT

Conference

ACC 2025

Type

Peer-reviewed article

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-BR

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:22

REVERSE-IT: Bentracimab restores platelet function in ticagrelor users

Presented By

Dr Deepak Bhatt, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, REVERSE-IT

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:20

TAVR non-inferior to SAVR in low-risk aortic stenosis after 5 years

Presented By

Prof. Michael Reardon, Houston Methodist Hospital, TX, USA

Trial

Evolut Low Risk

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:14

ALIGN-AR: Novel device for aortic regurgitation shows its potential

Presented By

Dr Raj Makkar, Cedars-Sinai Smidt Heart Institute, CA, USA

Trial

ALIGN-AR

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:12

Routine use of cerebral embolic protection during TAVR not supported

Presented By

Prof. Rajesh Kharbanda, University of Oxford, UK

Trial

BHF PROTECT-TAVI

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:09

TRILUMINATE: TEER procedure with TriClip device improves outcomes in patients with severe TR

Presented By

Dr Saibal Kar, Los Robles Regional Medical Center, CA, USA

Trial

TRILUMINATE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:06

FLAVOUR II: Novel non-invasive PCI-guidance strategy non-inferior to standard-of-care

Presented By

Dr Jian’an Wang, Second Affiliated Hospital of Zhejiang University School of Medicine, China

Trial

FLAVOUR II

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:03

Results for a deep learning ECG model relative to clinical assessment and current biomarkers

Presented By

Dr Antonius Büscher, University Hospital Münster, Germany

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:00

Real-world performance of pulse oximeters may lead to health disparities

Presented By

Dr Carolyn Hendrickson, University of California San Francisco, CA, USA

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 13:58

Digifab may decrease kidney injury in high-risk cardiac surgery patients

Presented By

Prof. Stephen Gottlieb, University of Maryland, MD, USA

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 13:55

REDICAE: Diuretics withdrawal appears feasible in stable HFrEF

Presented By

Dr Jesus Torres Zamudio, Reina Sofia University Hospital Cordoba, Spain

Trial

Phase 2, REDICAE

Conference

HFA 2025

22 May 2025 13:54

PREFER-HF: Is iron therapy helpful in HFpEF with iron deficiency?

Presented By

Dr José Morales-Rull, University Hospital Arnau de Vilanova, Spain

Trial

Phase 3, PREFER-HF

Conference

HFA 2025

22 May 2025 13:53

New gene therapy for HFrEF passes phase 1 testing

Presented By

Dr Roger Hajjar, Mass General Brigham, MA, USA

Trial

Phase 1, NAN-CS101

Conference

HFA 2025

22 May 2025 13:51

MUSIC-HFpEF: Encouraging first results of novel gene therapy for HFpEF

Presented By

Dr Marat Fudim, Duke University, NC, USA

Trial

Phase 1/2, MUSIC-HFpEF

Conference

HFA 2025

22 May 2025 13:50

FIVE-STAR: Mechanistic effects of finerenone in T2D plus CKD unravelled

Presented By

Prof. Atsushi Tanaka, Saga University, Japan

Trial

Phase 4, FIVE-STAR

Conference

HFA 2025

22 May 2025 13:48

High vs low positive end-expiratory pressure in IMV may impact survival

Presented By

Dr Min-Seok Kim, Asan Medical Centre, South Korea

Trial

HELP-AHF

Conference

HFA 2025

21 May 2025 10:55

Consistent results for nexiguran ziclumeran across wildtype and variant ATTR-CM

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 1

Conference

HFA 2025

21 May 2025 10:52

Promising results for novel HCM therapy

Presented By

Dr Anjali Owens, University of Pennsylvania, PA, USA

Trial

Phase 2, CIRRUS-HCM

Conference

HFA 2025

21 May 2025 10:47

SEQUOIA-HCM: Aficamten safe and efficacious for HCM across the globe

Presented By

Dr Caroline Coats, University of Glasgow, UK

Trial

Phase 3, SEQUOIA-HCM

Conference

HFA 2025

21 May 2025 10:45

GLADIATOR: Anti-ulcer agent geranylgeranylacetone explored in HFpEF

Presented By

Dr Geert Voordes, University Medical Center Groningen, the Netherlands

Trial

Phase 2, GLADIATOR

Conference

HFA 2025

21 May 2025 10:42

FUTURE-HF: Novel IVC sensor may help control volume and improve function outcomes

Presented By

Dr Kevin Damman, University Medical Center Groningen, the Netherlands

Trial

FUTURE-HF

Conference

HFA 2025

20 May 2025 10:27

FINEARTS-HF confirms: indefinite need for HF medication for optimal outcomes

Presented By

Dr Muthiah Vaduganathan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

HFA 2025

20 May 2025 10:25

PRAISE-HFrEF: Is it safe to use GLP1-receptor agonists in clinically severe HF?

Presented By

Dr Varun Sundaram, University Hospitals Harrington Heart & Vascular Institute Cleveland, OH, USA

Trial

PRAISE-HFrEF

Conference

HFA 2025

20 May 2025 10:22

HELIOS-B: Health benefits of vutrisiran for ATTR-CM may increase over time

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 3, HELIOS-B

Conference

HFA 2025

20 May 2025 10:21

SOGALDI-PEF: SGLT2 inhibitor plus MRA improves outcomes in HFp/mrEF

Presented By

Dr Joao Ferreira, University of Porto, Portugal

Trial

Phase 2, SOGALDI-PEF

Conference

HFA 2025

Presented By

Dr Ana Isabel Pinho, São João University Hospital Centre, Porto, Portugal

Conference

EHRA 2025

Type

News article

Presented By

Dr Sergio Castrejon, La Paz University Hospital, Madrid, Spain

Conference

EHRA 2025

Type

News article

6 May 2025 11:24

S-ICD: an alternative for sudden cardiac death prevention in Brugada syndrome

Presented By

Prof. Federico Migliore, University of Padova, Italy

Conference

EHRA 2025

Type

News article

6 May 2025 10:51

PFA shows potential in safety and efficacy of catheter ablations for ventricular arrhythmias

Presented By

Prof. Frederic Sacher, IHU Liryc, Bordeaux, France

Conference

EHRA 2025

Type

News article

6 May 2025 10:48

Electrical storm patients at increased risk of VT recurrence after catheter success

Presented By

Dr Joana Certo Pereira, Hospital de Santa Cruz, Carnaxide, Portugal

Conference

EHRA 2025

Type

News article

Presented By

Dr Patrick Badertscher, University Hospital Basel, Switzerland

Conference

EHRA 2025

Type

News article

6 May 2025 10:35

Apixaban vs aspirin: more bleedings overall but fewer at critical sites

Presented By

Prof. Deborah Michelle Siegal, University of Ottawa, Canada

Trial

Phase 4, ARTESIA

Conference

EHRA 2025

Type

News article

6 May 2025 10:31

SWISS-APERO demonstrates comparable safety, potential efficacy edge for Amulet

Presented By

Dr Roberto Galea, University Hospital Bern, Switzerland

Trial

SWISS-APERO

Conference

EHRA 2025

Type

News article

6 May 2025 10:28

ACC 2025 Highlights Podcast

Presented By

Dr Rachel Giles, Robert van den Heuvel, Medicom

Conference

ACC 2025

11 April 2025 11:29

Letter from the Editor AHA 2024

Editor

Prof. Marc P. Bonaca, University of Colorado, USA

Conference

AHA 2024

3 February 2025 15:35

PROMPT-AF: Novel ablation strategy improves outcomes for persistent AF

Presented By

Prof. Chenyang Jiang, Sir Run Run Shaw Hospital, China

Trial

PROMPT-AF

Conference

AHA 2024

Type

Peer-reviewed article

Presented By

Dr Kengo Kusano, National Cerebral and Cardiovascular Center, Japan

Trial

CRRF-PeAF

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

Will myeloperoxidase inhibition benefit patients with heart failure?

Presented By

Prof. Sanjiv Shah, Northwestern Feinberg School of Medicine, USA

Trial

Phase 2, ENDEAVOR

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

Is intranasal bumetanide a viable diuretic option in congestive HF?

Presented By

Dr Daniel Bensimhon, Cone Health, USA

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

REALIZE-K: MRA treatment optimisation in HFrEF plus hyperkalaemia

Presented By

Prof. Mikhail Kosiborod, University of Missouri, USA

Trial

Phase 4, REALIZE-K

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:02

SUMMIT: Tirzepatide reduces cardiovascular events in HFpEF plus obesity

Presented By

Prof. Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, SUMMIT

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:01

CLEAR Outcomes: Bempedoic acid reduces MACE and MALE in patients with PAD

Presented By

Prof. Marc Bonaca, University of Colorado, USA

Trial

CLEAR Outcomes

Conference

AHA 2024

Type

Peer-reviewed article

Presented By

Prof. Ray Kausik, Imperial College London, UK

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:00

KRAKEN: Encouraging phase 2 results of Lp(a)-lowering muvalaplin

Presented By

Prof. Stephen Nicholls, Monash University, Australia

Trial

Phase 2, KRAKEN

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:00

Reconditioned pacemakers may save lives in low/middle-income countries

Presented By

Dr Thomas Crawford, University of Michigan, USA

Trial

My Heart Your Heart

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 14:59

Comparing dual antihypertensive combination therapies in a South Asian population

Presented By

Prof. Dorairaj Prabhakaran, Centre for Chronic Disease Control, India

Trial

TOPSPIN

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 14:59

BPROAD: Intensive or standard BP treatment strategy in type 2 diabetes?

Presented By

Prof. Guang Ning, Shanghai Jiao Tong University School of Medicine, China

Trial

BPROAD

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 14:59

Promising results for CRISPR-based therapy in ATTR-CM

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 1

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 14:58

NUDGE-FLU: Effect of science-informed letters on influenza vaccination rates

Presented By

Dr Ankeet Bhatt, Stanford University, USA

Trial

NUDGE-FLU

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 14:58

Novel small-interfering RNA effectively reduced Lp(a) in phase 2

Presented By

Prof. Steven Nissen, Cleveland Clinic, USA

Trial

Phase 2

Conference

AHA 2024

3 February 2025 13:33

Full-dose or reduced-dose DOACs in high-risk VTE on extended therapy?

Presented By

Prof. Francis Couturaud, Brest University Hospital, France

Trial

Phase 3, RENOVE

Conference

ASH 2024

Type

Peer-reviewed article

29 January 2025 09:36

AHA Names 7 Cardiovascular Research Breakthroughs in 2024

Expert

Prof. Rachel Giles

Conference

AHA 2024

19 December 2024 11:40

AHA 2024 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AHA 2024

4 December 2024 12:31

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ESC 2024

7 November 2024 14:11

Guidelines for the management of elevated blood pressure and hypertension

Presented By

Prof. John William McEvoy; Prof. Rhian Touyz; Prof. Rosa Maria Bruno

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 14:04

Guidelines for the management of chronic coronary syndromes

Presented By

Prof. Christiaan Vrints; Dr Konstantinos Koskinas

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:54

Guidelines for the management of atrial fibrillation

Presented By

Prof. Isabel van Gelder; Prof. Dipak Kotecha

Conference

ESC 2024

Type

Peer-reviewed article

Presented By

Prof. Minglong Chen, First Affiliated Hospital of Nanjing Medical University, China

Trial

MIRACLE-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:05

SUPPRESS-AF: What is the value of adding LVA ablation to PVI in AF?

Presented By

Dr Masaharu Masuda, Kansai Rosai Hospital, Japan

Trial

SUPPRESS-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:03

ABYSS: Can beta-blocker safely be interrupted post-MI?

Presented By

Prof. Johanne Silvain, Pitié-Salpêtrière University Hospital, France

Trial

Phase 3, ABYSS

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:58

SWEDEGRAFT: Can a no-touch vein harvesting technique improve outcomes in CABG?

Presented By

Prof. Stefan James, Uppsala University, Sweden

Trial

SWEDEGRAFT

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:50

Bioadaptor meets expectations in reducing target lesion failures in coronary artery disease

Presented By

Prof. David Erlinge, Lund University, Sweden

Trial

INFINITY-SWEDEHEART

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:48

REC-CAGEFREE I: Can we avoid permanent stenting with drug-coated balloons?

Presented By

Dr Ling Tao, Xijing Hospital, China

Trial

REC-CAGEFREE I

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:44

OCCUPI: OCT-guided PCI improves outcomes in complex CAD

Presented By

Prof. Byeong-Keuk Kim, Yonsei University Hospital, South Korea

Trial

OCCUPI

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:39

Low-dose 3-drug pill GMRx2 shows promise in lowering BP

Presented By

Prof. Anthony Rodgers, George Institute, Australia

Trial

Phase 3, GMRx2_PCT; GMRx2_ACT

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:06

Is administering BP medication in the evening better than in the morning?

Presented By

Dr Ricky Turgeon, University of British Columbia, Canada

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 12:01

VERONICA: Improving BP control in Africa with a simple strategy

Presented By

Dr Dike Ojji, Abuja University, Nigeria

Trial

VERONICA-Nigeria

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:56

FINEARTS-HF: Finerenone improves outcomes in heart failure with preserved ejection fraction

Presented By

Prof. Scott Solomon, Brigham and Women's Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:45

MRAs show varied efficacy in heart failure across ejection fractions

Presented By

Prof. Pardeep Jhund, University of Glasgow, Scotland

Trial

RALES; EMPHASIS-HF; TOPCAT; FINEARTS-HF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:33

MATTERHORN: Transcatheter repair matches surgery for HF with secondary mitral regurgitation

Presented By

Prof. Volker Rudolph, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany

Trial

MATTERHORN

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:19

RESHAPE-HF2: Not a “tie-breaker” for TEER in heart failure

Presented By

Prof. Stefan Anker, Charité Universitätsmedizin, Germany

Trial

RESHAPE-HF2

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:15

STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines

Presented By

Prof. Dipak Kotecha, University of Birmingham, UK

Trial

STEEER-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:10

SCOFF: To fast or not to fast, that’s the question

Presented By

Dr David Ferreira, John Hunter Hospital, Australia

Trial

SCOFF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:08

WESTCOR-POC: Point-of-care hs-troponin testing increases emergency department efficiency

Presented By

Dr Viola Thulin, Haukeland University Hospital, Norway

Trial

WESTCOR-POC

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:05

PROTEUS: Can AI improve decision-making around stress echocardiography?

Presented By

Dr Ross Upton, Ultromics, UK

Trial

PROTEUS

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:03

RAPIDxAI: Can AI-augmented chest pain assessment improve cardiovascular outcomes?

Presented By

Dr Derek Chew, Monash University, Australia

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:01

HELIOS-B: Vutrisiran candidate for SoC in ATTR cardiomyopathy

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 3, HELIOS-B

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 10:55

Does RAS inhibitor discontinuation affect outcomes after non-cardiac surgery?

Presented By

Prof. Matthieu Legrand, University of California San Francisco, USA

Trial

STOP-or-NOT

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 10:50

Novel approach to managing severe tricuspid regurgitation proves its value

Presented By

Prof. Erwan Donal, Rennes University Hospital, France

Trial

TRI.Fr

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 10:47

NOTION-3: TAVI plus PCI improves outcomes in CAD plus severe aortic stenosis

Presented By

Dr Jacob Lønborg, Copenhagen University Hospital, Denmark

Trial

Phase 3, NOTION-3

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 10:44

RHEIA: TAVI outperformed surgery in women with aortic stenosis

Presented By

Prof. Hélène Eltchaninoff, University Hospital of Rouen, France

Trial

RHEIA

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 10:36

ESC 2024 Podcast

Presented By

Dr Rachel Giles, Medicom

Journal

Medicom

Conference

ESC 2024

17 September 2024 21:17

Meet the Expert: Dr Abdullahi Mohamed on Iron Deficiency in Patients with HF

Expert

Dr Abdullahi Mohamed, Herlev-Gentofte Hospital, Denmark

Conference

ESC 2024

9 September 2024 10:40

High risk for recurrent vascular events in young stroke patients

Presented By

Dr Jenna Broman, University of Helsinki, Finland

Conference

EAN 2024

Type

News article

Presented By

Prof. Carolyn Lam, Duke-National University, Singapore

Trial

Phase 2, MIRACLE

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:04

Empagliflozin did not reduce mortality for HF after MI regardless of T2D status

Presented By

Prof. Javed Butler, University of Mississippi, USA

Trial

EMPACT-MI

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:49

SGLT2 inhibitors decrease atrial fibrillation risk in patients with HFrEF

Presented By

Dr Joel Manuel Alejandro, University of Maryland, USA

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:45

Dr Tauben Averbuch, University of Calgary, Canada

Trial

PACT-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:27

Application of guideline-directed medical therapy in patients with HFrEF in the Netherlands

Presented By

Dr Jasper Brugts, Erasmus University Medical Center, the Netherlands

Trial

TITRATE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:17

PAP-guided management system appears safe in patients with HF

Presented By

Dr Michael Kiernan, Tufts University School of Medicine, USA

Trial

PROACTIVE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:12

Delivery of CRT guided by non-invasive anatomy assessment

Presented By

Dr Mikhail Chmelevsky, Cardiocentro Ticino Institute, Switzerland

Trial

CRT-DRIVE

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:03

RELIEVE-ing HFrEF with interatrial shunting

Presented By

Prof. Stefan Anker, Charité - University Hospital Berlin, Germany

Trial

RELIEVE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:57

Algorithm-based remote patient monitoring was associated with lower mortality in a retrospective cohort study

Presented By

Prof. Nicolas Girerd, University Hospital of Nancy, France

Trial

TELESAT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:46

High mortality and morbidity in suspected de novo HF in outpatient care

Presented By

Dr Lisa Anderson, St George’s Healthcare NHS Foundation Trust, UK

Trial

REVOLUTION-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:44

Bio-ADM as a marker for congestion in patients hospitalised for acute HF

Presented By

Mr Geert Voordes, University Medical Center Groningen, the Netherlands

Trial

STRONG-AF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:39

Hypertonic saline not effective in ambulatory patients with heart failure?

Presented By

Dr Marta Cobo Marcos, Iron Gate Majadahonda University Hospital, Spain

Trial

Phase 3, SALT-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:35

No effect of low-dose carperitide on mortality or hospitalisation in acute HF

Presented By

Dr Toshiyuki Nagai, Hokkaido University, Japan

Trial

LASCAR-AHF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:32

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

HFA 2024

16 July 2024 15:17

HFA 2024 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

HFA 2024

27 May 2024 16:19

Meet the Trialist: Innovating cardiac monitoring with MONITOR-HF

Expert

Dr Jasper Brugts, Erasmus University Medical Center, the Netherlands

Trial

MONITOR-HF

Conference

HFA 2024

22 May 2024 15:19

Preventive PCI of vulnerable intracoronary plaque leads to favourable outcomes

Presented By

Prof. Seung-Jung Park, University of Ulsan College of Medicine, South Korea

Trial

PREVENT

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:52

KARDIA-2: Add-on zilebesiran effectively lowers blood pressure

Presented By

Dr Akshay Desai, Brigham and Women's Hospital, USA

Trial

Phase 2, KARDIA-2

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:48

BRIDGE-TIMI 73a: Olezarsen halves triglyceride levels

Presented By

Dr Brian Bergmark, Brigham and Women's Hospital, USA

Trial

Phase 2, BRIDGE-TIMI 73a

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:41

Dr Mounica Vorla, University of Louisville School of Medicine, USA

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:00

Anxiety and depression: Lifestyle influential in MACE prevention

Presented By

Dr Shady Abohashem, Massachusetts General Hospital, USA

Trial

Mass General Brigham Biobank

Conference

ACC 204

Type

Peer-reviewed article

16 May 2024 13:57

Self-expanding versus balloon-expendable TAVR in patients with small aortic annuli

Presented By

Prof. Howard Herrmann, Perelman School of Medicine, PA, USA

Trial

SMART

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:52

Safety of TAVI non-inferior to SAVR for patients with lower surgical risk

Presented By

Prof. Moritz Seiffert, BG University Hospital Bergmannsheil, Germany

Trial

DEDICATE-DZHK6

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:50

Interatrial shunt for HF: neutral primary endpoint but potential benefit in HFrEF

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

RELIEVE-HF

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:45

Peripheral artery disease: procedure-guidance by IVUS superior to angiography

Presented By

Prof. Young-Guk Ko, Severance Cardiovascular Hospital; Yonsei University, South Korea

Trial

IVUS-DCB

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:43

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ACC 2024

16 May 2024 13:43

IVUS-guided PCI beats angiography in patients with acute coronary syndrome

Presented By

Prof. Shao-Liang Chen, Nanjing Medical University, China

Trial

IVUS-ACS

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:40

Addressing frailty in patients undergoing TAVR

Presented By

Dr Jonathan Afilalo, McGill University, Canada

Trial

PERFORM-TAVR

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:36

ACS: Necessary DAPT after PCI may be shorter than currently advised

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

ULTIMATE-DAPT

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:29

AEGIS-II: ApoA-1 did not reduce MACE in patients with myocardial infarction but may provide benefit in patients with high LDL levels

Presented By

Prof. Michael Gibson, Harvard Medical School, MA, USA

Trial

Phase 3, AEGIS-II

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:26

REDUCE-AMI: Re-evaluating the role of routine beta-blockade in patients with acute myocardial infarction

Presented By

Dr Troels Yndigegn, Lund University, Sweden

Trial

Phase 4, REDUCE-AMI

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:23

STEP-HFpEF DM: Semaglutide beneficial in patients with HFpEF and diabetes

Presented By

Prof. Mikhail Kosiborod, Saint Luke's Mid America Heart Institute, MO, USA

Trial

Phase 3, STEP-HFpEF DM

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:20

IMPROVE-HCM: Promising results for ninerafaxstat in non-obstructive HCM

Presented By

Prof. Martin Maron, Lahey Hospital & Medical Center, MA, USA

Trial

Phase 2, IMPROVE-HCM

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:15

Meet the Trialist: The “Sweet Spot” from RELIEVE-HF

Expert

Prof.Gregg Stone

Trial

RELIEVE-HF

Conference

ACC 2024

15 May 2024 15:40

Prof. Nico Reinsch, Alfried-Krupp-Hospital Rüttenscheid, Germany

Conference

EHRA 2024

Type

News article

29 April 2024 15:50

CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia

Presented By

Dr Atul Verma, McGill University Health Centre, Canada

Trial

CryoCure-VT

Conference

EHRA 2024

Type

News article

29 April 2024 15:48

PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block

Presented By

Dr Henry Huang, Rush University Medical Center, USA

Trial

PIRECNA

Conference

EHRA 2024

Type

News article

29 April 2024 15:46

MRI head-to-head comparison of lesion quality following various ablation techniques

Presented By

Dr Till Althoff, University of Barcelona, Spain

Conference

EHRA 2024

Type

News article

Presented By

Federico Tancredi Magni, University Medical Center Groningen, the Netherlands

Conference

EHRA 2024

Type

News article

Presented By

Dr Jonas Wörmann, University of Cologne, Germany

Conference

EHRA 2024

Type

News article

29 April 2024 15:12

New atrial fibrillation associated with a high risk of major cardiovascular outcomes

Presented By

Dr Alexander Benz, Population Health Research Institute, Canada

Trial

COMPASS

Conference

EHRA 2024

Type

News article

29 April 2024 15:10

Matters of the heart: late-breaking news from the American College of Cardiology

Presented By

Dr Rachel Giles, Medicom

Trial

RELIEVE-HF; EMPACT-MI

Conference

ACC 2024

23 April 2024 14:11

Custom content article

Presented By

Jacob

Conference

ESC 2024

28 March 2024 16:40

Join the conversation on Rare Disease Awareness Day

Expert

Prof. Rachel Giles

26 February 2024 11:42

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ACC 2023

29 January 2024 15:44

Successful results for semaglutide in the highly anticipated SELECT trial

Presented By

Dr Michael Lincoff, Cleveland Clinic, USA

Trial

Phase 3, SELECT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:37

Can a walking intervention improve functional status and quality of life in HFrEF?

Presented By

Dr Tomas Vetrovsky, Charles University, Czechia

Trial

WATCHFUL

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:30

Head-to-head: Surgical embolectomy versus ultrasound-assisted thrombolysis in high-risk pulmonary embolism

Presented By

Dr Stefan Stortecky, University of Bern, Switzerland

Trial

Phase 2, SPECIAL

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:26

Abelacimab substantially lowers bleeding risk compared with rivaroxaban

Presented By

Dr Christian Ruff, Brigham and Women’s Hospital, USA

Trial

Phase 2, AZALEA-TIMI 71

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:22

Liraglutide may improve post-ablation outcomes in obese patients with AF

Presented By

Dr Jeffrey Goldberger, University of Miami, USA

Trial

Phase 4, LEAF

Conference

AHA 2023

Type

Peer-reviewed article

Presented By

Dr John Hummel, Ohio State University, USA

Trial

Jewel IDE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:04

Sudden cardiac death in athletes: incidence, causes, and trends over 20 years

Presented By

Dr Bradley Petek, Oregon Health and Science University, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:01

Encouraging data for lepodisiran as Lp(a) lowering therapy

Presented By

Dr Steven Nissen, Cleveland Clinic, USA

Trial

Phase 1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:38

Gene editing may change the treatment landscape of hypercholesterolaemia

Presented By

Dr Andrew Bellinger, Verve Therapeutics, USA

Trial

Phase 1, heart-1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:35

REPRIEVE: Mechanisms behind MACE reduction in HIV population on pitavastatin

Presented By

Dr Michael Lu, Massachusetts General Hospital, USA

Trial

Phase 3, REPRIEVE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:31

Recaticimab may offer a solution for uncontrolled hypercholesterolaemia

Presented By

Dr Xin Du, Beijing Anzhen Hospital, China

Trial

Phase 3, REMAIN-2

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:27

Edoxaban versus warfarin in chronic thromboembolic pulmonary hypertension

Presented By

Dr Kazuya Hosokawa, Kyushu University, Japan

Trial

Phase 3, KABUKI

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:09

Sodium intake and blood pressure: new insights

Presented By

Dr Deepak Gupta, Vanderbilt University Medical Centre, USA

Trial

CARDIA-SSBP

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:04

Intensive BP intervention reduces risk of dementia

Presented By

Dr Jiang He, Tulane University, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:01

Post-partum intervention lowers BP after hypertensive pregnancy

Presented By

Dr Jamie Kitt, University of Oxford, UK

Trial

POP-HT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:58

Biannual zilebesiran associated with substantial BP reductions

Presented By

Prof. George Bakris, University of Chicago, USA

Trial

Phase 2, KARDIA-1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:56

MINT: Liberal or restrictive transfusion strategy in MI with anaemia?

Presented By

Dr Jeffrey Carson, Rutgers University, NJ, USA

Trial

Phase 3, MINT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:52

ORBITA-2 confirms PCI effective for symptom relief in patients with stable angina

Presented By

Dr Christopher Rajkumar, Imperial College London, UK

Trial

ORBITA-2

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:48

Nicotinamide riboside shows promising trend for walking function in PAD

Presented By

Prof. Mary McDermott, Northwestern University, USA

Trial

Phase 2, NICE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:43

Pemafibrate reduces microvascular complications of PAD and T2D

Presented By

Dr Aruna Pradhan, Brigham and Women’s Hospital, USA

Trial

Phase 3, PROMINENT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:39

Dapagliflozin improves cardiometabolic outcomes in myocardial infarction

Presented By

Prof. Stefan James, Uppsala University, Sweden

Trial

Phase 3, DAPA-MI

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:33

Interview: Medicare’s first drug price negotiations: concerning?

Expert

Prof. Marc Bonaca, University of Colorado, USA

4 January 2024 15:06

Top 10 medical breakthroughs in 2023

Expert

Dr Alex McDonald (Board member, Physician’s Weekly) and Dr Rachel Giles (Medical Science Officer, Medicom Medical Publishers)

18 December 2023 15:29

AHA 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AHA 2023

28 November 2023 11:36

Traditional Chinese medicine successful in HFrEF

Presented By

Dr Xinli Li, First Affiliated Hospital of Nanjing Medical University, China

Trial

Phase 4, QUEST

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:09

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ACC 2023

30 October 2023 16:08

CRT upgrade benefits patients with HFrEF and an ICD

Presented By

Dr Béla Merkely, Semmelweis University, Hungary

Trial

BUDAPEST CRT Upgrade

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:08

Catheter ablation saves lives in end-stage HF with AF

Presented By

Prof. Christian Sohns, Heart and Diabetes Center NRW, Germany

Trial

CASTLE-HTx

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:07

Immediate or staged revascularisation in STEMI plus multivessel disease?

Presented By

Prof. Barbara Stähli, University of Zürich, Switzerland

Trial

MULTISTARS AMI

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:07

Lp(a) and cardiovascular events: which test is the best?

Presented By

Prof. Michael Szarek, University of Colorado, USA

Trial

Phase 3, ODYSSEY OUTCOMES

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:06

Meta-analysis: Does FCM improve clinical outcomes in HF?

Presented By

Prof. Piotr Ponikowski, Medical University Wroclaw, Poland

Trial

CONFIRM-HF; AFFIRM-AHF; HEART-FID

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:06

No benefit of extracorporeal life support in MI plus cardiogenic shock

Presented By

Prof. Holger Thiele, University of Leipzig, Germany

Trial

ECLS-SHOCK

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

HEART-FID: Is intravenous ferric carboxymaltose helpful in HFrEF with iron deficiency?

Presented By

Dr Robert Mentz, Duke University, USA

Trial

Phase 3, HEART-FID

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

Heart failure: the 2023 update

Presented By

Prof. Theresa McDonagh; Prof. Roy Stuart Gardner; Prof. Alexandre Mebazaa; Prof. Ewa Jankowska; Prof. Marianna Adamo

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

Should we use anticoagulation in AHRE to prevent stroke?

Presented By

Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany

Trial

Phase 3, NOAH-AFNET 6

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

Functional revascularisation outperforms culprit-only strategy in older MI patients

Presented By

Dr Simone Biscaglia, Ferrara University Hospital, Italy

Trial

FIRE

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:04

Minimising atrial pacing does not reduce the risk for AF in sinus node disease

Presented By

Dr Mads Brix Kronborg, Aarhus University, Denmark

Trial

DANPACE II

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:04

Results of FRAIL-AF trial suggest increased bleeding risk with DOACs

Presented By

Dr Linda Joosten, University Medical Center Utrecht, the Netherlands

Trial

FRAIL-AF

Conference

ESC 2023

30 October 2023 16:04

Natriuresis-guided diuretic therapy to facilitate decongestion in acute HF

Presented By

Dr Jozine ter Maaten, University of Groningen, the Netherlands

Trial

PUSH-AHF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:04

Guidelines for Acute Coronary Syndrome

Presented By

Prof. Borja Ibañez; Prof. Maria Rubini Gimene; Dr John Coughlan; Prof. Margret Leosdottir

Conference

ESC 2023

30 October 2023 16:04

ARAMIS: Can anakinra alleviate acute myocarditis?

Presented By

Prof. Mathieu Kerneis, Sorbonne University, France

Trial

ARAMIS

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

Can aspirin be omitted after PCI in patients with high bleeding risk?

Presented By

Dr Masahiro Natsuaki, Saga University, Japan

Trial

Phase 4, STOPDAPT-3

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

Guidelines for the management of cardiomyopathies

Presented By

Prof. Elena Arbelo; Dr Juan Pablo Kaski

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

DICTATE-AHF: Early dapagliflozin to manage acute HF

Presented By

Prof. Zachary Cox, Lipscomb University College of Pharmacy, USA

Trial

Phase 3, DICTATE-AHF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

The optimal duration of anticoagulation therapy in cancer patients with DVT

Presented By

Dr Yugo Yamashita, Kyoto University, Japan

Trial

ONCO DVT

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

Expedited transfer to a specialised centre does not improve cardiac arrest outcomes

Presented By

Dr Tiffany Patterson, King’s College London, UK

Trial

ARREST

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

Angiography vs OCT vs IVUS guidance for PCI: a network meta-analysis

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, USA

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

Cardiovascular disease and diabetes: new guidelines

Presented By

Prof. Emanuele Di Angelantonio; Prof. Nikolaus Marx; Dr Katharina Schuett; Prof. Dirk Müller-Wieland; Prof. Bianca Rocca

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

Does colchicine prevent perioperative AF and MINS?

Presented By

Dr David Conen, McMaster University, Canada

Trial

Phase 3, COP-AF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

DAPT or clopidogrel monotherapy after stenting in high-risk East-Asian patients?

Presented By

Prof. Yaling Han, General Hospital of Northern Theater Command, China

Trial

OPT-BIRISK

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

OCTOBER trial: OCT-guided PCI improves clinical outcomes in bifurcation lesions

Presented By

Dr Lene Nyhus Andreasen, Aarhus University, Denmark

Trial

OCTOBER

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

Acoramidis improves survival and functional status in ATTR-CM

Presented By

Prof. Julian Gillmore, University College London, UK

Trial

Phase 3, ATTRIbute-CM

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

STEP-HFpEF: Semaglutide safe and efficacious in HFpEF plus obesity

Presented By

Dr Mikhail Kosiborod, University of Missouri, USA

Trial

Phase 3, STEP-HFpEF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

Inorganic nitrate strongly reduces CIN in high-risk patients undergoing angiography

Presented By

Dr Dan Jones, Queen Mary University of London, UK

Trial

Phase 2, NITRATE-CIN

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

Diagnostic tool doubles cardiovascular diagnoses in patients with COPD or diabetes

Presented By

Dr Amy Groenewegen, University Medical Center Utrecht, the Netherlands

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

Guidelines for the management of endocarditis

Presented By

Dr Stefano Caselli; Prof. Nina Ajmone Marsan; Dr Emil Fosbøl

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

ESC 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

ESC 2023

11 September 2023 09:51

How to manage arterial thrombosis and thromboembolism in COVID-19?

Expert

Dr Gregory Lip, Liverpool Heart and Chest Hospital, UK

21 August 2023 15:12

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

HFA 2023

8 August 2023 16:34

Frequent co-existence of atrial fibrillation and obstructive sleep apnoea in stroke patients

Presented By

Dr Maria Rita Lo Monaco, Catholic University of the Sacred Heart, Italy

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 16:27

Protein-bound uremic toxins predict HF events and death in patients with CKD

Presented By

Dr Bert Zwaenepoel, Ghent University Hospital, Belgium

Conference

HFA 2023

8 August 2023 16:20

VOICE-COVID-II : Alexa successful in SARS-CoV-2 symptoms screening

Presented By

Prof. Abhinav Sharma, McGill University Health CentreMontreal, Canada

Trial

VOICE-COVID-II

Type

Peer-reviewed article

8 August 2023 16:10

HF patients with metabolic dysfunction at high risk to develop depressive symptoms

Presented By

Dr Adesegun Kuye, Kharkiv National Medical University, Ukraine

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 16:08

Standardised diuretic protocol significantly increases natriuresis in acute HF

Presented By

Dr Jeroen Dauw, AZ Sint-Lucas, Belgium

Trial

Phase 2, ENACT-HF

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 16:04

Low concentrations of VEGF-C: a negative prognostic factor

Presented By

Dr Gracjan Iwanek, Wroclaw Medical University, Poland

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 16:00

Patisiran benefits maintained over 18 months in patients with transthyretin amyloidosis

Presented By

Prof. Marianna Fontana, University College London, Royal Free Hospital, UK

Trial

Phase 3, APOLLO-B

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 15:57

Aficamten may lower symptom burden in non-obstructive hypertrophic cardiomyopathy

Presented By

Prof. Ahmad Masri, Oregon Health & Science University, OR, USA

Trial

REDWOOD-HCM

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 15:52

Sacubitril/valsartan reduces natriuretic peptides in HF patients with ejection fraction >40%

Presented By

Prof. Robert Mentz, Duke University Medical Center, NC, USA

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 15:39

Dr Niklas Dyrby Johansen, Herlev and Gentofte Hospital, University of Copenhagen, Denmark

Trial

NUDGE-FLU

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 15:08

Clinics on wheels – Bringing healthcare to patients in underserved communities

Expert

Dr Priya Sarin Gupta, Mass General Brigham, MA, USA

18 July 2023 11:28

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ACC 2023

8 June 2023 11:20

Sotatercept improves exercise capacity in patients with PAH

Presented By

Prof. Marius Hoeper, Hannover Medical School, Germany

Trial

Phase 3, STELLAR

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 17:10

Fixed-dose macitentan plus tadalafil superior to either agent alone in PAH

Presented By

Prof. Kelly Chin, UT Southwestern Medical Center, TX, USA

Trial

Phase 3, A DUE

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 17:08

Immediate complete revascularisation non-inferior to staged complete revascularisation

Presented By

Dr Roberto Diletti, Erasmus MC, the Netherlands

Trial

BIOVASC

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 17:02

RENOVATE-COMPLEX-PCI results support intravascular-guided PCI for complex lesions

Presented By

Prof. Joo-Yong Hahn, Sungkyunkwan University School of Medicine, South Korea

Trial

RENOVATE-COMPLEX-PCI

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 16:59

No need to restrict vigorous exercise in selected HCM patients?

Presented By

Prof. Rachel Lampert, Yale School of Medicine, CT, USA

Trial

LIVE-HCM

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:26

No difference in CV outcomes between PET or CMR and SPECT

Presented By

Prof. Lisa Mielniczuk, University of Ottawa, Canada

Trial

AIMY-HF

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:24

Benefits of MitraClip sustained to 5 years in COAPT trial

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

COAPT

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:18

Transcatheter repair for patients with tricuspid regurgitation

Presented By

Dr Paul Sorajja, Minneapolis Heart Institute, MI, USA

Trial

TRILUMINATE

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:16

Minimally invasive versus conventional sternotomy for mitral valve repair

Presented By

Dr Enoch Akowuah, James Cook University Hospital, UK

Trial

UK Mini Mitral

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:11

Durable benefits of TAVR versus surgical aortic valve replacement in aortic stenosis patients

Presented By

Prof. John Forrest, Yale Medicine, CT, USA

Trial

Evolut Low Risk

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:07

PCI not better than GDMT in severe ischaemic cardiomyopathy

Presented By

Prof. Divaka Perera, King's College London, UK

Trial

REVIVED-BCIS2

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:05

Anticoagulation in non-critically ill hospitalised COVID patients

Presented By

Prof. Valentín Fuster, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 4, FREEDOM COVID Anticoagulation

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 10:02

Statins associated with reduced heart dysfunction from anthracyclines

Presented By

Prof. Tomas Neilan, Massachusetts General Hospital, MA, USA

Trial

Phase 2, STOP-CA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:58

Multifaceted strategy improves prescription of therapies for diabetes and ASCVD

Presented By

Prof. Neha Pagidipati, Duke University Hospital, NC, USA

Trial

COORDINATE-Diabetes

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:55

Bempedoic acid benefits statin-intolerant patients at high cardiovascular risk

Presented By

Prof. Steven Nissen, Cleveland Clinic, OH, USA

Trial

Phase 3, CLEAR Outcomes

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:49

Evolocumab improves coronary plaque morphology in stable CAD

Presented By

Prof. Annapoorna Kini, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 4, YELLOW III

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:40

Inflammation stronger predictor of MACE than cholesterol levels

Presented By

Prof. Paul Ridker, Brigham and Women's Hospital, MA, USA

Trial

Phase 3, PROMINENT, REDUCE-IT, STRENGTH

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:36

Oral PCSK9 inhibitor significantly lowers LDL-C

Presented By

Prof. Christie Ballantyne, Baylor College of Medicine, TX, USA

Trial

Phase 2

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:30

Baxdrostat in patients with uncontrolled hypertension

Presented By

Dr Deepak Bhatt, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 2, HALO

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:27

Hormone therapy for gender dysphoria associated with increased CV risk

Presented By

Dr Ibrahim Ahmed, Mercy Catholic Medical Center, PA, USA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:24

Pulsed-field ablation appears safe and effective for atrial fibrillation

Presented By

Prof. Atul Verma, McGill University Health Centre, Canada

Trial

PULSED AF

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:19

Half-dose tenecteplase safe and effective for STEMI without timely PCI

Trial

Phase 4, STREAM-2

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:15

Key correlates of incident dementia identified in the MESA study

Presented By

Dr Mohammad Ostovaneh, Johns Hopkins Hospital, MD, USA

Trial

MESA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:03

EHRA 2023

Type

News article

3 May 2023 16:18

CEASE-AF meets primary endpoint in persistent AF

Presented By

Prof. Nicolas Doll, Georg-August University, Germany

Trial

CEASE-AF

Conference

EHRA 2023

Type

News article

3 May 2023 16:16

Promising results for Marshall Plan ablation strategy

Presented By

Dr Thomas Pambrun, Bordeaux University Hospital, France

Trial

PLAN-MARSHALL

Conference

EHRA 2023

Type

News article

Presented By

Ms Jiayi Huang, University of Hong Kong, Hong Kong

Conference

EHRA 2023

Type

News article

3 May 2023 15:33

ANTWERP score selects HF patients for AF ablation

Presented By

Dr Marco Bergonti, Cardiocentro Ticino Institute, Switzerland

Trial

ANTWOORD II

Conference

EHRA 2023

Type

News article

3 May 2023 15:29

Epicardial ablation successful in Brugada syndrome

Presented By

Prof. Carlo Pappone, Vita-Salute San Raffaele University, Italy

Conference

EHRA 2023

Type

News article

3 May 2023 15:22

Highly increased risk of arrhythmias after mechanical ventilation for COVID-19

Presented By

Dr Andreas Liliequist, Karolinska University Hospital, Sweden

Conference

EHRA 2023

Type

News article

3 May 2023 15:11

ACC 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AAC 2023

22 March 2023 14:30

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Top 14 Medical Innovations for 2022

Expert

Dr Alex McDonald (Board member, Physician’s Weekly) and Dr Rachel Giles (Medical Science Officer, Medicom Medical Publishers)

25 January 2023 02:33

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

AHA 2022

Presented By

Dr Jason Andrade, University of Montreal, Canada

Trial

PROGRESSIVE-AF

Conference

AHA 2022

11 January 2023 14:09

Doubling the dose of self-administered etripamil terminates PSVT

Presented By

Dr James Ip, Weill Cornell Medicine, NY, USA

Trial

Phase 3, RAPID

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 14:05

Digitally delivered cognitive behavioural therapy successful in type 2 diabetes

Presented By

Prof. Marc Bonaca, University of Colorado, CO, USA

Trial

Phase 3, BT-001

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 14:00

Empagliflozin reduces risk of kidney disease progression and CV events in patients with CKD

Presented By

Prof. David Preiss, University of Oxford, UK

Trial

Phase 3, EMPA-KIDNEY

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 13:56

RESPECT-EPA misses primary endpoint but hints towards improvements in CV outcomes by EPA

Presented By

Dr Hiroyuki Daida, Juntendo University, Japan

Trial

RESPECT-EPA

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 13:50

Pemafibrate fails to reduce cardiovascular events in diabetes but may benefit the liver

Presented By

Dr Aruna Pradhan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, PROMINENT

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 13:46

Olpasiran leads to dramatic reductions in Lp(a) concentrations

Presented By

Prof. Michelle O´Donoghue, Brigham and Women's Hospital, MA, USA

Trial

Phase 2, OCEAN(a)-DOSE

Conference

AHA 2023

Type

Peer-reviewed article

11 January 2023 12:50

Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged

Presented By

Dr Luke Laffin, Cleveland Clinic, OH, USA

Trial

SPORT

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 12:45

No sex differences in lipid-lowering effect and treatment benefit of PCSK9 inhibitors

Presented By

Dr Frederick Rivera, Lincoln Medical Center, NY, USA

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 12:40

‘No’ to routine use of rivaroxaban in outpatients with COVID-19

Presented By

Dr Gregory Piazza, Brigham and Women’s Hospital, MA, USA

Trial

PREVENT-HD

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 12:21

COVID-19 pandemic: Older adults and those affected by the delta variant experienced increased cardiovascular morbidity and mortality

Presented By

Dr Pratyaksh Srivastava, Cedars-Sinai Medical Center, CA

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 10:01

COVID-19 mRNA vaccination does not amplify risk of cardiovascular hospitalisation

Presented By

Dr Anthony Simone, Kaiser Permanente Los Angeles Medical Center, USA

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 09:57

Higher LDL-cholesterol levels linked to higher CVD mortality risk in the elderly

Presented By

Dr Zhen Zhou, University of Tasmania, Australia

Trial

ASPREE

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 09:53

AF: Moderate alcohol intake possibly associated with a reduced mortality risk

Presented By

Dr Alireza Oraii, Population Health Research Institute, Canada

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 09:50

Periodontitis: An independent risk factor for AF

Presented By

Prof. Shunsuke Miyauchi, Hiroshima University, Japan

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 09:46

VICTORION-INCEPTION: inclisiran immediately after ACS for secondary prevention

Presented By

Dr Jeffrey Anderson

Trial

Phase 3, VICTORION-INCEPTION

Conference

AHA 2022

15 December 2022 15:58

ORION-3: long-term inclisiran safe and feasible

Presented By

Prof. Kausik “Kosh” Ray, Imperial College London, UK

Trial

ORION-3

Conference

AHA 2022

15 December 2022 15:48

AHA 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AHA 2022

28 November 2022 13:03

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ESC 2022

27 October 2022 14:59

Old dogs, new tricks: Acetazolamide plus loop diuretics improves decongestion

Presented By

Prof. Wilfried Mullens, Hospital Oost-Limburg, Belgium

Trial

Phase 4, ADVOR

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:43

No effect of neprilysin inhibition on cognition

Presented By

Prof. John McMurray, University of Glasgow, UK

Trial

Phase 3, PERSPECTIVE

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:41

Dapagliflozin DELIVERs for HFmrEF/HFpEF

Presented By

Prof. Scott Solomon, Brigham and Women's Hospital, Harvard Medical School, MA, USA

Trial

Phase 3, DELIVER

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:35

Pooled analysis of DAPA-HF and DELIVER

Presented By

Prof. Pardeep Jhund, University of Glasgow, UK

Trial

Phase 3, DAPA-HF, DELIVER

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:33

Meta-analysis of DELIVER and EMPEROR-Preserved

Presented By

Dr Muthiah Vaduganathan, Brigham and Women's Hospital, Harvard Medical School, MA, USA

Trial

Phase 3, DELIVER, EMPEROR-Preserved

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:27

Rheumatic heart disease-associated AF: standard-of-care holds ground

Presented By

Prof. Ganesan Karthikeyan, All India Institute of Medical Sciences, India

Trial

Phase 3, INVICTUS

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:14

New anticoagulant safe and maybe effective: PACIFIC-AMI and PACIFIC-Stroke outcomes

Presented By

Prof. John Alexander, Duke University, NC, USA & Prof. Ashkan Shoamanesh, McMaster University, Canada

Trial

Phase 2, PACIFIC-AMI, PACIFIC-Stroke

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:02

AXIOMATIC-SSP: Reducing risk of ischaemic stroke with factor XIa inhibition?

Presented By

Dr Mukul Sharma, McMaster University, Canada

Trial

Phase 2, AXIOMATIC-SSP

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 13:59

Evolving evidence for P2Y12 inhibition in chronic coronary syndromes: PANTHER

Presented By

Prof. Marco Valgimigli, Cardiocentro Ticino Foundation, Switzerland

Trial

PANTHER

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 13:55

Danish study suggests starting CVD screening before age 70

Presented By

Prof. Axel Cosmus Pyndt Diederichsen, Odense University Hospital, Denmark

Trial

DANCAVAS

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:59

Polypill SECUREs win in secondary prevention in elderly

Presented By

Dr Valentin Fuster, Mount Sinai Health System, NY, USA

Trial

Phase 3, SECURE

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:56

Long-term therapy with evolocumab associated with lower CV mortality

Presented By

Prof. Michelle O'Donoghue, Brigham and Women's Hospital, MA, USA

Trial

FOURIER

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:54

ARBs + beta-blockers may delay Marfan syndrome aortic root replacement

Presented By

Dr Alex Pitcher, Oxford University Hospitals NHS Foundation Trust, UK

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:52

ENTRIGUE: Subcutaneous pegozafermin in severe hypertriglyceridaemia

Presented By

Prof. Deepak Bhatt, Harvard Medical School, MA, USA

Trial

Phase 2, ENTRIGUE

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:49

First RCT evidence for use of AI in daily practice

Presented By

Dr David Ouyang, Cedars-Sinai Smidt Heart Institute, CA, USA

Trial

EchoNet-RCT

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:40

AI-enhanced echography supports aortic stenosis patients

Presented By

Prof. Geoffrey Strange, University of Notre Dame, Australia

Trial

AI-ENHANCED AS

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:38

Smartphones for AF detection

Presented By

Prof. Axel Bauer, Innsbruck Medical University, Austria

Trial

eBRAVE-AF

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:25

Medical therapy versus PCI for ischaemic cardiomyopathy

Presented By

Prof. Divaka Perera, Guy's & St Thomas' NHS Foundation Trust, London, UK

Trial

REVIVED-BCIS2

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:16

Allopurinol disappoints in ALL-HEART

Presented By

Prof. Isla Shelagh Mackenzie, University of Dundee, UK

Trial

ALL-HEART

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:13

Conservative or invasive management for high-risk kidney disease patients with ischaemia?

Presented By

Prof. Sripal Bangalore, New York University School of Medicine, NY, USA

Trial

Phase 4, ISCHEMIA-CKD EXTEND

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:10

Genotype-guided antiplatelet therapy in patients receiving PCI

Presented By

Dr Brenden Ingraham, Mayo Clinic, MN, USA

Trial

Phase 4, TAILOR-PCI

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 12:06

Prevention of VT and sudden cardiac death: the new recommendations

Presented By

Prof. Katja Zeppenfeld, Leiden University Medical Center, the Netherlands & Prof. Jacob Tfelt-Hansen, Copenhagen University Hospital, Denmark

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 11:56

New and first ESC cardio-oncology guideline

Presented By

Dr Teresa López-Fernández, La Paz University Hospital, Spain & Dr Alexander Lyon, Royal Brompton Hospital, London, UK

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 11:54

The 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension

Presented By

Prof. Stephan Rosenkranz, Heart Center at the University Cologne, Germany & Prof. Marion Delcroix, University Hospitals Leuven, Belgium

Type

Peer-reviewed article

Presented By

Prof. Morten Bøttcher, Aarhus University, Denmark

Trial

DanNICAD-2

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 10:38

High-dose influenza vaccine: mortality benefit?

Presented By

Dr Niklas Dyrby Johansen, Herlev and Gentofte Hospital, Denmark

Trial

Phase 2, DANFLU-1

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 10:30

FFR-guided decision-making in patients with AMI and multivessel disease

Presented By

Dr Joo-Yong Hahn, Samsung Medical Center, Seoul, South Korea

Trial

FRAME-AMI

Conference

Journal

JCI Insight

26 August 2022 02:21

Causal link between haematopoietic loss of Y chromosome and cardiac disease unravelled

Expert

Dr Soichi Sano, University of Virginia School of Medicine, Charlottesville, VA

Presented By

Prof. Adriaan Voors , University of Groningen, the Netherlands

Trial

Phase 2, SERENADE

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:49

Ghrelin improves cardiac output in HFrEF

Presented By

Prof. Lars Lund, Karolinska Institutet, Sweden

Trial

Phase 2, MetaAnEnd-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:47

Combination of filgrastim and dutogliptin appears safe in STEMI

Presented By

Prof. Markus Wallner , Medical University of Graz, Austria

Trial

Phase 2

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:44

Cardiac contractility modulation therapy promising for patients with HFpEF

Presented By

Prof. Cecilia Linde , Karolinska University Hospital, Sweden

Trial

CCM-HFpEF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:37

REBALANCE-HF: Encouraging observations for splanchnic nerve ablation in HFpEF

Presented By

Prof. Marat Fudim , Duke Cardiology Clinic, NC, USA

Trial

REBALANCE-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:34

DAPA-HF: Dapagliflozin is safe and efficacious in frail patients

Presented By

Dr Jawad Haider Butt , Copenhagen University Hospital, Denmark

Trial

Phase 3, DAPA-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:29

EMPEROR-Preserved: Empagliflozin stable across age groups

Presented By

Prof. Michael Böhm , University of the Saarland, Germany

Trial

Phase 3, EMPEROR-Preserved

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:26

EMPULSE: Empagliflozin delivers rapid and clinically meaningful decongestion

Presented By

Prof. Piotr Ponikowski , Medical University of Wroclaw, Poland

Trial

Phase 3, EMPULSE

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:23

Dapagliflozin performs consistently across LVEF in HF

Presented By

Dr Mikhail Kosiborod , St. Luke’s Hospital, MO, USA

Trial

Phase 4, DEFINE-HF, PRESERVED-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:21

Cardiac wasting relevant for clinical outcomes in cancer

Presented By

Dr Alessia Lena , Charité Universitätsmedizin Berlin, Germany

Conference

HFA 2022

Type

Peer-reviewed article

15 June 2022 15:34

POISE-3: Tranexamic acid for non-cardiac surgery

Presented By

Prof. Philip Devereaux; Dr Maura Marcucci, McMaster University, Canada

Trial

Phase 3, POISE-3

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:34

Treating chronic mild hypertension during pregnancy leads to better outcomes

Presented By

Prof. Alan Tita, University of Alabama, USA

Trial

CHAP

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:28

New VOYAGER PAD data: Should patients with both PAD and CKD get rivaroxaban?

Presented By

Dr Mark Svet, University of Colorado, USA

Trial

VOYAGER-PAD

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:24

Alirocumab significantly reduces high-risk coronary plaques

Presented By

Prof. Lorenz Räber, Bern University Hospital, Switzerland

Trial

Phase 3, PACMAN-AMI

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:20

Aggressive warming during non-cardiac surgery does not improve outcomes

Presented By

Prof. Daniel Sessler, Cleveland Clinic, USA

Trial

PROTECT

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:15

DIAMOND trial: Patiromer lowers risk of severe hyperkalaemia

Presented By

Prof. Javed Butler, University of Mississippi, MS, USA

Trial

Phase 3, DIAMOND

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:12

Replacing septal reduction therapy with mavacamten for HCM

Presented By

Prof. Milind Desai, Cleveland Clinic, USA

Trial

Phase 3, VALOR-HCM

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:08

Surprise outcome for SODIUM-HF

Presented By

Prof. Justin Ezekowitz, University of Alberta, Canada

Trial

Phase 3, SODIUM-HF

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:03

Sotagliflozin SCORED MACE benefit

Presented By

Prof. Deepak Bhatt, Brigham and Women's Hospital, USA

Trial

Phase 3, SCORED

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:57

Omecamtiv mecarbil does not impact exercise capacity of patients with HFrEF

Presented By

Prof. Michael Felker, Duke Clinical Research Institute, USA

Trial

Phase 3, METEORIC-HF

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:50

Symptomatic obstructive hypertrophic cardiomyopathy: long-term mavacamten control

Presented By

Prof. Florian Rader, Cedars-Sinai Medical Center, CA, USA

Trial

MALVA-LTE

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:47

COMPLETE revascularisation improves angina-related QoL

Presented By

Prof. Shamir Mehta, McMaster University, Canada

Trial

COMPLETE

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:24

Plot twist for negative FAME 3 results: early QoL benefits of PCI

Presented By

Dr Frederik Zimmermann, Catharina Hospital, the Netherlands

Trial

FAME 3

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:19

1-year CLASP TR results support tricuspid regurgitation repair

Presented By

Prof. Adam Greenbaum, Emory University School of Medicine, USA

Trial

CLASP TR

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:14

Head-to-head: post-TAVR edoxaban not better than DAPT

Presented By

Prof. Duk-Woo Park, Asan Medical Center, Korea

Trial

Phase 4, ADAPT-TAVR

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:09

Chocolate Touch vs Lutonix catheters

Presented By

Prof. Mehdi Shishehbor, Harrington Heart & Vascular Institute, USA

Trial

Chocolate Touch

Conference

ACC 2021

Type

Peer-reviewed article

15 June 2022 13:53

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By

Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea

Trial

FLAVOUR

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:49

Low-resource countries benefit from global STEMI initiative

Presented By

Prof. Cesar Herrera, Montefiore-Einstein Center for Heart and Vascular Care, USA

Trial

GHATI

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:44

Sodium thiosulfate ineffective at cardiac protection

Presented By

Dr Marie-Sophie de Koning, University Medical Center Groningen, the Netherlands

Trial

Phase 2, GIPS-IV

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:40

ICM-guided management did not improve MACE after MI

Presented By

Prof. Christian Jøns, Rigshospitalet, Denmark

Trial

BIO|GUARD-MI

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:36

PACIFIC-AF: Low bleeding rates for asundexian in atrial fibrillation

Presented By

Prof. Manesh Patel, Duke University School of Medicine, USA

Trial

Phase 2, PACIFIC-AF

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:31

RCT-IVVE trial: Do HF patients benefit from annual flu shots?

Presented By

Prof. Mark Loeb, McMaster University, Canada

Trial

Phase 4, RCT-IVVE

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:26

TRANSLATE-TIMI 70: Primary endpoint met but safety concerns for vupanorsen

Presented By

Dr Brian Bergmark, Brigham and Women’s Hospital, USA

Trial

Phase 2, TRANSLATE-TIMI 70

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:21

Lipoprotein(a) slashed by 98% in APOLLO trial

Presented By

Prof. Steven Nissen, Cleveland Clinic, USA

Trial

Phase 1, APOLLO

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:16

Dietary intervention from your supermarket

Presented By

Prof. Dylan Steen, University of Cincinnati, OH, USA

Trial

SuperWIN

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:05

HFA 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

HFA 2022

13 June 2022 21:56

Appropriate use of dose-adjusted and low-intensity DOACs defined, urged

Journal

JAMA Cardiology

9 June 2022 22:46

Adding PCSK9 inhibitor to rosuvastatin after acute MI improves coronary plaque reduction

Journal

08/06/2022

8 June 2022 18:05

Biodegradable, wireless device shows promise for temporary heart monitoring and control

Journal

Science

7 June 2022 19:16

Aortic stiffness a modifiable risk factor for dementia?

Journal

JAMA Neurology

7 June 2022 16:15

Letter from the Editor

Editor

Prof. Michiel Rienstra, University Medical Center Groningen, the Netherlands

Conference

EHRA 2022

1 June 2022 11:27

Benefits of SGLT2 inhibitors may extend beyond HF-associated outcomes

Presented By

Dr Ameenathul Fawzy, Liverpool Heart and Chest Hospital, UK

Conference

EHRA 2022

Type

Peer-reviewed article

Presented By

Dr Vivek Reddy, Mount Sinai Hospital, NY, USA

Trial

MANIFEST-PF

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 10:30

VANISH: Ablation reduces shock burden compared with anti-arrhythmic drug in ventricular tachycardia

Presented By

Prof. Michelle Samuel, University of Montreal, Canada

Trial

VANISH

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 10:26

Low AF recurrence rates after PVI using pulsed-field ablation

Presented By

Mr Thomas Kueffer, University of Bern, Switzerland

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 10:19

Pulsed-field ablation reduces neurocardiac damage versus cryoballoon ablation

Presented By

Dr Marc Lemoine, University Heart & Vascular Center Hamburg, Germany

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 10:15

Dr Frederik Dalgaard, Herlev and Gentofte Hospital, Denmark

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:52

RESET: No survival benefit of CRT-defibrillator over CRT-pacemaker in heart failure

Presented By

Prof. Nikolaos Dagres, Heart Center Leipzig, Germany

Trial

RESET-CRT

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:46

Insertable cardiac monitors effective for AF detection in cryptogenic stroke

Presented By

Dr Barbara Ratajczak-Tretel, University of Oslo, Norway

Trial

NOR-FIB

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:30

Cardiac magnetic resonance imaging improves prediction of post-MI sudden cardiac death

Presented By

Dr Nikolaos Dagres, Heart Center Leipzig, Germany

Trial

PROFID

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:18

AI model accurately predicts sudden cardiac death in overall population

Presented By

Prof. Xavier Jouven, Georges-Pompidou European Hospital, France

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:12

Developments in imaging tools for AF

Presented By

Prof. Lluis Mont , University of Barcelona, Spain

Conference

EHRA 2022

Type

Peer-reviewed article

31 May 2022 22:17

Large impact of remote screening tool on sleep apnoea diagnoses in AF

Presented By

Dr Dominique Verhaert, Maastricht University Medical Center, Netherlands

Conference

EHRA 2022

Type

Peer-reviewed article

31 May 2022 22:08

AI model accurately discriminates between arrhythmias

Presented By

Dr Arunashis Sau, Imperial College London, UK

Conference

EHRA 2022

Type

Peer-reviewed article

31 May 2022 22:01

Impact of AF screening on stroke prevention influenced by systolic blood pressure

Presented By

Dr Lucas Yixi Xing, Copenhagen University Hospital, Denmark

Conference

EHRA 2022

Journal

Journal of the American College of Cardiology

13 May 2022 20:18

Genetic testing for early-onset AF yields important prognostic information

12 May 2022 15:32

Lung function impairment tied to increased risk of heart failure

Journal

European Heart Journal

11 May 2022 22:02

DOACs safe, effective for A-fib patients with newly diagnosed cancer

Conference

ACC 2022

11 May 2022 19:38

E-cigarettes do not appear to confer heart benefits to users who also smoke traditional cigarettes

Journal

Circulation

11 May 2022 15:33

Race, sex affect NT-proBNP levels when assessing heart failure risk

Journal

JAMA Cardiology

3 May 2022 23:41

FDA approves Bristol Myers’ oral heart disease drug

29 April 2022 15:23

Pendulum swings further away from aspirin for CVD primary prevention

Journal

JAMA

26 April 2022 17:35

Frailty no bar to dapagliflozin in heart-failure patients

Journal

Annals of Internal Medicine

26 April 2022 17:33

Calcium supplements linked to harm in people with aortic stenosis

Journal

Heart

26 April 2022 00:30

Text-based gamification boosts physical activity in hypertensive postpartum women

Journal

JAMA Cardiology

25 April 2022 16:12

ACS patients with several metabolic risk factors may benefit most from PCSK9 inhibitors

Journal

The Lancet Diabetes & Endocrinology

20 April 2022 15:43

ACC 2022 Highlights Podcast

Presented By

Dr Rachel Giles

Journal

Medicom

Dapagliflozin improves stroke volume in patients with HFrEF

Expert

Dr Rohan Madhu Prasad, Michigan State University, USA

Conference

AHA 2021

4 February 2022 00:09

Afbeelding met persoon, muur, vrouw, binnen Automatisch gegenereerde beschrijving

Shortcomings and solutions for the management of young patients with hypercholesterolemia

Expert

Dr Shauna Newton, Massachusetts General Hospital, Boston, MA, USA

Conference

AHA 2021

4 February 2022 00:04

Afbeelding met persoon, person, muur, stropdas Automatisch gegenereerde beschrijving

The scope of remote healthcare in hypertension and hyperlipidaemia

Expert

Dr Alexander Blood, Brigham and Women’s Hospital, Massachusetts

Conference

AHA 2021

3 February 2022 23:38

VTE readmission risk extends beyond 30 days after complex cancer surgery

Journal

JAMA Surgery

3 February 2022 23:29

Reduction in atrial arrhythmias in patients with CIED on SGLT2 inhibitors

Expert

Prof. Ilan Goldenberg, University of Rochester, NY, USA

Trial

DAPA-HF

Conference

AHA 2021

3 February 2022 23:10

Inclisiran Lowers Cholesterol Across All BMI groups

Expert

Dr Lawrence A. Leiter, Clinical Nutrition and Risk Factor Modification Centre

Conference

AHA 2021

3 February 2022 08:52

AHA: Biomarker highly predictive of dapagliflozin response in HFrEF

Expert

David Berg, Brigham and Women's Hospital, Harvard Medical School, Boston

Trial

DAPA-HF

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

AHA 2021

18 January 2022 09:15

Vaccine-like mRNA injection effectively treats cardiac fibrosis in mice

Journal

Science

17 January 2022 18:55

Transcatheter pulmonary-valve replacement, surgery appear to have comparable outcomes

Journal

JACC

14 January 2022 17:53

2021 Guideline for Chest Pain: Top 10 takeaways

Presented By

Prof. Martha Gulati, University of Arizona, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:55

Accurate ejection fraction assessment in paediatric patients via artificial intelligence

Presented By

Dr Charitha Reddy, Stanford Children’s Health, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:49

Concomitant tricuspid annuloplasty reduces treatment failure in moderate tricuspid regurgitation

Presented By

Prof. James Gammie, University of Maryland, USA

Conference

AHA 2021

Type

Peer-reviewed article

Presented By

Prof. Biykem Bozkurt, Baylor College of Medicine Houston, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:24

Long-term reduced risk of CV events with ticagrelor plus aspirin after CABG

Presented By

Dr Qiang Zhao, Shanghai Jiao Tong University, China

Trial

DACAB-FE

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:17

Early surgery outperforms conservative management in asymptomatic severe aortic stenosis

Presented By

Prof. Marko Banovic, University Clinical Centre of Serbia, Serbia

Trial

AVATAR

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:11

External support device for SVG grafts in CABG surgery shows promise

Presented By

Prof. John Puskas, Mount Sinai Hospital, Israel

Trial

VEST Pivotal

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:04

Rivaroxaban regimen beneficial after revascularisation for claudication

Presented By

Prof. Marc Bonaca, University of Colorado, USA

Trial

VOYAGER PAD

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:57

LIBERTY 360 shows quality-of-life improvements after peripheral vascular intervention

Presented By

Dr Mohsin Chowdhury, Harvard Medical School, USA

Trial

LIBERTY 360

Conference

AHA 2021

Type

Peer-reviewed article

Presented By

Dr Alfredo Ricchiuto, Università Cattolica del Sacro Cuore, Italy

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:26

Empagliflozin efficacious in HF patients with preserved ejection fractions ≥50%

Presented By

Dr Stefan Anker, Charité University Berlin, Germany

Trial

EMPEROR-Preserved

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:15

EMPULSE: Empagliflozin improves outcomes of acute heart failure

Presented By

Prof. Adriaan Voors, University of Groningen, the Netherlands

Trial

Phase 3, EMPULSE

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:03

CHIEF-HF: Canagliflozin improves health status in heart failure

Presented By

Prof. John Spertus, University of Missouri-Kansas City, USA

Trial

Phase 3, CHIEF-HF

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:59

DREAM-HF: MPC therapy for HFrEF did not meet primary endpoint

Presented By

Dr Emerson Perin, Texas Heart Institute, US

Trial

Phase 3, DREAM-HF

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:52

Therapeutic approaches in heart failure with diabetes

Presented By

Prof. Lynne Stevenson, Vanderbilt University Medical Center, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:48

Remote healthcare programme improves hypertension and lipid control

Presented By

Dr Alexander Blood, Brigham and Women’s Hospital, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:19

Dr Yujiro Yokoyama, St. Luke’s University Health Network, USA

Conference

AHA 2021

Type

Peer-reviewed article

Presented By

Dr David Wilber, Loyola University Chicago, USA

Trial

aMAZE

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 12:59

Equal benefits of early rhythm control in AF subtypes

Presented By

Dr Andreas Goette, St. Vincenz Hospital Paderborn, Germany

Trial

EAST-AFNET 4

Conference

AHA 2021

Journal

JACC: Clinical Electrophysiology

3 December 2021 11:33

Extracoronary vascular events likely rare after spontaneous coronary artery dissection

Journal

JAMA Cardiology,

2 December 2021 11:30

AHA 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2021

30 November 2021 23:20

No support for calcium administration during out-of-hospital cardiac arrest

Journal

JAMA

30 November 2021 11:26

The scope of remote healthcare in hypertension and hyperlipidaemia

Expert

Dr Alexander Blood, Brigham and Women’s Hospital, MA, USA

Journal

Physician’s Weekly

Conference

ESC 2021

26 October 2021 16:58

Breathing problems: the most frequently reported symptom before cardiac arrest

Presented By

Mr Filip Gnesin, Nordsjaellands Hospital, Denmark

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:54

Lay responders can improve survival in out-of-hospital cardiac arrest

Presented By

Dr Martin Jonsson, Karolinska Institute, Sweden

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:44

Rivaroxaban improves clinical outcomes in discharged COVID-19 patients

Presented By

Prof. Eduardo Ramacciotti, Santa Casa School of Medicine, Brasil

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:40

COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing

Presented By

Prof. Alex Spyropoulos, Northwell Health, USA

Trial

Phase 3, HEP-COVID

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:34

Long COVID symptoms – Is ongoing cardiac damage the culprit?

Presented By

Dr Betty Raman, University of Oxford, UK

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:27

VOYAGER PAD: Fragile or diabetic patients also benefit from rivaroxaban

Presented By

Prof. Cecilia Low Wang, University of Colorado, USA

Trial

VOYAGER PAD

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:24

NATURE-PCSK9: Vaccine-like strategy successful in lowering CV events

Presented By

Prof. Brian Ference, University of Cambridge, UK

Trial

NATURE-PCSK9

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:19

Polypill: A successful tool in primary prevention

Presented By

Prof. Philip Joseph, McMaster University, Canada

Trial

TIPS-3; HOPE-3; Polylran

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 15:58

Smartphone app improves BP control independent of age, sex, and BMI

Presented By

Prof. Kazuomi Kario, Jichi Medical University, Japan

Trial

HERB-DH1

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 15:51

QUARTET demonstrates that simplicity is key in BP control

Presented By

Prof. Clara Chow, University of Sydney, Australia

Trial

QUARTET

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 15:06

Salt substitutes: a successful strategy to improve blood pressure

Presented By

Prof. Yangfeng Wu, Peking University Clinical Research Institute, China

Trial

Phase 4, DECIDE-Salt

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 14:51

Valsartan seems to attenuate hypertrophic cardiomyopathy progression

Presented By

Prof. Carolyn Ho, Brigham and Women’s Hospital, USA

Trial

Phase 2, VANISH

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 14:41

Dapagliflozin reduces incidence of sudden death in HFrEF patients

Presented By

Dr James Curtain, University of Glasgow, Scotland

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 14:19

Empagliflozin: First drug with clear benefit in HFpEF patients

Presented By

Prof. Stefan Anker, Charité University Hospital, Germany

Trial

Phase 3, EMPEROR-Preserved

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 13:45

CardioMEMS: neutral outcome but possible benefit prior to COVID-19

Presented By

Prof. JoAnn Lindenfeld, Vanderbilt University Medical Center, USA

Trial

GUIDE-HF

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 13:36

Cardiac arrest without ST-elevation: instant angiogram does not improve mortality

Presented By

Prof. Steffen Desch, University Heart Center Lübeck, Germany

Trial

TOMAHAWK

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 13:32

Older hypertensive patients benefit from intensive blood pressure control

Presented By

Prof. Jun Cai, FuWai Hospital, China

Trial

STEP

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:45

Antagonising the mineralocorticoid receptor beneficial for patients with diabetes and CKD

Presented By

Prof. Bertram Pitt, University of Michigan School of Medicine, USA

Trial

Phase 3, FIGARO-DKD

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:40

2021 ESC Guidelines on Heart Failure

Presented By

Prof. Carolyn Lam, Duke-NUS Medical School, Singapore

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:34

2021 ESC/EACTS Guidelines on Valvular Heart Disease

Presented By

Dr Victoria Delgado, Leiden University Medical Center, the Netherlands

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:18

2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy

Presented By

Prof. Jean-Claude Deharo, Hospital La Timone of Marseille, France

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:05

2021 ESC Guidelines on Cardiovascular Disease Prevention

Presented By

Prof. Frank Visseren, Guidelines Task Force Chair

Conference

ESC 2021

ESC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

EMPEROR-Preserved, ENVISAGE-TAVI, TOMAHAWK, FIGARO-DKD, FIDELITY, STEP, GUIDE-HF

Journal

The Lancet

30 August 2021 16:12

EMPORER-Preserved: Interview with Prof. Stefan Anker

Principal Investigator

Prof. Stefan Anker

Trial

EMPEROR-Preserved

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

HFA 2021

20 August 2021 11:30

Delaying diabetes onset a target for heart-failure prevention

Journal

Journal of the American College of Cardiology: Heart Failure

19 August 2021 23:40

Iron substitution improves LVEF in intensively treated CRT patients with iron deficiency

Presented By

Dr Pieter Martens, Hospital Oost-Limburg, Belgium

Trial

Phase 4, IRON-CRT

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 16:10

Novel mineralocorticoid receptor antagonist effective irrespective of HF history

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

FIDELIO-DKD

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 16:05

Iron substitution in iron-deficient HF patients is highly cost-effective

Presented By

Prof. Phil McEwan, Swansea University, UK

Trial

AFFIRM-AHF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:59

Omecamtiv mecarbil might be less effective in patients with atrial fibrillation or flutter

Presented By

Prof. Scott Solomon, Brigham and Women’s Hospital, MA, USA

Trial

GALACTIC-HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:52

Vericiguat effective irrespective of atrial fibrillation status

Presented By

Prof. Piotr Ponikowski, Wrocław Medical University, Poland

Trial

VICTORIA

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:45

Baroreflex activation: a novel option to improve heart failure symptoms

Presented By

Prof. Andrew Coats, University of Warwick, UK

Trial

BEAT-HF; HOPE4HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:35

Beta-blocker withdrawal to enhance exercise capacity in heart failure?

Presented By

Prof. Julio Nuñez Villota, University Clinical Hospital of Valencia, Spain

Trial

Phase 4, PRESERVE-HR

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:29

Inconclusive results for dapagliflozin treatment in heart failure

Presented By

Prof. John McMurray, University of Glasgow, UK

Trial

DETERMINE-Reduced; DETERMINE-Preserved

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:23

Dr Nuno Melo, Centro Hospitalar e Universitário de São João, Portugal

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:53

Echocardiographic parameters linked to dementia diagnosis

Presented By

Dr Karol Nowak, Jagiellonian University Medical College, Poland

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:49

Telemedicine: Every light has its shadow

Presented By

Dr Arvind Singhal, Royal Brompton Hospital, UK

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:46

COVID-19-related HF: from systemic infection to cardiac inflammation

Presented By

Prof. Marco Metra, University of Brescia, Italy

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 10:19

Increased COVID-19 mortality in patients with cardiorenal comorbidity

Presented By

Dr Johan Bodegård

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 10:07

Myocardial infarction outcomes were significantly affected by the pandemic

Presented By

Dr Ayman Haq, Baylor University Medical Center, USA

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 10:03

Empagliflozin linked to lower cardiovascular risk and renal events in real-world study

Presented By

Prof. Leo Niskanen, University of Eastern Finland, Finland

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:43

Efficacy of dapagliflozin and empagliflozin not influenced by diabetes status

Presented By

Prof. Faiez Zannad, University of Lorraine, France

Trial

EMPEROR-Reduced; DAPA=HF; DAPA-CKD; EMPA-Kideney

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:39

TAPSE effective biomarker associated with high-risk of severe COVID-19

Presented By

Dr Neil Bodagh, King´s College Hospital NHS Foundation Trust, UK

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:38

COVID-19 in AF patients with HF: no higher mortality but longer hospital stay

Presented By

Prof. Bektaş Murat, Eskisehir Osmangazi University, Turkey

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:38

Biomarker panel predicts SGLT2 inhibitor response

Presented By

Dr Muthiah Vaduganathan, Brigham and Women´s Hospital, MA, USA

Trial

CANVAS

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:33

Psychoactive substances put young people at risk of cardiovascular disease

Presented By

Dr Vijay Chopra, Max Super Speciality Hospital Saket, India

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:28

Heart failure patients might be at an increased risk for head and neck cancer

Presented By

Dr Mark Luedde, Christians-Albrechts-University of Kiel, Germany

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:21

The challenge of improving the quality of life of heart failure patients

Presented By

Prof. Ileana L. Piña, Central Michigan University, USA

Trial

DAPA-HF; PROVE-HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:20

Trastuzumab associated with cardiotoxicity in breast cancer

Presented By

Dr Ana Filipa Cardoso, Hospital Senhora da Oliveira-Guimarães, Portugal

Conference

HFA 2021

HFA 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Dapagliflozin fails to show a significant protective effect in COVID-19

Presented By

Prof. Mikhail Kosiborod, Saint Luke’s Mid America Heart Institute, USA

Trial

DARE-19

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:46

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By

Dr Matthew Price, Scripps Clinic, USA

Trial

PROTECT AF, PREVAIL

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:31

PARADISE-MI: Sacubitril/valsartan not superior to ramipril in reducing HF events

Presented By

Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA

Trial

Phase 3, PARADISE-MI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:29

STRENGTH trial fails to demonstrate cardioprotective effect of omega-3 fatty acids

Presented By

Dr Steven Nissen, Cleveland Clinic, USA

Trial

STRENGTH, REDUCE-IT

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:25

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:24

Apixaban outcomes similar to current standard of care following TAVR

Presented By

Prof. Jean-Philippe Collet, Sorbonne Université, France

Trial

ATLANTIS

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:14

No difference in ischaemic risk or bleeding with low vs high-dose aspirin for secondary prevention: Lessons and questions from the ADAPTABLE trial

Presented By

Prof. William Schuyler Jones , Duke Clinical Research Institute, USA

Trial

ADAPTABLE

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:03

Etripamil nasal spray significantly improves PSVT-related symptoms

Presented By

Dr Bruce Stambler, Piedmont Heart Institute, USA

Trial

Phase 3, NODE-301

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:38

Similar outcomes with fractional flow reserve and angiography-guided revascularisation

Presented By

Dr Etienne Puymirat, Hôpital Européen Georges-Pompidou

Trial

FLOWER-MI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:30

Evinacumab lowers triglyceride levels in severe hypertriglyceridaemia

Presented By

Dr Robert Rosenson, Icahn School of Medicine at Mount Sinai, USA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:29

Rivaroxaban reduces total ischaemic events after peripheral artery revascularisation

Presented By

Dr Rupert Bauersachs, Klinikum Darmstadt, Germany

Trial

VOYAGER PAD

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:13

Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19

Presented By

Prof. Renato Lopes, Duke University Medical Center, USA

Trial

Coalition ACTION

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:02

Older adults with heart failure benefit from rehabilitation programme

Presented By

Dr Dalane Kitzman , Wake Forest School of Medicine, NC, USA

Trial

REHAB-HF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 21:42

Ibrutinib tied to worsening blood pressure, hypertension

Journal

Heart

9 July 2021 21:36

Moderate hypothermia not superior to mild hypothermia following out-of-hospital cardiac arrest

Presented By

Dr Michel Le May , University of Ottawa, Canada

Trial

CAPITAL-CHILL

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 21:16

Quality improvement intervention fails to improve care for patients with heart failure

Presented By

Prof. Adam DeVore, Duke University School of Medicine, USA

Trial

CONNECT-HF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 20:54

TALOS-AMI: Exploring outcomes after switching to clopidogrel versus ticagrelor at 1 month from MI

Presented By

Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea

Trial

TALOS-AMI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 20:46

Prasugrel better than ticagrelor in ACS patients undergoing PCI

Journal

JAMA Cardiology

9 July 2021 20:00

Clopidogrel monotherapy associated with better net outcomes relative to aspirin monotherapy 6-18 months after PCI

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-EXAM

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 19:52

Sacubitril/valsartan does not reduce NT-proBNP versus valsartan alone in HFrEF

Presented By

Prof. Douglas Mann, Washington School of Medicine, USA

Trial

Phase 4, LIFE

Conference

ACC 2021

9 July 2021 19:02

Preliminary results encouraging for EVOQUE tricuspid valve replacement

Presented By

Dr Susheel Kodali , Columbia University Medical Center, USA

Trial

TRISCEND

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 18:18

Novel use of ivabradine in reversible cardiomyopathy

Presented By

Dr Eric Torkildsen, Lehigh Valley Health Network, USA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 18:15

Atorvastatin does not reduce mortality in COVID-19

Presented By

Dr Behnood Bikdeli, Yale University School of Medicine, USA

Trial

INSPIRATION

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 18:08

Health equity and the role of the cardiologist: 7 priorities to consider

Presented By

Prof. Michelle Albert, University of California, USA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 17:39

Ablation-based rhythm control as effective as rate control in AF and HF

Presented By

Prof. Anthony Tang, University of Ottawa, Canada

Trial

RAFT-AF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 14:41

Finerenone reduces the risk of AF onset in patients with CKD and diabetes

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 13:46

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Presented By

Dr Gregg Stone, Mount Sinai Medical Centre, USA

Trial

ISCHEMIA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 10:20

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

ACC 2021

9 July 2021 10:00

Interview with ACC President Dr Dipti Itchhaporia

Expert

Dr Dipti Itchhaporia

Presented By

Dr Luca Segreti, Azienda Ospedaliero, Universitaria Pisana, Italy

Trial

CHARISMA

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 14:17

Personalised pulmonary vein isolation procedure feasible and effective

Presented By

Dr Cheryl Terés, Teknon Medical Centre, Spain

Trial

Ablate-by-LAW

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 14:11

Pulmonary vein isolation: cryoballoon non-inferior to radiofrequency ablation

Presented By

Dr Bastian Kaiser, Robert-Bosch-Hospital Bad Cannstatt, Germany

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 13:21

Pulmonary vein isolation lesions plus personalised methods shows promising results

Conference

EHRA 2021

Type

Peer-reviewed article

Journal

JAMA Neurology

15 June 2021 23:30

2021 EHRA practical guide: DOACs in pre-operative and bleeding patients

Presented By

Prof. Thomas Vanassche, University Hospitals Leuven, Belgium

Conference

EHRA 2021

ACC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Presented By

Dr Jason Cottrell, Ohio Health Riverside Methodist Hospital, USA

Conference

ACC 2021

19 May 2021 10:25

Atorvastatin does not reduce mortality in COVID-19

Presented By

Dr Behnood Bikdeli, Brigham and Women’s Hospital, USA

Trial

INSPIRATION

Conference

ACC 2021

19 May 2021 10:23

Therapeutic anticoagulation inferior to prophylactic anticoagulation in COVID-19

Presented By

Prof. Renato Lopes, Duke University, USA

Trial

ACTION

Conference

ACC 2021

19 May 2021 10:22

Moderate hypothermia not superior to mild hypothermia following out-of-hospital heart attack

Presented By

Dr Michel Le May, University of Ottawa, USA

Trial

CAPITAL CHILL

Conference

ACC 2021

19 May 2021 10:19

Memory decline in older adults similar with CABG and PCI

Journal

JAMA

18 May 2021 23:08

No harm signal in new study on drug-coated devices for PAD treatment

Journal

JAMA Internal Medicine

18 May 2021 17:33

TALOS-AMI: Superior outcomes clopidogrel over ticagrelor following 1-month DAPT

Presented By

Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea

Trial

TALOS-AMI

Conference

ACC 2021

18 May 2021 11:51

Dapagliflozin fails to show a significant protective effect in COVID-19

Presented By

Prof. Mikhail Kosiborod, Saint Luke’s Mid America Heart Institute, USA

Trial

DARE-19

Conference

ACC 2021

18 May 2021 11:49

Rivaroxaban reduces total ischaemic events after peripheral artery revascularisation

Presented By

Dr Rupert Bauersachs, Klinikum Darmstadt, Germany

Trial

VOYAGER PAD

Conference

ACC 2021

18 May 2021 11:47

Similar outcomes fractional flow reserve and angiography-guided revascularisation

Presented By

Prof. Etienne Puymirat, University of Paris, France

Trial

FLOWER-MI

Conference

ACC 2021

18 May 2021 11:44

Clopidogrel superior to aspirin as monotherapy after DAPT in HOST-EXAM trial

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-EXAM

Presented By

Dr Jean-Phillippe Collet, Sorbonne Université, France

Trial

Phase 3, ATLANTIS

Conference

ACC 2021

17 May 2021 10:28

Sacubitril/valsartan does not lower risk of heart failure versus ramipril

Presented By

Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA

Trial

Phase 3, PARADISE-MI

Conference

ACC 2021

17 May 2021 10:25

Mavacamten emerges as a new therapy for hypertrophic cardiomyopathy

Presented By

Prof. John Spertus, St. Luke’s Mid America Heart Institute, USA

Trial

Phase 3, EXPLORER-HCM

17 May 2021 10:24

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

17 May 2021 10:22

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By

Dr Matthew Price, Scripps Clinic, California, USA

Journal

LAAO registry

Conference

ACC 2021

17 May 2021 10:20

Mavacamten significantly improves QoL of patients with hypertrophic cardiomyopathy

Presented By

Prof. John Spertus, Saint Luke’s Mid America Heart Institute, USA

Trial

Phase 3, EXPLORER-HCM

Conference

ACC 2021

Type

Peer-reviewed article

15 May 2021 22:34

Atypical MI symptoms tied to higher mortality, poorer emergency response

Journal

European Heart Journal - Acute Cardiovascular Care

13 May 2021 22:39

Drug candidate for pulmonary arterial hypertension identified

Journal

Science Translational Medicine

11 May 2021 22:08

High risk of repeat stroke in patients with symptomatic carotid web

Journal

JAMA Neurology

11 May 2021 22:04

EHRA 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Presented By

Prof. Salim Yusuf , Population Health Research Institute, Hamilton, Canada

Trial

TIPS-3

Journal

Physician’s Weekly

Conference

AHA Scientific Sessions 2020

15 April 2021 16:38

AHA2020: Inclisiran effective across age and genders for hyperlipidemia

Presented By

Dr. Kausik “Kosh” Ray, Imperial College London, UK

Trial

Phase 3, ORION-11

Journal

Physician’s Weekly

Conference

AHA 2020

15 April 2021 16:23

No age cap for lipid-lowering therapy

Presented By

Prof. Børge Nordestgaard, University of Copenhagen, Denmark

Journal

Physician’s Weekly

Conference

AHA Scientific Sessions 2020

15 April 2021 15:28

HDL anti-inflammatory capacity yields greater insight into heart-disease risk

Journal

Circulation

14 April 2021 16:47

PCSK9 inhibition as primary prevention for VTE: Is it LDL or Lp(a)?

Presented By

Dr Nicholas A. Marston, Women’s Hospital, Boston, USA

Trial

FOURIER, ODYSSEY OUTCOMES, JUPITER

Journal

Physician’s Weekly

Editor

Prof. Marc Bonaca, University of Colorado, USA

Journal

Journal of the American College of Cardiology

18 February 2021 21:49

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By

Dr Connie Hess; Prof. Judith Hsia

Trial

VOYAGER PAD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:45

Sotatercept: potential new treatment option for PAH

Presented By

Prof. Vallerie McLaughlin, University of Michigan, USA

Trial

Phase 2, PULSAR

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:37

Finerenone lowers CV events in diabetic CKD patients

Presented By

Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:33

Mavacamten effective in obstructive hypertrophic cardiomyopathy

Presented By

Dr Sheila Hegde, Brigham and Women’s Hospital, USA

Trial

Phase 3, EXPLORER-HCM

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:28

Children exposed to tobacco smoke have worse heart function as adults

Presented By

Dr Chigozie Ezegbe, University of Tasmania, Australia

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:25

Transgender people have unaddressed heart disease risks

Presented By

Dr Kara Denby, Cleveland Clinic, USA

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:23

Rilonacept reduces risk of pericarditis recurrence

Presented By

Dr Alan Klein, Cleveland Clinic, USA

Trial

Phase 3, RHAPSODY

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:18

Intensive blood pressure lowering benefits older adults

Presented By

Prof. William Cushman, University of Tennessee Health Science, USA

Trial

SPRINT

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:13

Dobutamine versus milrinone in cardiogenic shock

Trial

Capital Do-Re-Mi

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:10

Longer chest compression pause worsens outcomes after paediatric IHCA

Presented By

Dr Kasper Glerup Lauridsen, Aarhus University, Denmark

Conference

AHA 2020

Type

Peer-reviewed article

Presented By

Prof. John McMurray, University of Glasgow, Scotland

Trial

DAPA-CKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:18

“Strongly consider an SGLT2-inhibitor in most T2DM patients”

Presented By

Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

Phase 3, SOLOIST-WHF; SCORED

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:14

Additional HFrEF education and patient-engagement tools

Presented By

Prof. Larry Allen, University of Colorado School of Medicine, USA

Trial

EPIC-HF

Presented By

Dr Baris Gencer, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:54

No CV benefit from omega 3 in high-risk patients

Presented By

Prof. Michael Lincoff, Cleveland Clinic, USA

Trial

STRENGTH

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:44

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By

Prof. R. Scott Wright, Mayo Clinic, USA

Trial

Phase 3, ORION

Conference

AHA 2020

Type

Peer-reviewed article

Presented By

Prof. Ann Marie Navar, University of Texas Southwestern, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:22

Meta-analyses: ACEI/ARB and COVID-19

Presented By

Dr Yujiro Yokoyama, St. Luke's University Hospital

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:18

Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Presented By

Dr Zaniar Ghazizadeh, Brigham and Women’s Hospital, USA

Trial

Yale Cardiovascular COVID Registry

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 12:08

High-dose influenza vaccine in patients with CVD

Presented By

Prof. Orly Vardeny, University of Minnesota Medical School, USA

Trial

Phase 4, INVESTED

Conference

AHA 2020

Journal

The Lancet

Conference

AHA 2020

18 November 2020 22:18

AHA 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2020

18 November 2020 12:39

Silent heart disease common, easily identified with at-home questionnaire

Conference

AHA 2020

17 November 2020 18:25

Studies show cardiovascular benefit with sotagliflozin

Journal

New England Journal of Medicine

Conference

AHA 2020

Prof. Helmut Baumgartner, University Hospital Münster, Germany

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:46

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By

Dr Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, EMPEROR-Reduced trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:40

First-in-class cardiac myosin inhibitor effective in obstructive hypertrophic cardiomyopathy

Presented By

Prof. Iacopo Olivotto, Azienda Ospedaliera Universitaria Careggi, Italy

Trial

Phase 3, EXPLORER-HCM trial

Type

Peer-reviewed article

5 November 2020 13:37

Reduced cardiovascular outcomes with early rhythm control

Presented By

Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany

Trial

EAST-AFNET 4

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:35

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By

Prof. Roberto Ferrari, University of Ferrara, Italy

Trial

ATPCI trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:30

POPular TAVI: Aspirin-only antiplatelet strategy?

Presented By

Dr Jorn Brouwer, St Antonius Hospital, the Netherlands

Trial

POPular TAVI trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:28

Reduced NT-proBNP in HFpEF with sacubitril/valsartan

Presented By

Prof. Burkert Pieske, Charité University Medicine Berlin, Germany

Trial

Phase 3, PARALLAX study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:26

DAPA-CKD: Dapagliflozin improves CKD survival ± diabetes

Presented By

Prof. Hiddo Heerspink, University of Groningen, the Netherlands

Trial

DAPA-CKD trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:23

Low-dose colchicine reduces CV death and ischaemic events in coronary disease

Presented By

Dr Stefan Nidorf, Heart Care Western Australia, Australia

Trial

LoDoCo2 trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:19

Similar outcomes sPESI and HESTIA for pulmonary embolism triage

Presented By

Prof. Pierre-Marie Roy, University Hospital of Angers, France

Trial

HOME-PE trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:16

Antihypertensives also reduce CV risk in people with normal blood pressure

Presented By

Prof. Kazem Rahimi, University of Oxford, UK

Trial

BPLTTC study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:14

COVID-19: Continuing versus suspending ACE inhibitors and ARBs

Presented By

Prof. Renato Lopes, Duke University, USA

Trial

Phase 4, BRACE CORONA trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:10

Drug initiation strategy not associated with increased use of oral anticoagulants

Presented By

Prof. Sean Pokorney , Duke University, USA

Trial

IMPACT-AFib trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:07

Restrictive blood transfusion non-inferior and cost-effective strategy

Presented By

Prof. Philippe Gabriel Steg, University of Paris, Frane

Trial

REALITY trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:05

Increased mortality with colchicine in patients with ACS

Presented By

Prof. Jamie Layland , Monash University, Australia

Trial

COPS trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:00

Rivaroxaban protects limbs and ischaemic events in CAD-PAD patients

Presented By

Prof. William Hiatt, University of Colorado, USA

Trial

VOYAGER PAD trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:57

Antisense APOC3 oligonucleotide lowers triglyceride and atherogenic lipoproteins

Presented By

Prof. Jean-Claude Tardif, University of Montréal, Canada

Trial

Phase 2, AKCEA-APOCIII-LRx study

Conference

ESC 2020

Type

Peer-reviewed article

Presented By

Prof. Yutao Guo , Chinese PLA General Hospital, China

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:27

The Yale COVID-19 Cardiovascular Registry

Presented By

Dr Manan Pareek, Yale University School of Medicine, USA

Trial

Yale COVID-19 Cardiovascular Registry

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:24

COVID-19 treatments and the importance of randomised trials

Presented By

Prof. Martin Landray, University of Oxford, UK

Trial

RECOVERY

Conference

ESC 2020

8 September 2020 23:31

Letter from the Editor

Editor

Prof. Marc P. Bonaca, University of Colorado, USA

Conference

ISTH 2020

8 September 2020 17:04

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By

Dr Kira MacDougall, Staten Island University Hospital, USA

Trial

PAUSE

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:27

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By

Dr Farès Moustafa, CHU Clermont Ferrand, France

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:21

Physical rehabilitation improves health outcomes after pulmonary embolism

Presented By

Dr Stephan Nopp, Medical University Vienna, Austria

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:18

Guidelines adherence reduces bleeding risk after surgery and childbirth for VWD patients

Presented By

Dr Brian Craven, Royal Free London NHS Foundation Trust, United Kingdom

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:15

Factor V Leiden mutation linked to atrial fibrillation

Presented By

Erin Mathiesen Hald, UiT The Arctic University of Norway, Tromsø, Norway

Trial

Cohort study, Tromsø Study

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:08

Increased rates of arterial thromboembolism in cancer patients

Presented By

Dr Frits Mulder, Amsterdam UMC, University of Amsterdam, the Netherlands

Conference

ISTH 2020

Type

Peer-reviewed article

Presented By

Prof. Roberta Gualtierotti, University of Milan, Italy

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:21

TWILIGHT sub-study: complex PCI patients

Presented By

Prof. G. Dangas, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 15:20

COVID-19 associated with higher VTE rates relative to influenza

Presented By

Dr Milou Stals, Leiden University Medical Centre, the Netherlands

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Trial

Cohort study

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:15

LAAO Watchman registry data positive

Presented By

Prof. James V. Freeman, Yale University School of Medicine, USA

Conference

ACC 2020

8 September 2020 15:14

COVID-19 not associated with heightened VTE risk after discharge

Presented By

Dr Matthias Engelen, University Hospital Leuven, Belgium

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:09

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By

Prof. Renato D. Lopes, Duke University School of Medicine, USA

Trial

AUGUSTUS

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:59

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By

Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:53

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:41

Novel gene therapy leads to normal FIX activity levels in severe haemophilia B

Presented By

Dr Pratima Chowdary, Royal Free London NHS Foundation Trust, United Kingdom

Trial

Phase 1/2, B-AMAZE

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:31

Haemophilia gene therapy: progress and obstacles

Presented By

Prof. Amit Nathwani, University College London, United Kingdom

Trial

Review study

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:27

Recombinant factor VIII safe and effective in PUPs A-LONG study

Presented By

Dr Christoph Königs, University Hospital Frankfurt, Germany

Trial

Phase 3, PUPs A-LONG

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:22

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By

Prof. J. Alexander, Duke University, USA

Trial

AUGUSTUS

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 14:06

Homozygous FH responds to alirocumab

Presented By

Prof. D. Blom, University of Cape Town, South Africa

Trial

ODYSSEY HoFH

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 14:02

Evinacumab significantly reduces LDL-C in homozygous FH patients

Presented By

Dr F. Raal, University of the Witwatersrand, South Africa

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 13:51

Higher serum levels of eicosapentaenoic acid correlate with reduced CV events

Presented By

Dr D. Bhatt, Brigham and Women's Hospital, USA

Trial

REDUCE-IT EPA analysis

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 13:44

Quit smoking: vaping + counselling helps

Presented By

Prof. M.J. Eisenberg, McGill University, Canada

Trial

Conference

ACC 2020

Type

Peer-reviewed article

Presented By

Prof. M. Mack, Baylor Scott & White Heart Hospital, USA

Trial

PARTNER 3

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 12:58

Renal denervation better than sham for blood pressure

Presented By

Prof. M. Böhm, Saarland University Medical Center, Germany

Trial

SPYRAL PIVOTAL - SPYRAL HTN-OFF MED

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 12:54

Radial artery best for second bypass

Presented By

Prof. M. Gaudino, Weill Cornell Medicine, USA

Trial

RADIAL

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 12:50

PCI and CABG are equal in left main CAD

Presented By

Dr D.W. Park, Asan Medical School, South Korea

Trial

PRECOMBAT

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 12:45

Infusion of ethanol in the vein of Marshall for persistent AF

Presented By

Dr M. Valderrabano, Baylor College of Medicine, USA

Trial

VENUS

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 12:40

Letter from the Editor

Editor

Dr Marc Bonaca

7 September 2020 23:46

Rivaroxaban and aspirin effective and safe for PAD patients

Presented By

Prof. Marc Bonaca, University of Colorado, USA

Trial

VOYAGER PAD

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:19

Subgroup analysis VOYAGER PAD

Presented By

Prof. W. Hiatt, University of Colorado, USA

Trial

VOYAGER PAD

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:17

TAILOR-PCI misses endpoint but still provides valuable insights

Presented By

Prof. N. Pereira, Mayo Clinic, USA

Trial

TAILOR-PCI

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:16

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By

Dr G.R. Hong, Yonsei University College of Medicine, South Korea

Trial

ENAVLE

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:15

Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel

Presented By

Dr V. Nijenhuis, St. Antonius Hospital, the Netherlands

Trial

POPular-TAVI

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:14

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By

Prof. G. Agnelli, University of Perugia, Italy

Trial

Phase 3, CARAVAGGIO

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By

Prof. N. Rosencher, Paris Center University Hospital, France

Trial

PRONOMOS

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:07

ISTH 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ISTH 2020

7 September 2020 21:10

Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy

Presented By

Dr Carolyn Y. Ho, Brigham and Women's Hospital, USA

Trial

Phase 2, MAVERICK-HCM

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 17:57

Sacubitril-valsartan in hospitalized HF patients could have benefits

Journal

JAMA Cardiology

7 September 2020 17:53

Vericiguat shows beneficial effects in a very high-risk HF population

Presented By

Prof. Paul Armstrong, University of Alberta, Canada

Trial

Phase 3, Victoria

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 17:48

No role for sodium nitrite in out-of-hospital cardiac arrest

Presented By

Dr Francis Kim, University of Washington, USA

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 17:46

ACC.20/WCC Highlights Podcast Part 1 of 3

Presented By

Dr Rachel Giles, Medicom

Trial

VICTORIA trial, VOYAGER-PAD trial, TAILOR-PCI trial, PARTNER 3 trial, CARAVAGGIO trial

Conference

ACC 2020

5 September 2020 10:45

ACC.20/WCC Highlights Podcast Part 2 of 3

Presented By

Dr Rachel Giles, Medicom

Trial

REDUCE-IT EPA analysis, TAVR, STS/ACC TVT Registry, AUGUSTUS trial, VOYAGER PAD

Conference

ACC 2020

5 September 2020 10:29

ACC.20/WCC Highlights Podcast Part 3 of 3

Presented By

Dr Rachel Giles, Medicom

Trial

TICO trial, TWILIGHT-COMPLEX substudy, EXPAND trial, MAVERICK-HCM trial, REDUCE-IT EPA analysis

5 September 2020 10:22

ECG findings can help manage adults with congenital heart disease

Journal

JAMA Cardiology

4 September 2020 17:48

Aspirin alone best anti-clotting strategy after TAVI

Journal

New England Journal of Medicine

Conference

ESC 2020

4 September 2020 16:21

Elderly NSTEMI patients benefit from invasive treatment

Journal

The Lancet

3 September 2020 19:26

Heart-failure patients who have received flu and pneumonia shots have better outcomes

Conference

ESC 2020

3 September 2020 17:48

AF incidence up 3% annually in community-based study

Journal

JAMA Network Open

2 September 2020 18:36

Dr Eric Van Belle, CHU Lille, France

Trial

FRANCE-TAVI

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:30

DAPA-HF: Dapagliflozin also good for heart failure patients without diabetes, of any age, or any health status

Presented By

Prof. John J. McMurray & Prof. Felipe A. Martinez

Trial

Phase 3, DAPA-HF

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:16

ORION-9: Inclisiran RNAi halves LDL in familial hypercholesterolaemia patients

Presented By

Prof. Frederick Raal, University of the Witwatersrand, South Africa

Trial

Phase 3, ORION-9

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:00

Immediate coronary angiography after cardiac arrest does not improve survival

Presented By

Dr Jorrit Lemkes, Amsterdam University Medical Center, the Netherlands

Trial

COACT

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:00

Early apixaban safe as secondary prevention of stroke from AF

Presented By

Dr Arthur Labovitz, University of South Florida, USA

Trial

AREST

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 18:48

New RNAi therapies to reduce triglycerides: 2 studies show favourable results

Presented By

Prof. Christie Ballantyne & Prof. Gerald Watts

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 18:06

Complete revascularisation for obstructive non-culprit lesions with vulnerable plaque

Presented By

Dr Natalia Pinilla-Echeverri, McMaster University, Canada

Trial

COMPLETE

Conference

AHA 2019

Type

Peer-reviewed article

Presented By

Dr Sanket S. Dhruva, University of California, San Francisco, USA

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 15:06

Inclisiran safely halves LDL-Cholesterol

Presented By

Prof. R. Scott Wright, Mayo Clinic, Rochester, USA

Trial

ORION-10

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:51

Testosterone gel increases left ventricular mass

Presented By

Dr Elizabeth Hutchins, UCLA, USA

Trial

Testosterone Cardiovascular Trial

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:51

New guidelines on the prevention of cardiovascular conditions

Presented By

Prof. Roger S. Blumenthal, Johns Hopkins University, USA

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:36

RECOVERY: Benefit of early surgery in asymptomatic severe aortic stenosis

Presented By

Prof. Duk-Hyun Kang, Asan Medical Center, South Korea

Trial

RECOVERY

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:33

ISCHEMIA trial: Invasive treatment only better for angina burden

Presented By

Prof. Judith Hochman, New York University School of Medicine, USA

Trial

ISCHEMIA

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:17

Colchicine prevents cardiovascular events

Presented By

Prof. Jean-Claude Tardif, University of Montreal, Canada

Trial

COLCOT

Conference

AHA 2019

26 February 2020 13:56

Introduction to the AHA 2019 Conference Report

Conference

AHA 2019

Expert

Dr Konstantinos Koskinas, Bern University Hospital, Switzerland

Trial

EVOPACS

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 22:33

Early vasodilation in acute HF does not improve outcomes

Trial

GALACTIC

Conference

ESC 2019

Type

Peer-reviewed article

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 20:34

Complete revascularisation superior to culprit-lesion-only PCI

Trial

COMPLETE

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 19:37

Decreasing use of preventive medication a few years after CABG

Presented By

Dr Erik Bjoerklund, Gothenburg, Sweden

Trial

SWEDEHEART

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 19:35

Ticagrelor in diabetic patients reduces CV events but increases major bleeding

Expert

Dr Deepak Bhatt, Harvard Medical School, USA

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 18:38

Reduced doses rivaroxaban and apixaban may be beneficial to reduce renal impairment

Trial

RELOADED

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 18:37

Apixaban superior to VKAs for major bleeding, stroke/STE and all-cause mortality

Trial

NAXOS

Conference

ESC 2019

Type

Peer-reviewed article

Trial

ORION-11

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 15:41

Catheter ablation reduces all-cause mortality risk in AF-HF patients

Expert

Dr Michelle Samuel, McGill University Health Centre, Canada

Conference

ESC 2019

Type

Peer-reviewed article

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 12:46

Rivaroxaban monotherapy non-inferior to combination therapy in AF and stable CAD patients

Expert

Dr Satoshi Yasuda, National Cerebral and Cardiovascular Centre, Japan

Trial

AFIRE

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 12:29

Catheter ablation plays key role in 2019 ESC Guidelines on tachycardia

Expert

Prof. Josep Brugada

Conference

ESC 2019

Type

Peer-reviewed article

Trial

SYNTAX

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 07:51

PURE study: risk factors cardiovascular disease in low- and high-income countries

Expert

Dr Salim Yusuf

Trial

PURE

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 06:53

Similar MACE rates but higher all-cause mortality in PAD patients with diabetes

Trial

EXSCEL

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 16:45

Lower rates stroke/SE with DOACs in frail non-valvular AF patients

Presented By

Prof. Gregory Lip, University of Birmingham, United Kingdom

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 15:50

Similar rates of stroke/SE associated with DOAC vs warfarin use in obese non-valvular AF patients: Results from an observational registry

Presented By

Dr Steven Deitelzweig, Ochsner Health System, USA

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 14:55

TAVR superior and non-inferior to SAVR in low-risk patients

Trial

PARTNER 3, Evolut Low Risk

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 14:25

Convincing evidence of the role of icosapent in reducing subsequent CV events

Presented By

Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

REDUCE-IT

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 13:57

Immediate angiography not better than delayed angiography in non-STEMI cardiac arrest patients

Trial

COACT

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 13:29

Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications

Presented By

Dr Brian Yum, Weill Cornell Medicine, USA

Trial

Cohort study, REGARDS

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 13:07

Clopidogrel monotherapy after 1-month DAPT may be beneficial in stent patients

Trial

STOPDAPT-2

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 12:59

Ticagrelor monotherapy safe after dual antiplatelet therapy

Trial

GLASSY; GLOBAL LEADERS

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 12:34

Apixaban is safe and effective in real-world setting for treatment of venous thromboembolism

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 12:17

BNP still a reliable prognostic marker before and during sacubitril/valsartan treatment

Trial

PARADIGM-HF

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 12:10

P2Y12 inhibitor monotherapy is a novel antiplatelet strategy after short duration DAPT

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 11:39

Treatment patterns PAH have changed recently

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 11:19

High 5-year survival rates for older HF patients without initial severe comorbidity

Presented By

Dr Christian Madelaire, University of Copenhagen Herlev Hospital, Denmark

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 11:13

Early discharge and home treatment feasible for low-risk pulmonary embolism patients

Trial

HoT-PE

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 11:01

Higher incidence arrhythmia post-percutaneous closure of secundum ASD in patients >60 years

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 15:30

Diagnosing cardiac sarcoidosis with endomyocardial biopsies

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 15:12

Patients with polyvascular disease significantly undertreated with lipid lowering therapies

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 15:12

Unplanned hospital readmission is common after congenital cardiac surgery

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 14:34

Substantial impact of temporary interruptions of warfarin versus DOAC

Presented By

Dr Malini Madhavan, Mayo Clinic, USA

Trial

ORBIT-AF

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 14:17

DECLARE TIMI-58 trial shows benefits of dapagliflozin in high-risk subgroups

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 14:16

Letter from the Editor

Editor

Dr Marc Bonaca, University of Colorado School of Medicine, USA

Conference

ACC 2019

4 June 2019 13:50

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 13:30

Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin

Trial

AUGUSTUS

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 13:19

Superior outcomes of DES compared with BMS in very elderly population

Conference

ACC 2019

4 June 2019 13:18

Smartwatch can detect atrial fibrillation with high degree of accuracy

Presented By

Dr Mintu Turakhia, Stanford University, USA

Trial

Apple Heart Study

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 12:20

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 11:58

Letter from the ESC Congress Programme Committee Chairs

Expert

Marco Roffi, FESC University Hospital of Geneva, Switzerland, and Silvia Priori, FESC University of Pavia, Italy

Conference

ESC 2019

Type

Peer-reviewed article

9 March 2019 11:59

Letter from the Advisory Board

Editor

Robert P. Giugliano, MD, SM, Cardiovascular Division Brigham and Women’s Hospital Associate Professor in Medicine Harvard Medical School Boston, MA, US

Conference

ESC 2019

Type

Peer-reviewed article

9 March 2019 11:54

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

AHA 2018

12 November 2018 10:43

Letter from the ESC Congress Programme Committee Chair

Expert

Professor Stephan Achenbach, FESC, University of Erlangen, Germany

Conference

ESC 2018

29 August 2018 11:32

Letter from the Advisory Board

Conference

ESC 2018

29 August 2018 11:17

Editor Biography

Editor

Conference

ESC 2017

30 August 2017 12:15

Letter from the Advisory Board

Conference

ESC 2017

30 August 2017 12:13

Letter from the Advisory Board

Conference

ESC 2017

30 August 2017 12:10

Letter from the ESC Congress Programme Committee Chair

Expert

Professor Stephan Achenbach, FESC, University of Erlangen, Germany

Conference

ESC 2017

Expert

Prof. Matthias Heringlake, University of Luebeck, Germany

Conference

EACTA 2017

21 April 2017 09:05

Editor Biography

Editor

Prof. Marc Bonaca, Harvard Medical School, MA, USA

Conference

ACC 2017

19 March 2017 10:59

Interview with Dr. Richard A. Chazal

Expert

Dr. Richard A. Chazal, Heart and Vascular Institute for Lee Health, Florida, USA

Conference

ACC 2017

19 March 2017 09:53

Dermatology

Dr Georgina Long, Melanoma Institute Australia

Trial

Phase 3, RELATIVITY-098

Conference

ASCO 2025

5 June 2025 13:16

Letter from the Editor

Editor

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Conference

DDD 2025

5 June 2025 12:06

Management of atopic dermatitis in children in 2025

Presented By

Dr Marlies de Graaf, University Medical Center Utrecht, the Netherlands)

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 12:03

New horizon for classifying and managing vascular anomalies

Presented By

Dr Carine van der Vleuten, Radboud University Medical Center, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:57

Novel markers to monitor treatment response and progression in Sézary syndrome

Presented By

Dr Sara Marchisio, University of Turin, Italy

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:47

Vitiligo and the risk for skin cancer

Presented By

Dr Rosalie Luiten, Cancer Center Amsterdam, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:43

Crucial role of TFAP2a in skin health unravelled

Presented By

Dr Jos Smits, Radboud University Medical Center, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:38

Emerging intralesional therapies for BCC

Presented By

Dr Antonio Cozzio, Kantonsspital St Gallen, Switzerland

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:30

Diagnosis and management of atypical melanocytic lesions

Presented By

Dr Willeke Blokx, University Medical Center Utrecht, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:16

Expanding treatment armamentarium for actinic keratosis and Bowen’s disease

Presented By

Dr Klara Mosterd, Maastricht University Medical Center, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 11:07

A guide to recognise and manage Schnitzler syndrome in clinical practice

Presented By

Dr Heleen de Koning, Erasmus Medical Center, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 10:39

VEXAS syndrome and its cutaneous manifestations

Presented By

Dr Joost Meijer, University Medical Center Groningen, the Netherlands

Conference

DDD 2025

Type

Peer-reviewed article

5 June 2025 10:31

VANTAGE: Promising data of volixibat in cholestatic pruritus

Presented By

Dr Kris Kowdley, Liver Institute Northwest, WA, USA

Trial

Phase 2, VANTAGE

Conference

DDW 2025

Type

News article

21 May 2025 11:26

DDD 2025 Highlights Podcast

Presented By

Dr Rachel Giles, Robert van den Heuvel, Medicom

Conference

DDD 2025

1 May 2025 10:57

Letter from the Editor

Editor

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Conference

AAD 2025

17 April 2025 18:12

What’s new in acne?

Presented By

Dr Julie Claire Harper, Birmingham, AL, USA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 18:01

Nearly all participants respond to deucravacitinib in lichen planopilaris study

Presented By

Dr Alyssa Stockard , Mayo Clinic, AZ, USA

Trial

Phase 2

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 17:55

Dupilumab in bullous pemphigoid

Presented By

Prof. Frédéric Caux, Avicenne Hospital, University of Paris 13, France

Trial

Phase 3, LIBERTY-BP ADEPT

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 17:52

Breaking the cutaneous lupus loop with deucravacitinib

Presented By

Prof. Victoria Werth, University of Pennsylvania, PA, USA

Trial

Phase 2, PAISLEY CLE

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 17:44

Active psoriatic arthritis: POETYK PsA-2 trial results

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

Phase 3, POETYK PsA-2

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 17:31

Upadacitinib efficacious in palmoplantar pustulosis

Presented By

Prof. Yuling Shi, Tongji University School of Medicine, China

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 17:24

Delgocitinib gets the upper hand in chronic hand eczema

Presented By

Prof. April Armstrong, University of California, Los Angeles, CA, USA

Trial

DELTA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 17:00

Excellent long-term data for TYK2 inhibitor ESK-001 in psoriasis

Presented By

Dr Andrew Blauvelt, Blauvelt Consulting LLC, MD, USA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:54

ICONIC-LEAD in plaque psoriasis

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada

Trial

Phase 3, ICONIC-LEAD

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:49

A ‘TYK’ above placebo: ICP-488 in plaque psoriasis

Presented By

Dr Xiaoguang Zhang, Second Hospital of Hebei Medical University, China

Trial

Phase 2

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:44

TYK2 inhibitor D-2570 safe and effective in psoriasis

Presented By

Dr Ling Zhang, InventisBio Co., China

Trial

Phase 2

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:42

Flexing upadacitinib dose adjustment for AD and itch relief

Presented By

Dr Melinda Gooderham, SKiN Health, Canada

Trial

Phase 3, FLEX-UP

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:36

ROCKET ignites interest in rocatinlimab

Presented By

Prof. Emma Guttman, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, ROCKET-Horizon

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:33

Reduced biopsy rate and improved malignancy rate with high-end imaging tool

Presented By

Dr Jordan Phillipps, Washington University School of Medicine, MO, USA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:24

Cutaneous immune-related AEs may predict toxicities in ICI-treated patients

Presented By

Elle Kim, John Hopkins University, MD, USA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:19

Clinical patterns and outcomes in hypopigmented mycosis fungoides

Presented By

Dr Jong Bin Park, Kosin University, South Korea

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:10

Bempikibart shows its potential for hair regrowth in alopecia areata

Presented By

Dr Brett King, Yale Medicine, CT, USA

Trial

Phase 2, SIGNAL-AA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:08

Ivarmacitinib stimulates hair regrowth in severe alopecia areata

Presented By

Prof. Jianzhong Zhang, Peking University People’s Hospital, China

Trial

Phase 3

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 15:51

Baricitinib regrows hair in adolescents with alopecia areata

Presented By

Prof. Thierry Passeron, Nice University Hospital, France

Trial

Phase 3, BRAVE-AA-PEDS

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 15:41

Briquilimab breaks walls in chronic spontaneous urticaria

Presented By

Prof. Martin Metz, Charité Universitätsmedizin, Germany

Trial

Phase 1/2, BEACON

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 15:34

New anti-IL-23p19 inscribes its name on the plaque

Presented By

Dr Furen Zhang, Shandong Academy of Medical Science, China

Trial

Phase 2

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 15:20

AAD 2025 Highlights Podcast

Presented By

Dr Rachel Giles & Robert van den Heuvel, Medicom

Conference

AAD 2025

20 March 2025 15:39

Letter from the Editor

Editor

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Conference

EADV 2024

6 November 2024 15:34

3-Year results highlight durable effects of IL-13 inhibitor in AD

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

ADjoin

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:59

IL-22RA1 inhibition shows potential in atopic dermatitis

Presented By

Dr Christine Bangert, Medical University Vienna, Austria

Trial

Phase 2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:56

Lifelong psychosocial burden linked to early-onset atopic dermatitis

Editor

George Washington University School of Medicine, USA

Trial

Scars of Life

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:53

Second-generation selective PDE4 inhibitor shows promise in AD

Presented By

Prof. Eric Simpson, Oregon Health and Science University, USA)

Trial

Phase 2, ADESOS

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:50

Prurigo nodularis: long-term treatment decreases relapse events

Presented By

Prof. Franz Legat, Medical University Graz, Austria

Trial

Phase 3

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:47

JAK1 inhibitor shows promising long-term efficacy in PN

Presented By

Dr Shawn Kwatra, Johns Hopkins University School of Medicine, USA

Trial

Phase 2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:44

Deucravacitinib treatment in lichen planopilaris

Presented By

Dr Aaron Mangold, Mayo Clinic, USA

Trial

Phase 2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:41

Delgocitinib cream outperforms oral alitretinoin in chronic hand eczema

Presented By

Prof. Ana Giménez-Arnau, Autonomous University of Barcelona, Spain

Trial

Phase 3, DELTA FORCE

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:33

Atopic hand eczema: similar treatment success for dupilumab and topical delgocitinib

Presented By

Prof. April Armstrong, University of California Los Angeles, USA

Trial

DELTA; LIBERTY-AD-HAFT

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:30

Targeting IL-17A offers a promising treatment perspective in hidradenitis suppurativa

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:26

Bimekizumab shows sustained 2-year efficacy in hidradenitis suppurativa

Presented By

Prof. Christos Zouboulis, Dessau Medical Center, Germany

Trial

BE HEARD

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:22

Familial hidradenitis suppurativa tied to metabolic disease

Presented By

Dr Suzan Al-Gburi, University Hospital Cologne, Germany

Trial

EpiCAi; BATMAN

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:19

Imsidolimab potential future therapeutic avenue for generalised pustular psoriasis

Presented By

Prof. Adam Reich, University of Rzeszów, Poland

Trial

Phase 3, GEMINI-1; GEMINI-2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:04

A new era of care: Artificial intelligence in psoriasis

Presented By

Prof. Alexander Navarini, University Hospital of Basel, Switzerland

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:00

Deuruxolitinib significantly improves hair satisfaction in AA

Presented By

Dr Paradi Mirmirani, Kaiser Permanente Vallejo Medical Center, USA

Trial

THRIVE-AA

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:56

Topical pan-JAK inhibitor mitigates inflammatory biomarkers in frontal fibrosing alopecia

Presented By

Prof. Maryanne Senna, Harvard Medical School, USA

Trial

Phase 2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:51

Vitiligo: Prolonged facial re-pigmentation maintained with continued ruxolitinib cream

Presented By

Dr David Rosmarin, Indiana University School of Medicine, USA

Trial

TRuE-V

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:39

Anti-KIT antibody: the next frontier in CSU treatment?

Presented By

Prof. Martin Metz, Charité-University Hospital Berlin, Germany

Trial

Phase 2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:33

New targets identified for acute and chronic wound healing

Presented By

Dr Marta Bertolini, (QIMA Monasterium GmbH, Germany

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:29

PsoBest registry: Biologics dominate treatment for moderate-to-severe psoriasis

Presented By

Prof. Matthias Augustin, University Medical Center Hamburg-Eppendorf, Germany

Trial

PsoBest registry

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:23

Semaglutide improves outcomes for patients with obesity and HS

Presented By

Dr Daniel Lyons, St Vincent’s University Hospital, Ireland

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:14

Advanced BCC: histological subtype and time to complete response may predict tumour recurrence

Presented By

Dr Maria Mannino, Catholic University of the Sacred Heart, Italy

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:02

Neoadjuvant nivolumab/ipilimumab improves DMFS in stage III resectable melanoma

Presented By

Dr Minke Lucas, Netherlands Cancer Institute, the Netherlands

Trial

Phase 3, NADINA

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:00

New neoadjuvant combinations in stage III melanoma

Presented By

Dr Alexander Menzies, University of Sydney, Australia

Trial

Phase 1/2, KEYMAKER-U02

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 11:58

Long-term benefit of nivolumab, ipilimumab, and pembrolizumab: 10-year survival data

Trial

Phase 3, KEYNOTE-006, CheckMate 067

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 11:53

EADV 2024 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EADV 2024

9 October 2024 23:36

Early treatment with ambrisentan might prevent PAH development in patients with SSc

Presented By

Dr Panagiota Xanthouli, Heidelberg University Hospital, Germany

Trial

Phase 2, EDITA

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:34

Dermatomyositis: Triple therapy with tacrolimus beats cyclosporin regimen

Presented By

Prof. Yasuhiro Katsumata, Tokyo Women’s Medical University, Japan

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:31

Highly significant event-free survival benefit with neoadjuvant nivolumab/ipilimumab in stage III melanoma

Presented By

Prof. Christian Blank, Antoni van Leeuwenhoek, the Netherlands

Trial

Phase 3, NADINA

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 14:16

Neoadjuvant intralesional daromun improves relapse-free survival in stage III melanoma

Presented By

Prof. Axel Hauschild, Universitätsklinikum Schleswig-Holstein, Germany

Trial

Phase 3, PIVOTAL

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 14:13

Intratumoural tilsotolimod shows no benefit for advanced refractory melanoma

Presented By

Prof. Caroline Robert, Gustave Roussy, France

Trial

Phase 3, ILLUMINATE-301

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 14:09

How close are we to personalised medicine in psoriatic arthritis?

Presented By

Prof. Ennio Lubrano, University of Molise, Ital

Conference

IFPA 2024

Type

News article

17 July 2024 14:38

Genetic and immunological advances in risk assessment and treatment of psoriatic diseases

Presented By

Prof. Wilson Liao, University of California San Francisco, USA

Conference

IFPA 2024

Type

News article

17 July 2024 14:32

Using advances in the genetics of psoriatic disease to better predict treatment response

Presented By

Prof. Carl Goodyear, University of Glasgow, Scotland

Conference

IFPA 2024

Type

News article

17 July 2024 14:28

Depression complicates the management of psoriatic disease

Presented By

Dr Wiebke Sondermann, University Hospital Essen, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:20

The unfavourable role of obesity in psoriatic disease

Presented By

Prof. Ulrich Mrowietz, University Medical Center Schleswig-Holstein, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:13

Managing obesity and fibromyalgia in psoriatic disease

Presented By

Prof. Philip Mease, University of Washington, USA

Conference

IFPA 2024

Type

News article

Presented By

Dr Oseme Etomi, Guy's and St Thomas' Hospital, UK

Conference

IFPA 2024

Type

News article

17 July 2024 13:44

Towards prevention of psoriatic arthritis in patients with psoriasis

Presented By

Prof. Laura Coates, University of Oxford, UK

Conference

IFPA 2024

Type

News article

17 July 2024 13:39

Diagnosing generalised pustular psoriasis

Presented By

Dr Siew Eng Choon, Monash University Malaysia

Conference

IFPA 2024

Type

News article

17 July 2024 13:37

Itch and pain are major components of psoriatic disease and require management

Presented By

Prof. Adam Reich; Dr Anushka Irani

Conference

IFPA 2024

Type

News article

17 July 2024 12:07

Can diet help with the management of psoriasis?

Presented By

Prof. Wendy Hall, King's College London, UK

Trial

APPLE; METRED-P

Conference

IFPA 2024

Type

News article

17 July 2024 12:00

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By

Dr Vinod Chandran

Conference

IFPA 2024

Type

News article

Presented By

Dr Karien Gosens, Mauritskliniek, the Netherlands

Trial

Phase 1/2, VACCAIN-T

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 13:08

Artificial intelligence in dermatology: current applications and future horizons

Presented By

Tobias Sangers, Leiden University Medical Center, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 13:01

Digital dermatology in the Dutch treatment landscape

Presented By

Dr Milan Tjioe, Bravis Hospital, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 12:57

Improving risk classification in cutaneous squamous cell carcinoma

Presented By

Dr Marlies Wakkee, Erasmus MC Rotterdam, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 12:54

Skin cancer in transplant patients: practical challenges

Presented By

Dr Elsemieke Plasmeijer, Leiden University Medical Center, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 12:47

Ins and outs of tumour-infiltrating lymphocytes therapy in metastatic melanoma

Presented By

Dr Tom Seijkens, Netherlands Cancer Institute, the Netherlands

Conference

DDD 2024

31 May 2024 12:40

Understanding bullous pemphigoid: a rare skin condition

Presented By

Prof. Barbara Horváth, University Medical Center Groningen, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 12:24

Advancements in gene therapy for epidermolysis bullosa

Presented By

Dr Peter van den Akker, University Medical Center Groningen, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 12:22

Interview: State-of-the-art dermatology care in the Netherlands: “The future of dermatology is bright”

Expert

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

7 May 2024 14:48

DDD 2024 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

DDD 2024

6 May 2024 10:43

Letter from the Editor

Presented By

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Conference

AAD 2024

22 April 2024 17:00

Children with atopic dermatitis may be smaller and heavier than healthy children

Presented By

Prof. Amy Paller, Northwestern University‘s Feinberg School of Medicine, USA

Trial

PEDISTAD

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:54

JAK inhibitors have similar incidence rates of long-term adverse events as traditional immunomodulators

Presented By

Olivia Lamberg, University of Michigan, USA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:52

Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years

Presented By

Prof. Maryanne Senna, Harvard Medical School, USA

Trial

BRAVE-AA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:43

GUIDE demonstrates: Hit hard and early in psoriasis

Presented By

Prof. Knut Schäkel, University Clinic Heidelberg, Germany

Trial

Phase 3, GUIDE

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:36

Hidradenitis suppurativa treatment with secukinumab linked to low immunogenicity

Presented By

Prof. Martina Porter, Beth Israel Deaconess Medical Center, USA

Trial

Phase 3, SUNSHINE; SUNRISE

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:33

HS: Targeting IL-1 pathway potential option after anti-TNF failure

Presented By

Prof. Falk Bechara, Ruhr-University Bochum, Germany

Trial

Phase 2

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:29

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 2, STRIDE

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:01

Durable skin clearance by IL-23 blockers due to reduction of resident memory T cells

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

Phase 2, KNOCKOUT

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:41

Amlitelimab leads to a high response 28 weeks after treatment discontinuation

Presented By

Prof. Stephan Weidinger, Christian-Albrechts-University Kiel, Germany

Trial

Phase 2, STREAM-AD

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:35

Delgocitinib cream: A promising treatment option for chronic hand eczema

Presented By

Prof. Melinda Gooderham, Queens University, Canada

Trial

Phase 3, DELTA 3

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:31

Upadacitinib: A novel treatment option for vitiligo

Presented By

Prof. Thierry Passeron, Nice University Hospital, France

Trial

Phase 2

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:21

JAK1 inhibitor meets primary endpoint in prurigo nodularis

Presented By

Prof. Martin Metz, Charité University Hospital, Germany

Trial

Phase 2

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:17

Botanical drug solution leads to sustained hair regrowth in paediatric alopecia

Presented By

Prof. Bianca Piraccini, University of Bologna, Italy

Trial

RAAINBOW

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:14

SGLT2 inhibition: A possible mode-of-action for inflammatory skin diseases?

Presented By

Allison Holt, UMass Chan Medical School, USA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:06

Promising first results of novel topical treatment for congenital ichthyosis

Presented By

Dr Christopher Bunick, Yale School of Medicine, USA

Trial

Phase 3, ASCEND

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:02

Ritlecitinib also effective in patients with total hair loss

Presented By

Dr Melissa Piliang, Cleveland Clinic, USA

Trial

Phase 3, ALLEGRO

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 14:57

Meet the Trialist: Dr Andrew Blauvelt on the KNOCKOUT Trial

Expert

Dr Andrew Blauvelt

Trial

Phase 2, KNOCKOUT

Conference

AAD 2024

22 April 2024 12:12

AAD 2024 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AAD 2024

24 March 2024 15:02

Join the conversation on Rare Disease Awareness Day

Type

Peer-reviewed article

28 November 2023 13:13

IL-13 inhibitor shows potential in atopic dermatitis

Presented By

Prof. Eric Simpson, Oregon Health and Science University, USA

Trial

Phase 2, TREK-AD

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 13:08

Encouraging results for amlitelimab in atopic dermatitis

Presented By

Prof. Stephan Weidinger, University Hospital Schleswig-Holstein, Germany

Trial

Phase 2, STREAM-AD

Conference

EADV 2023

Type

Peer-reviewed article

Presented By

Prof. Bruce Strober, Yale University School of Medicine, USA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 12:01

First-in-class oral IL-23 inhibitor safe and effective for moderate-to-severe plaque psoriasis

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada

Trial

Phase 2, FRONTIER 1

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:57

Skin tape stripping allows a novel precision medicine approach in HS

Presented By

Dr Kristina Navrazhina, Icahn School of Medicine at Mount Sinai, USA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:51

Nanobodies: A novel way to treat HS

Presented By

Prof. Brian Kirby, St. Vincent´s University Hospital, Ireland

Trial

Phase 2, MIRA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:48

Anti-IL17 blockade leads to maintained pain reduction in patients with HS

Presented By

Dr John Ingram, Cardiff University, UK

Trial

Phase 3, SUNSHINE; SUNRISE

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:44

JAK1 inhibition: a promising forthcoming treatment option in vitiligo

Presented By

Prof. Khaled Ezzedine, University Paris-Est Créteil, France

Trial

Phase 2

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:17

Vitiligo: Continuation of topical ruxolitinib successful in many initial non-responders

Presented By

Dr Albert Wolkerstorfer, Amsterdam University Medical Centers, the Netherlands

Trial

Phase 3, TRuE-V1; TRuE-V1

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 11:10

JAK3/TEC inhibition achieves clinically meaningful responses in AA

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:31

Alopecia areata: remarkable regrowth rates with deuruxolitinib

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

Phase 3, THRIVE-AA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:28

Botanical drug solution improves hair regrowth in children and adolescents with AA

Presented By

Prof. Ulrike Blume-Peytavi, Charité – Berlin University Medicine, Germany

Trial

RAAINBOW

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:23

Nemolizumab shows high success rates in prurigo nodularis

Presented By

Prof. Sonja Ständer, Münster University Hospital, Germany

Trial

Phase 3, OLYMPIA 1

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:19

Remibrutinib reduces itch, sleep problems, and activity impairment in patients with CSU

Presented By

Dr Ana Giménez-Arnau, Autonomous University and Pompeu Fabra University, Spain

Trial

Phase 2

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:13

Innovative wound gel reduces frequency of painful dressing changes in epidermolysis bullosa

Presented By

Prof. Dimitra Kiritsi, University of Freiburg, Germany

Trial

Phase 3, EASE

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:08

Women with psoriasis face increased adverse effects with systemic therapy

Presented By

Dr Fabio Verardi, University Hospital Zurich, Switzerland

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 09:50

Improved AI tool shows high sensitivity rates in skin cancer detection

Presented By

Dr Kashini Andrew, University Hospitals Birmingham NHS Foundation Trust, UK

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 09:46

Dermoscopy training combined with AI significantly improves skin cancer detection

Presented By

Dr Christian Dorado Cortez, University Hospital of Saint-Etienne, France

Conference

EADV 2024

Type

Peer-reviewed article

28 November 2023 09:43

Topical gene therapy for recessive dystrophic epidermolysis bullosa

Expert

Prof. Peter Marinkovich, Stanford University, CA, USA

17 November 2023 16:41

EADV 2023 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EADV 2023

30 October 2023 01:34

Analysing the Link Between Psoriasis and Chronic Kidney Disease

Presented By

Prof. Khaled Ezzedine, University Paris-Est Créteil, France

Conference

EADV 2023

17 October 2023 11:18

IL-23p19 inhibitors have a superior drug survival compared with other biologics

Presented By

Dr Zenas Yiu, University of Manchester, UK

Trial

BADBIR Registry

Conference

EADV 2023

Presented By

Peter van de Kerkhof, Radboudumc, the Netherlands

Conference

WCD 2023

31 August 2023 18:18

Rocatinlimab delivers efficacy and safety in atopic dermatitis

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 18:08

Head-to-head: paraffin- versus ceramide-based moisturiser for paediatric AD

Presented By

Prof. Sachin Gupta, All India Institute of Medical Sciences, India

Conference

WCD 2023

Type

Peer-reviewed article

Presented By

Dr Elena Pezzolo, San Bortolo Hospital, Italy

Conference

WCD 2023

Type

Peer-reviewed article

Presented By

Prof. Tsen-Fang Tsai, (National Taiwan University Hospital, Taiwan

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:26

Patients with AA report high long-term regrowth rates with baricitinib

Presented By

Dr Maryanne Senna, Harvard Medical School, MA, USA

Trial

BRAVE-AA1 and BRAVE-AA2

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:22

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By

Prof. Melissa Piliang, Cleveland Clinic, OH, USA

Trial

Phase 3, ALLEGRO

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:18

TikTok videos on hair disorders lack reliability

Presented By

Dr Betty Nguyen, University of Miami, FL, USA

Conference

WCD 2023

Type

Peer-reviewed article

Presented By

Prof. Raja Sivamani, Pacific Skin Institute, CA, USA

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:04

OLYMPIA 2: Positive results for nemolizumab in prurigo nodularis

Presented By

Prof. Sonja Ständer, University Hospital Münster, Germany

Trial

Phase 3, OLYMPIA 2

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 14:59

PRFM or PRP therapy for trophic ulcers due to leprosy?

Presented By

Prof. Amrita Sil, Rampurhat Government Medical College & Hospital, India

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 13:19

Large teledermatology project in a remote island in Eastern Indonesia

Presented By

Dr Marlous Grijsen, University of Oxford, UK

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 12:56

Can AI-driven teledermatology increase access to healthcare in rural African settings?

Presented By

Mr Philippe Gottfrois, Basel University, Switzerland

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 12:54

Oleogel-S10 shows long-term efficacy and safety in dystrophic epidermolysis bullosa

Presented By

Prof. Dedee Murrell, University of New South Wales, Australia

Trial

Phase 3, EASE

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 11:50

Picosecond alexandrite laser safe and effective in benign pigmentary disorders

Presented By

Dr Kentaro Oku, Hills Grace Clinic, Japan

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 11:46

Gentamicin improves symptoms in paediatric Nagashima-type palmoplantar keratosis

Presented By

Dr Shan Wang, National Center for Children’s Health, China

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 11:41

WCD 2023 Highlights Podcast

Presented By

Dr Rachel Giles

Conference

WCD 2023

30 July 2023 22:40

Clinics on wheels – Bringing healthcare to patients in underserved communities

Expert

Dr Priya Sarin Gupta, Mass General Brigham, MA, USA

18 July 2023 11:28

Biologics in psoriasis: can they prevent joint involvement?

Presented By

Ms Kathleen Miao, Keck School of Medicine of USC, CA, USA

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 12:46

JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata

Presented By

Dr Maryanne Senna, Lahey Hospital and Medical Center, MA, USA

Trial

Phase 3, THRIVE-AA1

Conference

AAD 2023

Type

Peer-reviewed article

Presented By

Prof. April Armstrong, Keck School of Medicine of University of California, LA, USA

Trial

Phase 2

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 11:51

As-needed ruxolitinib shows successful long-term symptom control in AD

Presented By

Dr Andrew Blauvelt, Oregon Medical Research Center, OR, USA

Trial

Phase 3, TRuE-AD1 and TRuE-AD2

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 11:43

Dupilumab: a viable option for atopic hand and foot eczema

Presented By

Prof. Eric Simpson, Oregon Health & Science University, OR, USA

Trial

Phase 3, LIBERTY-AD-HAFT

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 11:33

Topical roflumilast beneficial in atopic dermatitis

Presented By

Prof. Lawrence Eichenfield, University of California San Diego, CA, USA

Trial

Phase 3, INTEGUMENT-1 and INTEGUMENT-2

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 11:27

IL-22 receptor blocker reduces itch and skin lesions in AD

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

Phase 2

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 11:17

Delgocitinib shows promise as topical therapy for chronic hand eczema

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada

Trial

Phase 3, DELTA 1

Conference

AAD 2023

Type

Peer-reviewed article

Editor

Prof. Peter van de Kerkhof, Radboud University, the Netherlands

Conference

AAD 2023

11 May 2023 16:48

Letter from the Editor

Editor

Prof. Peter van de Kerkhof, Radboud University, the Netherlands

Conference

DDD 2023

11 May 2023 14:17

Eligibility and selection of JAK inhibitors for constitutional eczema

Presented By

Dr Dirk Jan Hijnen, Erasmus MC, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:57

The rise of JAK inhibitors for alopecia areata

Presented By

Dr Brett King, Yale University, CT, USA

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:47

Obesity and the skin: state of affairs

Presented By

Dr Mariëtte Boon , Leiden University Medical Center, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:30

The role of surgeons in stage I–II melanoma

Presented By

Dr Dirk Grünhagen, Erasmus MC, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:26

Skin diseases and nutrition

Presented By

Prof. Reinhart Speeckaert, UZ Gent, Belgium

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:21

Melanoma: Surveillance and follow-up

Presented By

Dr Remco van Doorn, Leiden University Medical Center, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:19

When to screen for anal intraepithelial neoplasia?

Presented By

Prof. Henry de Vries, Amsterdam UMC, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:12

The importance of anti-microbial proteins in the skin

Presented By

Dr Hanna Niehues, Radboud University Medical Center, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:08

Scabies: Therapy failure and tips for the clinic

Presented By

Dr Robert Vodegel, Medical Center Leeuwarden, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:03

Life-threatening skin infections

Presented By

Dr Sandra Arend , Leiden UMC, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 12:58

OCT non-inferior to biopsy in basal cell carcinoma

Presented By

Dr Tom Wolswijk , Maastricht UMC, the Netherlands

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 12:42

AAD 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AAD 2023

4 April 2023 23:46

DDD 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

DDD 2023

27 March 2023 06:34

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Top 14 Medical Innovations for 2022

Expert

Dr Alex McDonald (Board member, Physician’s Weekly) and Dr Rachel Giles (Medical Science Officer, Medicom Medical Publishers)

25 January 2023 02:33

Tralokinumab improves symptoms and quality of life in adolescents with moderate-to-severe AD

22 November 2022 17:09

Patients & physicians have discordant views of atopic dermatitis symptoms

5 November 2022 11:09

High potential for secukinumab as next biologic treatment for HS

Presented By

Prof. Alexandra Kimball, Harvard Medical School, MA, USA

Trial

Phase 3, SUNSHINE; SUNRISE

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 11:06

Hidradenitis suppurativa: TYK2/JAK1 inhibitor shows promise

Presented By

Prof. Alexandra Kimball, Harvard Medical School, MA, USA

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 11:03

Dupilumab leads to clinically relevant improvements in signs and symptoms of prurigo nodularis

Presented By

Prof. Gil Yosipovitch, University of Miami, FL, USA

Trial

Phase 2, LIBERTY-PN PRIME

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:59

Nalbuphine: aspiring to become another treatment for prurigo nodularis?

Presented By

Prof. Sonja Ständer, University Medical Centre of Münster, Germany

Trial

Phase 3, PRISM

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:57

Notalgia paresthetica: may κ-opioid receptor agonists be a long-awaited effective therapy?

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 2, KOMFORT

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:55

Enhancing re-pigmentation rates with topical ruxolitinib in all body areas

Presented By

Prof. Thierry Passeron, University Côte d’Azur, France

Trial

Phase 3, TRuE-V1; TRuE-V2

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:50

Markedly lower skin cancer risk in vitiligo patients

Presented By

Dr John Ferguson, St John’s Institute of Dermatology, UK

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:47

Myths regarding “health benefit” of suntan prevail in majority of population

Presented By

Prof. Thierry Passeron, Université Côte d’Azur, France

Conference

EADV 2022

Type

Peer-reviewed article

Presented By

Dr Jonathan Shapiro, Maccabi Healthcare Services, Israel

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 10:24

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:30

Topical gel plus finasteride beneficial for patients with androgenetic alopecia

Presented By

Dr Michela Starace, University of Bologna, Italy

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:20

Deuruxolitinib achieves hair regrowth, even in patients with severe alopecia areata

Presented By

Prof. Brett King, Yale University School of Medicine, CT, USA

Trial

Phase 3, THRIVE-AA1

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:18

Baricitinib possible therapeutic option for children with AD

Presented By

Dr Antonio Torrelo Fernández, Hospital Infantil Universitario Niño Jesús, Spain

Trial

Phase 3, BREEZE-AD-PEDS

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:15

Amlitelimab therapy leads to sustained decrease of IL-22 in AD patients

Presented By

Dr Stephan Weidinger, University Hospital Schleswig-Holstein, Germany

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:10

IL-13 inhibition with lebrikizumab shows high maintenance rates in AD

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, OR, USA

Trial

Phase 3, ADvocate

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:05

Does 8 weeks of emollients use prevent AD in high-risk infants?

Presented By

Prof. Alan Irvine, Trinity College Dublin, Ireland

Trial

STOP AD

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:02

Roflumilast foam led to high response rates in seborrheic dermatitis

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, OR, USA

Trial

Phase 3, STRATUM

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:00

EADV 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EADV 2022

27 September 2022 11:49

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Medical Center, the Netherlands

Conference

SPIN 2022

26 August 2022 11:00

Therapies for atopic dermatitis: still moving forward

Presented By

Prof. Christian Vestergaard, Aarhus University Hospital, Denmark

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:58

Children with AD: high risk of bacterial infections in carriers of a filaggrin gene variant

Presented By

Prof. Alina Suru , Carol Davila University of Medicine and Pharmacy, Romania

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:53

Men on biologics report fewer adverse events than women

Presented By

Ms Jette van Lint , Pharmacovigilance Centre Lareb, the Netherlands

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:51

Conceptual framework of adverse drug reactions may improve treatment of patients with IMIDs

Presented By

Ms Jette van Lint , Pharmacovigilance Centre Lareb, the Netherlands

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:49

No adverse pregnancy outcomes in patients exposed to baricitinib

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:47

Systemic treatment for psoriasis: what is on the horizon?

Presented By

Prof. Diamant Thaci , University of Lübeck, Germany

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:45

Topical therapy in psoriasis: an important partner in combination therapy

Presented By

Prof. Peter van de Kerkhof, Radboud University Medical Centre, the Netherlands

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:40

GPP flares: pronounced undertreatment is common

Presented By

Dr Wendell Valdecantos , Boehringer Ingelheim Pharmaceuticals, CT, USA

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:38

All patients with GPP benefit from IL-36 inhibitor therapy

Trial

Phase 2, Effisayil 1

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:37

IL-17A/F inhibitor bimekizumab shows higher response and maintenance rates compared with secukinumab

Trial

Phase 3, BE RADIANT

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:35

Greater PASI reductions lead to less impairment in social and sexual life

Trial

Phase 3, VOYAGE 1, VOYAGE 2

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:32

Paediatric psoriasis: ixekizumab beneficial in difficult-to-treat areas

Presented By

Dr Marieke Seyger , Radboud University Medical Centre, the Netherlands

Trial

Phase 3, IXORA-PEDS

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:30

Psoriasis patients see great benefit in achieving complete skin clearance

Presented By

Prof. Matthias Augustin , University Medical Centre Hamburg, Germany

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:25

Predilection sites for skin signs of vitiligo disease activity determined

Presented By

Dr Liesbeth Delbaere , Ghent University Hospital, Belgium

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:24

Vitiligo-childhood onset commonly under 10 years

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:21

IHS4 better suited as an outcome measure in HS trials?

Presented By

Prof. Thrasyvoulos Tzellos, Nordland Hospital Trust, Norway

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:18

New treatments for HS: IL-17 inhibitors next in practice?

Presented By

Dr Axel Villani, University of Lyon, France & Prof. Thrasyvoulos Tzellos, Nordland Hospital Trust, Norway

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:05

Alopecia areata: light at the end of the tunnel

Presented By

Prof. Maryanne Senna , Harvard Medical School, MA, USA

Trial

Phase 3, BRAVE-AA1, BRAVE-AA2

Conference

SPIN 2022

Type

Peer-reviewed article

Presented By

Dr Juan Raul Castro Ayarza , Medicarte, Colombia

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 09:43

SPIN 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Presented By

Dr Brian Rankin, University of Calgary, Canada

Trial

Cohort study

Conference

AAD 2022

Type

Peer-reviewed article

18 May 2022 12:27

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Medical Center, the Netherlands

Conference

AAD 2022

17 May 2022 12:36

Upadacitinib: Fast and more pronounced skin improvement in AD patients

Presented By

Prof. Jonathan Silverberg, George Washington University School of Medicine, USA

Trial

Phase 3, Heads Up

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:35

Dermatology diseases need the highest doses of biologics

Presented By

Dr Charlotte Greif, Beth Israel Deaconess Medical Center, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:24

JAK inhibitors in AD: Setting the efficacy bar even higher

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Measure Up 1; JADE Mono-1; JADE Compare; Heads Up

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:21

Lebrikizumab treatment leads to encouraging outcomes in multiple traits of AD

Presented By

Prof. Jonathan Silverberg, George Washington University School of Medicine, USA

Trial

Phase 3, ADvocate 1; ADvocate 2

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:18

Novel IL-4/IL-13 blocker shows high efficacy with only modest conjunctivitis signal

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:15

New insights into psoriasis comorbidity

Presented By

Prof. Joel Gelfand, University of Pennsylvania, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:12

Prof. Gil Yosipovitch, University of Miami, USA

Trial

Phase 3, LIBERTY-PN PRIME 2

Conference

AAD 2022

17 May 2022 11:59

Fungal skin infections in children: A diagnosis to keep in mind

Presented By

Prof. A. Yasmine Kirkorian, George Washington University School of Medicine, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 11:54

Innovative gel speeds up clearance of molluscum contagiosum lesions

Presented By

Prof. John Browning, University of Texas, USA

Trial

Phase 3, B-SIMPLE4

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 11:51

JAK inhibition offers promising treatment prospects for uncommon dermatoses

Presented By

Prof. Matthew Vesely, Yale School of Medicine, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 11:48

JAK inhibitors may offer a new horizon in the treatment of sarcoidosis

Presented By

Prof. William Damsky, Yale School of Medicine, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 11:12

Light at the end of the tunnel for vitiligo therapy

Presented By

Dr David Rosmarin, Tufts Medical Center, USA

Trial

Phase 3, TRuE-V1; TRuE-V2

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 11:05

JAK inhibitors: A risk assessment

Presented By

Prof. Brett King, Yale School of Medicine, USA

Conference

AAD 2022

Type

Peer-reviewed article

Journal

JAMA Dermatology

6 May 2022 00:55

Adjuvant pembrolizumab may cut recurrence, mortality in stage-II melanoma

Journal

The Lancet

14 April 2022 18:07

AAD 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AAD 2022

14 April 2022 11:02

Is melanoma screening by primary care practitioners linked with overdiagnosis?

Journal

JAMA Dermatology

12 April 2022 23:14

International consensus reached on methotrexate dosing for psoriasis

Journal

JAMA Dermatology

7 April 2022 22:30

Topical ruxolitinib continues to show promise for vitiligo

Conference

American Academy of Dermatology Annual Meeting

29 March 2022 17:14

Arthritis drug beats placebo for treating severe alopecia areata

Journal

The New England Journal of Medicine

28 March 2022 16:42

U.S. FDA approves new Bristol Myers cancer immunotherapy

21 March 2022 14:57

Dermatologists may be unaware of scalp cooling for chemo-induced hair loss

Journal

Journal of the American Academy of Dermatology

18 March 2022 19:54

Melanoma-secreted amyloid beta likely curbs neuroinflammation, promotes brain metastases

Journal

Cancer Discovery

15 March 2022 22:25

IV gentamicin shows promise for genetic blistering skin disorder

Journal

JAMA Dermatology

7 March 2022 22:07

Merkel cell cancers recur more often than other skin cancers, usually within three years

Journal

JAMA Dermatology

3 March 2022 19:35

U.S. FDA declines to approve Amryt’s topical gel for rare skin diseases

28 February 2022 16:11

For sentinel node-positive melanoma treatment, location matters

Journal

Annals of Surgery

21 February 2022 18:04

Race, socioeconomic status tied to melanoma survival

Journal

Journal of the American Academy of Dermatology

18 February 2022 16:28

Therapeutic lymph node dissection may not be needed in melanoma when index node responds

Journal

JAMA Surgery

Presented By

Dr Alexander Egeberg, Copenhagen University Hospital Gentofte, Denmark

Trial

Phase 3, UNCOVER

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 11:15

The Yin and Yang of opposing vectors: an explanation for side effects of biologics

Presented By

Prof. Curdin Conrad, Lausanne University Hospital, Switzerland

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 11:07

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By

Dr Charlie Bridgewood, University of Leeds, UK

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 10:51

DLQI scores underestimated during lockdowns?

Presented By

Dr Ali Alsharqi, St. Vincent’s University Hospital, Ireland

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 10:34

TNF blockers likely beneficial for psoriatic patients with COVID-19

Presented By

Prof. Catherine Smith, King’s College London, UK

Trial

PsoProtect

Conference

PFG 2021

Type

Peer-reviewed article

2 February 2022 15:42

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By

Dr Ali Al-Janabi, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:22

IL-36 gene expression in GPP lesions reduced by spesolimab

Presented By

Dr Ahmed Farag

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:09

Inhibition of heat shock protein: A novel way to treat psoriasis?

Presented By

Dr Anne Bregnhøj, Aarhus University Hospital, Denmark

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:02

Guselkumab shows highest drug survival among systemic treatments

Presented By

Dr Zenas Yiu, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:55

Risankizumab superior to ustekinumab in skin histopathology scores

Presented By

Dr Kathleen Smith

Trial

Phase 3, UltiMMa-1 trial

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:49

Tapering biologics: No alarming signs of increased anti-drug antibodies

Presented By

Dr Juul van den Reek , Radboudumc, the Netherlands

Trial

Phase 4, CONDOR

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:43

Intermediate monocytes are possible predictors of response to secukinumab

Presented By

Dr Jonathan Hardman-Smart, King’s College London, UK

Trial

Phase 3, SIGNATURE

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:34

Gut microbiota of psoriasis patients: less diverse and reduced functionality

Presented By

Dr Tanja Todberg, University of Copenhagen, Denmark

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:29

Psoriasis associated with a higher cancer risk

Presented By

Mr Alex Trafford, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:23

Comorbidity and clinical features of psoriasis vary according to HLA-C*06:02 status

Presented By

Dr Ravi Ramessur, King’s College London, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:20

Psoriasis patients with cardiovascular comorbidity characterised by high systemic inflammation

Presented By

Dr Niamh Kearney, St. Vincent’s University Hospital, Ireland

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:16

HLA-C*06:02-positive patients on ustekinumab show higher drug survival in a real-world scenario

Presented By

Dr Oras Alabas, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 14:05

Selective IL-23 inhibition normalises gene expression in active PsA

Presented By

Ms Michelle Miron

Trial

Phase 3, DISCOVER-1&-2

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 13:48

Protective factors identified against anti-drug antibody formation to adalimumab in psoriasis

Presented By

Dr Teresa Tsakok, King’s College London, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 13:37

Superficial radiotherapy tied to remission, better quality of life in severe Hailey-Hailey disease

Journal

JAMA Dermatology

28 January 2022 22:02

Dermatologists and psoriasis patients call for specialized care to prevent heart disease

Journal

JAMA Dermatology

26 January 2022 16:22

Radiomic signature may predict survival in pembrolizumab-treated advanced melanoma

Journal

JAMA Oncology

25 January 2022 23:28

FDA approves expanded use of AbbVie’s arthritis drug to treat eczema

14 January 2022 21:36

High-fiber diet tied to better immunotherapy response and progression-free survival in melanoma

Journal

Science

3 January 2022 22:11

Oral JAK inhibitor continues to show promise for alopecia areata

Journal

Journal of Allergy and Clinical Immunology

29 December 2021 20:34

Novel inflammatory marker improves prognostication in epidermal necrolysis

Journal

JAMA Dermatology

28 December 2021 21:21

One week enough to clear pustular psoriasis in half of patients after experimental infusion

Journal

The New England Journal of Medicine

22 December 2021 23:00

PFGC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Presented By

Prof. James Grichnik, University of South Florida, USA

Conference

ICD 2021

Type

News article

2 December 2021 17:21

Equity in dermatology: Skin Care For All

Presented By

Dr Jeslyn Tengkawan, Johns Hopkins University; Capella Project Foundation,

Conference

ICD 2021

Type

News article

2 December 2021 17:18

Challenges in diagnosis and treatment of leprosy in Brazil

Presented By

Prof. Caroline Talhari, Amazonas State University, Brazil

Conference

ICD 2021

Type

News article

2 December 2021 17:16

A PASSION to provide dermatological care in LMICs

Presented By

Dr Christophe Hsu, University Hospital of Basel, Switzerland

Conference

ICD 2021

Type

News article

2 December 2021 17:13

Paediatric dermatology in Tunisia: common diagnoses

Presented By

Dr Nejib Doss, Military Hospital of Tunis, Tunisia

Conference

ICD 2021

Type

News article

2 December 2021 17:08

Registry of vitiligo patients aims to break the stigma

Expert

Pirogov Russian National Research Medical University, Russia

Conference

ICD 2021

Type

News article

2 December 2021 17:02

Ceramides and their role in skincare

Presented By

Prof. John Su; Dr Katherine Armour

Conference

ICD 2021

Type

News article

2 December 2021 16:47

10% thioglycolic acid gel peels: a safe and efficient option for pigmented purpuric dermatosis

Presented By

Dr Arunima Ray, IMS and SUM Hospital, India

Conference

ICD 2021

Type

News article

2 December 2021 16:43

Benefits of microneedling with platelet-rich plasma for acne scars

Presented By

Dr Jaishree Sharad, Skinfiniti Aesthetic Skin and Laser Clinic, India

Conference

ICD 2021

Type

News article

2 December 2021 16:33

Phase 2

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:32

TYK2 inhibitor deucravacitinib shows impressive long-term response in psoriasis

Presented By

Prof. Richard Warren, University of Manchester, UK

Trial

Phase 3, POETYK PSO

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:31

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Medical Center, the Netherlands

Conference

EADV 2021

18 November 2021 13:30

Tapinarof cream for psoriasis leads to high clearance rates and remittive effect

Presented By

Dr Linda Stein Gold, Henry Ford Health System, USA

Trial

PSOARING 3

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:30

CSU: Ligelizumab likely safe and effective for adolescents

Presented By

Prof. Bülent Şekerel, Hacettepe University, Turkey

Trial

Phase 2

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:29

Long-term disease control in AD could be in reach with anti-OX40 antibody KHK4083

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 2

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:28

Topical JAK1/JAK2 inhibitor effective in vitiligo

Presented By

Dr David Rosmarin, Tufts Medical Center Boston, USA

Trial

Phase 3, TRuE-V1; TruE-V2

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:27

Abrocitinib demonstrates fast itch control and skin clearance in atopic dermatitis

Presented By

Prof. Kristian Reich, University Medical Center Hamburg-Eppendorf, Germany

Trial

Phase 3, JADE DARE

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:26

AD patients with stable response fare well with a monthly dose of tralokinumab

Presented By

Prof. Stephan Weidinger, University of Kiel, Germany

Trial

ECZTRA1 and 2

Conference

EADV 2021

Type

Peer-reviewed article

Presented By

Prof. Mahira Hamdy El Sayed, Ain Shams University, Egypt

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:18

A patient-related approach to freedom of disease

Presented By

Elfie Deprez , Ghent University Hospital, Belgium

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:17

Ixekizumab superior to secukinumab in real-world psoriasis study

Presented By

Dr Caterina Cariti, University of Turin, Italy

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:16

Nail psoriasis: An important target to be treated

Presented By

Prof. Peter van de Kerkhof , Radboudumc, the Netherlands

Conference

EADV 2021

Type

Peer-reviewed article

Journal

Science Translational Medicine

16 November 2021 22:22

Supplemental patch testing often needed to identify allergens in contact dermatitis

Journal

JAMA Dermatology

9 November 2021 21:22

‘Diligent’ dermatology care needed in organ-transplant recipients

Journal

JAMA Dermatology

22 October 2021 22:08

EADV 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

PSOARING 3, JADE-DARE, HEADS UP

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:46

PsoBarrier EU: Large survey evaluating quality of care in Europe

Presented By

Dr Anna Langenbruch, Universitätsklinikum Hamburg-Eppendorf, Germany

Trial

PsoBarrier EU

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:43

Bridging the gap between patients and access to psoriasis specialists

Presented By

Dr Silvia Fernandez Barrio, AEPSO, Argentina

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:42

Psoriasis and PsA in transgender adults on hormone therapy

Presented By

Ms Julia Gao, Fenway Health, MA, USA

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 13:41

Psoriasis: New disease severity classification

Presented By

Prof. Lone Skov, University of Copenhagen, Denmark

Conference

WPPAC 2021

Type

Peer-reviewed article

Presented By

Prof. Alexander Nast, Charité Universitätsmedizin Berlin, Germany

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 12:09

Psoriatic arthritis: Guidelines and best practice

Trial

Phase 3, BE ACTIVE, PATERA

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:19

Patients with PsA have a higher cardiovascular risk

Presented By

Dr Natalia Guajardo-Jauregui, Autonomous University of Nuevo León, Mexico

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:16

Potential role of inflammation in cardiovascular comorbidity

Presented By

Dr Alexander Egeberg, Herlev and Gentofte Hospital, Denmark

Trial

Phase 3, CANTOS, CIRT

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:13

Psoriasis: New treatments and current pipeline

Presented By

Prof. Kristian Reich, Dermatologikum Hamburg, Germany

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:08

Rapid pustule and skin clearance with IL-36 receptor inhibitor spesolimab

Presented By

Prof. Hervé Bachelez, Hôpital Saint-Louis, France

Trial

Phase 2, Effisayil 1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:04

Selective TYK2 inhibitor effective in moderate-to-severe plaque psoriasis

Trial

Phase 3, POETYK PSO-1, POETYK PSO-2

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 10:59

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Medical Center, the Netherlands

Conference

WPPAC 2021

16 September 2021 14:03

Nodal classification system improves assessment of cutaneous melanoma mortality risk

Journal

JAMA Surgery

8 September 2021 18:15

Severe atopic dermatitis tied to depressive symptoms, internalizing behaviors in children

Journal

JAMA Dermatology

Journal

Journal of Allergy and Clinical Immunology

23 July 2021 17:47

IFPA WPPAC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

WPPAC 2021

20 July 2021 16:16

Patch tests ‘essential’ in patients who develop facial dermatitis from face masks

Journal

Journal of the American Academy of Dermatology

25 June 2021 21:10

Autologous bacteriotherapy shows promise against atopic dermatitis

Journal

JAMA Dermatology

24 June 2021 17:39

Google searches for new measure of skin tones to curb bias in products

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:30

Comorbidity does not influence crisaborole efficacy in atopic dermatitis

Trial

Phase 3, CrisADe CORE 1 and 2

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:30

Comorbidity is common in adult and paediatric atopic dermatitis patients

Presented By

Prof. Jonathan Silverberg, George Washington University, WA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:30

Lower burden of high-risk atherosclerotic plaques in psoriasis patients treated with biologics

Presented By

Prof. Nehal N. Mehta, National Heart, Lung, and Blood Institute, MD, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:30

Botulinum toxin A: a contradictory role in hair loss

Presented By

Prof. Natasha Mesinkovska, UC Irvine School of Medicine, CA, USA

Conference

aad vmx 2021

Type

Peer-reviewed article

7 June 2021 13:21

New therapeutic options add value to current acne treatment

Presented By

Dr John Barbieri, Perelman School of Medicine, University of Pennsylvania, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:20

Significant improvements in the system armamentarium for AD treatment

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:20

Nicotinamide and probiotics can support acne therapy

Presented By

Prof. Juliana Choi, Penn Dermatology Perlman, PA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:15

Convincingly low levels of infections with long-term tildrakizumab

Trial

reSURFACE 1 and 2

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:15

No increased risk of infection with long-term dupilumab for atopic dermatitis

Trial

LIBERTY AD OLE

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:15

Topical pan-JAK inhibitor cream safe and efficacious in atopic dermatitis

Presented By

Prof. Jonathan Silverberg, George Washington University, WA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:10

Atopic dermatitis in children has a severe impact on their families

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:05

IL-17 inhibitor effective in axial manifestations of psoriatic arthritis

Trial

Phase 3, MAXIMISE

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:00

Platelet-rich plasma in androgenetic alopecia – hype or hope?

Presented By

Prof. Ronda S. Farah, University of Minnesota, MN, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:00

‘Maskne’ – How can it be managed?

Presented By

Prof. Juliana Choi, Penn Dermatology Perlman, PA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:00

Meaningful amelioration of quality of life in paediatric AD patients on dupilumab

Trial

Phase 3, LIBERTY AD PEDS

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:00

Small molecule effective in moderate-to-severe psoriasis

Presented By

Prof. April Armstrong, Keck School of Medicine at UCLA, CA, USA

Trial

Phase 3, POETYK PSO-1 and 2

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:50

Bruton’s tyrosine kinase inhibition promising for pemphigus vulgaris

Presented By

Prof. Dedee F. Murrell, St George Hospital, University of New South Wales, Australia

Trial

Phase 2, BELIEVE

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:48

Bimekizumab superior to secukinumab in psoriasis

Presented By

Prof. Kristian Reich, University Medical Center Hamburg-Eppendorf, Germany

Trial

Phase 3, BE RADIANT

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:47

Etrasimod – a new mode of action for treatment of atopic dermatitis

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:45

Women at higher risk for dermatologic side effects during immunotherapy

Presented By

Mr Jordan T. Said, Harvard School of Medicine, MA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:44

Novel easy-to-use foam formulation clears scalp psoriasis in one-third of patients

Presented By

Prof. Leon Kircik, Icahn School of Medicine at Mount Sinai Medical Center, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:43

Anti-cholinergic gel demonstrates superior long-term tolerability and efficacy in axillary hyperhidrosis

Presented By

Dr Brandon M. Kirsch, Kirsch Dermatology, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 10:42

Baricitinib shows long-term effectiveness against moderate to severe atopic dermatitis

Journal

JAMA Dermatology

4 June 2021 16:35

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Medical Center, the Netherlands

19 May 2021 23:33

Rituximab bests mycophenolate mofetil as one-year treatment for pemphigus vulgaris

Journal

The New England Journal of Medicine

19 May 2021 17:30

AAD VMX 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EADV 2020

18 December 2020 13:11

Metastatic-melanoma immunotherapy may be tied to increase in second cancers

Journal

JAMA Network Open

Presented By

Dr Kevin Phan, Liverpool Hospital, Australia

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:34

Meaningful sleep improvement with IL-13 inhibition

Presented By

Prof. Jonathan Silverberg, George Washington University, USA

Trial

Phase 3, ECZTRA

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:33

Preventing foot odour with zinc oxide coated socks

Presented By

Dr Punyawee Ongsri, Mahidol University, Thailand

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:32

Baricitinib in AD: Efficacy paired with consistent long-term results

Presented By

Prof. Jonathan Silverberg , George Washington University, USA

Trial

Phase 3, BREEZE-AD3

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:31

Bacterial resistance in skin infections – a challenging threat

Presented By

Prof. Domenico Bonamonte, Bari University, Italy

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:30

Chronic inducible urticaria can require some detective work

Presented By

Prof. Marcus Maurer, Charité Universitätsmedizin Berlin, Germany

Trial

COLD-CE, CHED

Conference

EADV 2020

17 December 2020 14:28

Borreliosis: A multifaceted disease

Presented By

Dr Markus Starink, Amsterdam University Medical Centre, the Netherlands

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:28

JAK inhibitors in AA: re-establishing the immune privilege of hair follicles

Presented By

Prof. Taisuke Ito, Hamamatsu University School of Medicine, Japan

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:27

Chronic spontaneous urticaria: hives, wheals & biomarkers

Presented By

Prof. Ana Giménez-Arnau, Autonomous University of Barcelona, Spain

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:27

Scabies – A global health challenge

Presented By

Prof. Olivier Chosidow, Henri Mondor University Hospital, France

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:27

Ligelizumab for chronic spontaneous urticaria: a new star on the horizon

Presented By

Prof. Marcus Maurer, Charité Universitätsmedizin Berlin, Germany

Conference

EADV 2020

Type

Peer-reviewed article

Presented By

Dr Anne-Claire Fougerousse; Dr Giovanni Damiani

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:12

Much to be learned about COVID-19 and the skin

Presented By

Prof. Esther Freeman, Director of the COVID-19 Dermatology Registry

Trial

COVID-19 Dermatology Registry

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:00

Selective IL-23 blocker shows potential in psoriasis treatment

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3, OASIS-2

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:44

Promising results with nanobody treatment in psoriasis

Presented By

Dr Kim A. Papp, Probity Medical Research, Canada

Trial

Phase 2

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:40

Light at the end of the tunnel for chronic hand eczema

Presented By

Prof. Margitta Worm, Prof. Howard Sofen

Trial

Phase 2

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:37

Epidermolysis bullosa: Novel wound treatment on the horizon

Presented By

Prof. Dedee F. Murrell, St George Hospital, University of New South Wales, Australia

Trial

Phase 3

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:32

Efficacious non-steroidal topical for psoriasis

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, PSOARING

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:28

Oral JAK 1 inhibitor leads to fast itch relieve and remarkable skin clearance in AD

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, Measure Up

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 13:24

Interview past EADV President Prof. Carle Paul

Expert

Prof. Carle Paul

Conference

EADV 2020

17 December 2020 13:23

Effects IL-13 blocker improves with longer treatment duration

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, ECZTRA

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 12:37

Suicidality and psychological adverse events tied to finasteride

Journal

JAMA Dermatology

11 November 2020 23:16

Bezafibrate improves itch in patients with cholestatic diseases

Journal

Gastroenterology

4 November 2020 22:21

Gut microbe curbs systemic inflammation in psoriasis

Conference

EADV 2020

4 November 2020 20:13

EADV 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

28 August 2020 14:19

Selective IL-23 blocker safe in elderly psoriasis patients

Presented By

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Trial

reSURFACE

Conference

AAD 2020

Type

Peer-reviewed article

19 August 2020 13:18

Spironolactone safe for androgenetic alopecia in cancer survivors

Presented By

Dr Chapman Wei, George Washington University, USA

Conference

AAD 2020

Type

Peer-reviewed article

19 August 2020 07:33

Baricitinib beneficial in head and neck AD

Presented By

Dr Eric Simpson, Oregon Health and Science University, USA

Trial

Phase 3, BREEZE-AD1 and BREEZE-AD2

Conference

AAD 2020

Type

Peer-reviewed article

19 August 2020 07:23

Continuous terbinafine most effective for toenail onychomycosis

Presented By

Dr N Stec

Conference

AAD 2020

Type

Peer-reviewed article

19 August 2020 07:17

AAD 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AAD 2020

7 August 2020 19:10

ECLIPSE trial: skin clearance independent of PsA status at baseline

Presented By

Prof. Kristian Reich

Trial

Phase 3, ECLIPSE

Conference

AAD 2020

Type

Peer-reviewed article

7 August 2020 13:12

Intranasal kappa-opioid agonist effective for intractable pruritus

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 13:16

HS patients carry higher risk for systemic lupus erythematosus

Trial

phase 1

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 13:04

Biologics in HS – a growing armamentarium

Presented By

Prof. Joslyn Kirby, Penn State University, USA

Trial

PIONEER

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 12:48

How to manage cutaneous side effects of immunotherapy

Presented By

Prof. Jennifer N. Choi, Northwestern Feinberg School of Medicine, USA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 09:02

Cannabinoids: a future role in dermatology?

Presented By

Prof. Adam Friedman, School of Medicine & Health Sciences, USA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 09:01

Psoriasis therapy for children and pregnancies

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

CRIB, CADMUS, IXORA-PEDS

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 08:03

Biologic psoriasis treatment to lower cardiovascular risk?

Presented By

Prof. Joel Gelfand, University of Pennsylvania, USA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 08:01

A new topical PDE-4 inhibitor effective in psoriasis

Presented By

Prof. Mark Lebwohl

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 08:00

IL-17A and IL-17F blockade remarkably effective in psoriasis

Presented By

Prof. Kristian Reich; Prof. Kenneth B. Gordon

Trial

BE VIVID and BE READY

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:09

Good response and pruritus reduction in AD with novel selective JAK1 inhibitor

Presented By

Dr Melinda Gooderham

Trial

JADE MONO-2

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:08

Novel IL-23 blocker risankizumab highly effective and tolerable in psoriasis

Presented By

Prof. Richard B. Warren

Trial

IMMerge

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:07

IL-13 blocker tralokinumab effective in AD

Presented By

Prof. Eric Simpson

Trial

ECZTRA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:06

Tape stripping – a painless way to distinguish AD and psoriasis?

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:05

IL-4/IL-13 blocker dupilumab effective in children with severe AD

Presented By

Prof. Amy S. Paller, Northwestern University Feinberg School of Medicine, USA

Trial

Phase 3, LIBERTY AD PEDS

Conference

AAD 2020

6 August 2020 07:04

Pembrolizumab leads to higher toxicity risk in obese melanoma patients

Presented By

Ms Surya Ravichandran, Duke University, USA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:03

Can gene expression help to pick the right biologic to treat psoriasis in cancer patients?

Presented By

Dr Nikolai Klebanov , Brigham and Women’s Hospital, USA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:01

Omalizumab for cancer-induced dermatoses

Presented By

Ms Dulce M. Barrios, Memorial Sloan Kettering Cancer Center (USA)

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:00

Better compliance in AD skin care with novel emollient stick

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 06:37

IL-17A blocker effective in paediatric psoriasis patients

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3, IXORA-PEDS

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 20:51

Small molecules: interesting novel treatment options in AD

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, German

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 20:27

Rituximab beats mycophenolate mofetil in pemphigus vulgaris

Presented By

Prof. Pascal Joly, Rouen University Hospital, France

Trial

Phase 3, PEMPHIX, Ritux 3

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 19:52

IL-1⍺ blockade: a new treatment option in AD

Presented By

Prof. Alice Gottlieb, Icahn School of Medicine at Mount Sinai, USA

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 19:51

IL-4/IL-13 blockade leads to rapid itch reduction in adolescents

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, LIBERTY AD ADOL

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 18:58

Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata

Presented By

Dr James Cassella

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 18:54

Acne highly influenced by climate, pollutants, and unhealthy diet

Presented By

Dr Delphine Kerob, Vichy Laboratories, France

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 17:56

JAK inhibition plus TCS lead to high clearance rates in AD

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Trial

Phase 3, BREEZE-AD7

Type

Peer-reviewed article

9 December 2019 16:53

How to manage conjunctivitis in AD patients treated with a biologic

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, Germany

Conference

EADV 2019

Type

Peer-reviewed article

Presented By

Prof. Amit Pandya, University of Texas Southwestern Medical Center, USA

Conference

EADV 2019

9 December 2019 13:08

Above-the-neck melanoma more prone to metastases

Presented By

Dr Mohammed Al Abadie, Cross Hospital; Cannock Chase Hospital, United Kingdom

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:53

The Rosacea Tracker may aid clinical decision-making

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:46

Comorbidities more common in chronic urticaria, psoriasis, and AD

Presented By

Dr Karsten Weller, Charité University Hospital, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:40

IL-17 blocker: effective and safe in patients with comorbidities

Presented By

Dr Alice Gottlieb, Tufts University School of Medicine, USA

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:19

Reduced sleep quality in dermatoses influenced by itch and pain

Presented By

Dr Karolina Kaaz, Wroclaw Medical University, Poland

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 19:58

Systemic photoprotection: a valuable addition to topical sun protection

Presented By

Prof. Salvador González Rodriguez, University of Alcala de Henares, Spain

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 19:35

ESPRIT registry: sharp decline in mortality in patients treated with a TNF blocker

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

ESPRIT

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 19:23

Anxiety and depression are common in families of AD infants

Presented By

Dr Vesna Grivcheva-Panovska, University Clinic in Skopje (Macedonia)

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 18:59

D-Dimer as future biomarker in CSU management?

Presented By

Dr Antonio Cristaudo, San Gallicano Dermatological Institute, Italy

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 18:41

Relationship psoriasis and NAFLD: new data on the hepato-dermal axis

Presented By

Dr Daniel Nieto, La Paz Hospital, Spain

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 18:25

Novel selective IL-23 blocker equally effective in patients with metabolic syndrome

Presented By

Dr Alice Gottlieb, Tufts University School of Medicine, USA

Trial

reSURFACE 1 and 2

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 17:28

Selective IL-23 blocker crushes fumaric acids in all assessed efficacy endpoints

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 16:30

Certolizumab pegol efficacious for head and neck psoriasis

Presented By

Prof. Peter van de Kerkhof, Radboud University, the Netherlands

Trial

Phase 3, CIMPASI-1 and CIMPASI-2

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 15:02

New guidance on rosacea therapy according to phenotype

Presented By

Prof. Martin Schaller, University of Tübingen, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:49

Ligelizumab for CSU: symptom control and high response rates in re-treatment

Presented By

Prof. Marcus Maurer, Charité – Universitätsmedizin Berlin, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:45

The underestimated effect of visible light

Presented By

Dr Serena Lembo, University of Naples Federico II, Italy

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:38

No hint of teratogenicity through ixekizumab

Presented By

Prof. Alexander Egeberg, Herlev and Gentofte Hospital, Denmark

Trial

PSOLAR

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:32

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Nijmegen

Conference

EADV 2019

9 October 2019 12:47

Statin use elevates risk of eczema and atopic dermatitis

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 20:50

Will malignant melanoma become a curable disease?

Presented By

Prof. Claus Garbe; Prof. Caroline Robert

Trial

COMBI-d, COMBI-v, COMBI-i, KEYNOTE-001

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 20:46

Cutaneous adverse events due to EGFR inhibitors

Presented By

Dr Pietro Sollena, University of the Sacred Heart in Rome, Italy

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 20:44

Keloids: a faulty switch in wound healing?

Presented By

Prof. Greg Goodman, Monash University, Australia

Conference

WCD 2019

26 August 2019 20:36

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Nijmegen Medical Center

Conference

WCD 2019

26 August 2019 20:32

Insights into pathogenesis of AD define novel therapeutic targets

Presented By

Prof. Graham Ogg & Prof. Emma Guttman-Yassky

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 20:29

Novel treatment options for many dermatologic indications

Presented By

Prof. Lone Sko; Prof. Lars Iversen

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 20:13

Peer-reviewed article

26 August 2019 19:06

Novel treatment options in alopecia areata and vitiligo

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 18:20

Antibiotics in hidradenitis suppurativa

Presented By

Dr Dunja Ana Vekic, University of New South Wales, Australia

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 18:08

Treating keloids with lasers

Presented By

Dr Matteo Tretti Clementoni, Laserplast, Italy

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 17:40

New targets and biologics for cutaneous lupus erythematosus

Presented By

Prof. Victoria P. Werth, University of Pennsylvania, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 15:59

Novel selective IL-23 blocker highly effective over 2 years

Trial

Phase 3, IMMhance

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:52

Surgical management of melanoma

Presented By

Prof. John Kelly, The Alfred Hospital, Australia

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:48

What the future of keloid treatment could hold

Presented By

Dr Somesh Gupta, All India Institute of Medical Sciences, India

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:42

Biologicals beyond TNF blockade

Presented By

Prof. Brian Kirby, St. Vincent’s University Hospital, Ireland

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:11

Novel lupus classification will aid future research

Presented By

Prof. Joseph F. Merola, Brigham and Women´s Hospital, Harvard Medical School, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:02

Skin toxicity of immune checkpoint inhibitors

Presented By

Prof. Jennifer N. Choi, Northwestern Feinberg School of Medicine, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 10:44

Combinations are hot in AD treatment

Presented By

Dr Magdalena Trzeciak, Medical University of Gdansk, Poland

Trial

LIBERTY AD CHRONOS

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 10:34

Registries – an important research tool in biologics

Presented By

Prof. Bruce E. Strober, UConn Health, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 10:10

Advances in target-oriented therapy: psoriatic arthritis

Presented By

Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland

Trial

ECLIPSA, TICOPA

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 23:48

Favourable safety profile of long-term use of ixekizumab

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 22:50

Brodalumab onset of action is significantly faster than ustekinumab: Results from the phase 3 AMAGINE-2 and -3 studies

Presented By

Dr Sandra Philipp, Charité-Universitätsmedizin Berlin, Germany

Trial

Phase 3, AMAGINE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 21:59

Adalimumab vs adalimumab + methotrexate in psoriasis: First-year results on effectiveness, drug survival, safety, and immunogenicity

Presented By

Dr Gayle van der Kraaij, Amsterdam UMC, the Netherlands

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 20:57

Understanding genetics to unravel psoriasis and atopic dermatitis pathogenesis

Presented By

Prof. Jonathan Barker, Kings College London, United Kingdom

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 20:34

Granulomatous rosacea: exploratory histological markers

Presented By

Dr EunHye Hong, Hallym University Sacred Heart Hospital, Korea

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 20:10

Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients

Presented By

Dr Sandra Phillip, Charité-Universitätsmedizin Berlin, Germany

Trial

Phase 3, CADMUS Jr

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 19:59

Live imaging of cutaneous immune responses

Presented By

Prof. Kenji Kabashima, Kyoto University, Japan

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 19:19

Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis?

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Trial

ECLIPSE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 18:23

Fumarates and vitamin A derivatives advance and latest insights in non-biologic systemic therapeutic agents in psoriasis and atopic dermatitis

Presented By

Prof. Peter van de Kerkhof, Radboud University Medical Center, the Netherlands

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 18:02

ABP501 biosimilar for adalimumab: What you need to know

Presented By

Prof. Brian Kirby, St Vincent's Hospital, Dublin, Ireland

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 17:24

Switching infliximab biosimilars safe in treating chronic plaque psoriasis

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 16:26

Sustained and complete responses from the phase 3 AMAGINE-2 and -3 studies

Presented By

Prof. Lluís Puig, Hospital de la Santa Creu i Sant Pau, Spain

Trial

Phase 3, AMAGINE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 15:29

Certolizumab: Long-term safety and efficacy results for psoriasis-related nail disease

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

Phase 3, CIMPASI

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 15:05

Reduction in coronary artery disease in psoriasis patients treated with biologic therapies, possible implications for atopic dermatitis

Presented By

Dr Nehal Mehta; Prof. Emma Guttman-Yassky

Trial

NHANES

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 14:38

Atopic dermatitis and psoriasis: on a spectrum?

Presented By

Prof. Emma Guttman-Yassky, Mount Sinai Medical School, USA

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 13:39

Letter from the Editor

Editor

Prof. dr Peter C.M. van de Kerkhof, Radboud University Nijmegen Medical Centre, the Netherlands

Conference

SPIN 2019

21 June 2019 12:45

Treatment goals in psoriasis

Presented By

Prof. Ulrich Mrowietz

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 12:44

Small molecules, apremilast, and TYK2

Presented By

Prof. Richard Langley, Dalhousie University, Canada

Trial

ESTEEM, PALACE, LIBERATE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 09:45

Reduction in coronary artery disease in psoriasis patients treated with biologic therapies

29 April 2019 12:50

Letter from the Editor

Editor

Prof. Peter CM van de Kerkhof, Radboud University Nijmegen Medical Centre, the Netherlands

Conference

AAD 2019

23 April 2019 12:28

Interview with AAD president Prof. George J. Hruza

Expert

Prof. George J. Hruza, Laser & Dermatologic Surgery Center, St Louis, USA

Conference

AAD 2019

23 April 2019 12:12

Secukinumab maintains improvements in psoriasis through 5 years of treatment

Presented By

Prof. Richard Langley, Dalhousie University, Canada

Trial

ERASURE/FIXTURE

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 23:10

Bermekimab – a future treatment for atopic dermatitis?

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 22:17

JAK1/2 inhibitor effective in alopecia areata

Presented By

James Cassella, Concert Pharmaceuticals, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 21:21

Oral antibiotics for acne treatment

Presented By

Dr Neal Bhatia, Therapeutics Clinical research, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 20:59

New and emerging atopic dermatitis therapies

Presented By

Prof. David Cohen, New York University School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 20:43

Novel anti-IgE drug enables durable urticaria control

Presented By

Dr Diane Baker, Baker Allergy, Asthma, and Dermatology Clinic, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 20:22

JAK inhibitors: a new therapeutic tool for dermatologists

Presented By

Prof. Brett King, Yale School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 20:08

Plaque psoriasis – Efficacy of guselkumab

Trial

Phase 3, VOYAGE 1, VOYAGE 2

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 20:06

Dual IL-17A and IL-17F blocker leads to unprecedented response rates in psoriasis

Presented By

Dr Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

BE ABLE

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 19:24

Pemphigus patients prone to osteoporosis

Presented By

Dr Raj Chovatiya, Northwestern University Feinberg School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 19:10

JAK inhibitors: a pathogenesis-directed therapy for alopecia areata

Presented By

Prof. Brittany Craiglow, Yale University School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 19:10

Thicker AK lesions benefit from laser pretreatment with high channel density

Presented By

Dr Yeo-Rye Cho, Dong-A University Busan, Korea

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 18:27

Tralokinumab improves eczema and reduces staphylococcus aureus colonisation in AD

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 18:14

New standardised cantharidin product against molluscum contagiosum efficacious in two phase 3 trials

Presented By

Prof. Lawrence Eichenfield, University of California, San Diego School of Medicine and Rady´s Children´s Hospital, USA

Trial

CAMP

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 17:30

Increased cancer risk for patients with keloids

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 16:31

Bruton’s tyrosine kinase inhibitor highly effective in pemphigus vulgaris

Presented By

Prof. Dedee Murrell, University of New South Wales, Australia

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 15:36

Intralesional 5-fluorouracil induced high clearance rates in cutaneous squamous cell carcinoma

Presented By

Dr Emma Guttman-Yassky, Mount Sinai School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 15:20

Serlopitant reduces pruritus associated with psoriasis

Presented By

Dr David Pariser, Pariser Dermatology Specialists Virginia, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:38

Hair Loss: No Reason for Therapeutic Nihilism

Presented By

Dr Glynis Ablon, Dr Melissa Piliang, Prof. Antonella Tosti, Dr Jeff Donovan

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:16

Vitiligo in children

Presented By

Prof. Pearl Grimes, Vitiligo & Pigmentation Institute of Southern California, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:14

Can JAK inhibitors close the current therapeutic gap in AD?

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:12

Psoriasis and Biologics: The Beat Goes On

Presented By

Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:06

Should we use more hormonal therapy?

Presented By

Dr Julie Claire Harper, Dermatology & Skin Care Center, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:01

Surgical treatment for selected vitiligo cases

Presented By

Dr Iltefat Hamzavi, Henry Ford Hospital, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:00

JAK-inhibitors: an emerging treatment option for vitiligo

Presented By

Prof. John Harris, University of Massachusetts, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 13:53

Food triggers eczema – an imperturbable belief of patients

Presented By

Dr Peter Lio, Northwestern University Chicago, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 13:45

Letter from The Editor

Editor

Prof. dr. Peter van de Kerkhof, Radboud University Medical Centre, Nijmegen, the Netherlands

Conference

AAD 2018

31 January 2019 12:16

Better gastrointestinal tolerability with biologics than the conventional therapy

Conference

AAD 2018

Type

Peer-reviewed article

21 December 2018 17:56

Living in the golden age of psoriasis and atopic dermatitis therapies

Expert

Dr Erik Joseph Stratman, Marshfield Clinic, Wisconsin, USA

Conference

AAD 2018

21 December 2018 16:46

Improvement in impact of genital psoriasis on sexual activity with use of ixekizumab

Presented By

Dr Jennifer Cather

Trial

Aesthetics Center in Dallas, USA

Conference

AAD 2018

Type

Peer-reviewed article

21 December 2018 15:59

Intralesional cryosurgery and itching in psoriasis

Presented By

Prof. Yaron Har-Shai, University of Technion, Israel; Dr Philippa Dickison, University of Sydney, Australia

Conference

AAD 2018

Type

Peer-reviewed article

21 December 2018 14:03

Winter effect and preventing scarring

Presented By

Prof. Hillary Baldwin, Acne Treatment and Research Center, New Jersey, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:56

AD sleep disturbance, antihistamines and osteoporosis

Presented By

Prof. Jonathan Silverberg, Northwestern University’s Feinberg School of Medicine, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:36

Melanoma incidence continues to rise in Europe

Presented By

Emily Dando, University of Pittsburgh School of Medicine, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:15

Oral therapeutics, supersaturation and excimer laser

Presented By

Dr John Koo, University of California San Francisco, USA

Trial

ESTEEM 2

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:15

A glimpse into the future

Presented By

Prof. Wilma Bergfeld, Cleveland Clinic, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:08

Lesions in paediatric patients and possible correlation with coffee drinking

Presented By

Dr Ryan Kelm, Feinberg School of Medicine, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 17:22

IL-17C inhibition in AD and new oral treatments

Presented By

Prof. Diamant Thaçi, University Clinic Schleswig-Holstein, Germany; Prof. Emma Guttmann-Yassky, Mount Sinai Hospital, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 17:20

New agents and combination therapy

Presented By

Prof. Wilma Bergfeld, Cleveland Clinic, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 17:11

Restrictive antibiotic use and novel tetracycline

Presented By

Dr Leon Kircik, Indiana University School of Medicine, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 17:00

New topical and systematic treatments

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 16:42

Dual JAK/SYK inhibitor and anti-IL-33 blockade

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada; Prof. Graham Ogg, Oxford University, United Kingdom

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 16:25

Psoriasis: Selective IL-23 blocker, analysis of VOYAGE-2, dual IL-17 inhibitor and ustekinumab

Presented By

Prof. Kenneth Gordon, Medical College of Wisconsin, USA; Prof. Kristian Reich, SCIderm Research Institute, Germany; Dr Kim Papp, Probity Medical Research, Canada; Prof. Joel Gelfand, University of Pennsylvania Perelman School of Medicine, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 15:30

CNNs and targeted combination therapy

Presented By

Dr Allan Halpern, Memorial Sloan Kettering Cancer Center, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 15:27

Hyperhidrosis: Soft molecule and anticholinergic towelettes

Presented By

Dr Stacey Smith, California Dermatology & Clinical Research Institute, USA; Dr Adelaide Hebert, University of Texas Health Science Center, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 14:01

Psoriasis management online?

Presented By

Prof. April Armstrong, Keck School of Medicine, University of Southern California, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 12:25

IL-4/IL-13 inhibition

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

SOLO

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 11:49

Behcet’s syndrome and hidradenitis suppurativa

Presented By

Dr Yusuf Yazici, New York University School of Medicine, USA; Prof. Evangelos Giamarellos-Bourboulis, University of Athens Medical School, Greece

Trial

RELIEF

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 11:06

Letter from the Editor

Editor

Prof. dr Peter CM van de Kerkhof, Radboud University Nijmegen Medical Centre, the Netherlands

Conference

EADV 2018

16 September 2018 11:36

Interview with Prof. Martin Röcken

Expert

Prof. Martin Röcken, Chair of the scientific programming committee of EADV, University of Tübingen, Germany

Conference

EADV 2018

16 September 2018 11:34

Letter from the Editor

Editor

Prof. dr Peter CM van de Kerkhof, Radboud University Nijmegen Medical Centre, the Netherlands

Conference

EADV 2017

17 September 2017 11:27

Letter from the Editor

Presented By

Dr Vincent Picozzi, Virginia Mason Medical Centre, Seattle, WA, USA

Trial

Phase 3, PANOVA-3

Conference

ASCO 2025

2 June 2025 13:54

STRIDE: Semaglutide improves function, symptoms, and outcomes in patients with peripheral artery disease and type 2 diabetes

Presented By

Prof. Marc P. Bonaca, University of Colorado, CO, USA

Trial

Phase 3, STRIDE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:42

What is the optimal stent type for drainage of pancreatic pseudocysts?

Presented By

Dr Tomotaka Saito, Tokyo University, Japan

Trial

WONDER-02

Conference

DDW 2025

Type

News article

21 May 2025 11:39

Minor papilla sphincterotomy not better than sham in preventing acute pancreatitis

Presented By

Dr Gregory Coté, Oregon Health and Science University, OR, USA

Trial

SHARP

Conference

DDW 2025

Type

News article

21 May 2025 11:37

Bile-IgG4 assessment improves diagnostic workflow for hepatobiliary diseases

Presented By

Ms Fowsiyo Ahmed, Mayo Clinic, MN, USA

Conference

DDW 2025

Type

News article

21 May 2025 11:28

Therapeutic equivalence between denosumab and biosimilar Bmab-1000

Presented By

Dr Subramanian Loganathan, Biocon Biologic Ltd, India

Trial

Phase 3, DEVOTE

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:37

DPP-4 is better target to lower migraine rates in patients with type 2 diabetes

Presented By

Dr Chen Ting-Chuan, Taichung Veterans General Hospital, Taiwan

Conference

EHC 2024

Type

News article

6 January 2025 11:10

Neoadjuvant chemoradiation does not improve surgical outcomes or survival in pancreatic cancer

Presented By

Dr Aurélien Lambert, Lorraine Cancer Institute, France

Trial

Phase 2, PANDAS/PRODIGE 44

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:18

Liraglutide achieves 5.8% reduction in BMI for children aged 6-12

Presented By

Dr Claudia Fox, University of Minnesota Medical School, MN, USA

Trial

Phase 3, SCALE Kids

Conference

EASD 2024

23 September 2024 16:06

FINE-HEART: Finerenone demonstrates benefits in patients with T2D

Presented By

Dr Pardeep Jhund, University of Glasgow & Queen Elizabeth University Hospital, UK

Trial

Phase 3, FINE-HEART

Expert

Dr Alex McDonald (Board member, Physician’s Weekly) and Dr Rachel Giles (Medical Science Officer, Medicom Medical Publishers)

25 January 2023 02:33

Arterial stiffness may best hypertension for predicting diabetes risk in Chinese patients

Journal

Hypertension

1 June 2022 22:36

Head-to-head: Etoposide and irinotecan equally effective in neuroendocrine carcinoma

Presented By

Dr Chigusa Morizane, National Cancer Center Hospital, Japan

Trial

Phase 3, JCOG1213, TOPIC-NEC

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 12:26

Dapagliflozin tied to reduction in new-onset diabetes in patients with CKD, heart failure

Journal

The Lancet Diabetes and Endocrinology

17 December 2021 21:28

High-frequency spinal cord stimulation provides lasting relief of painful diabetic neuropathy

Journal

Diabetes Care, Journal of Diabetes Science and Technology

6 December 2021 21:08

Icosapent ethyl reduced ischemic events, even with reduced kidney function

Conference

EASD 2020

Type

News article

14 December 2020 12:38

High risk of vascular dementia in patients with T2D

Presented By

Dr Carlos Celis-Morales, University of Glasgow, Scotland

Conference

EASD 2020

Type

News article

14 December 2020 12:36

HbA1c reduction with GLP-1RA leads to lower risk of CV events in cardiovascular outcome trials

Presented By

Dr Mart Roosimaa , University of Tartu, Estonia

Conference

EASD 2020

Type

News article

14 December 2020 12:35

Diabetes still goes unnoticed, resulting in delayed diagnosis

Presented By

Dr Katie Young, University of Exeter Medical School, United Kingdom

Conference

EASD 2020

Type

News article

14 December 2020 12:34

Shared pathways for COVID-19 and diabetes?

Conference

EASD 2020

Type

News article

14 December 2020 12:32

Patients with RA have higher risk of developing diabetes

Presented By

Dr Zixing Tian, University of Manchester, United Kingdom

Conference

EASD 2020

Type

News article

14 December 2020 12:31

Once-weekly insulin is a promising treatment option

Presented By

Dr Julio Rosenstock, University of Texas Southwestern, USA

Trial

Phase 2

Conference

EASD 2020

Type

News article

14 December 2020 12:29

Non-invasive monitoring by measuring glycated albumin in tears

Presented By

Dr Masakazu Aihara, University of Tokyo, Japan

Conference

EASD 2020

Type

News article

14 December 2020 12:28

More exercise means less risk of all-cause mortality amongst T2D patients.

Presented By

Dr Yun-Ju Lai , Taichung Veterans General Hospital, Taiwan

Conference

EASD 2020

Type

News article

14 December 2020 12:27

Intermittent fasting: consuming fewer calories but in a different way.

Presented By

Prof. Krista Varady, University of Illinois, Chicago, USA

Conference

EASD 2020

Type

News article

14 December 2020 12:24

Timing of mealtime insulin can affect quality of life

Conference

EASD 2020

Type

News article

14 December 2020 12:22

EASD 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EASD 2020

8 December 2020 15:44

Spread through air spaces is prognostic in lung neuroendocrine tumours

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 22:04

Prognostic value of distant organ-specific metastases in newly diagnosed lung neuroendocrine tumours

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 21:08

Gastroenterology

Dr Kyung Park, Keimyung University Dongsan Hospital, South Korea

Trial

Phase 3

Conference

DDW 2025

Type

News article

21 May 2025 12:42

Novel treatment option to prevent NSAID-induced peptic ulcers

Presented By

Dr Song Baek, Daewoong Pharmaceutical Co Ltd, South Korea

Trial

Phase 3

Conference

DDW 2025

Type

News article

Presented By

Dr Kyuwon Kim, Chung-Ang University Hospital, South Korea

Conference

DDW 2025

Type

News article

21 May 2025 12:34

Molecular assessments improve anti-TNF outcomes in IBD

Presented By

Dr Florian Tran, University Hosptial Schleswig-Holstein, Germany

Trial

GUIDE-IBD

Conference

DDW 2025

Type

News article

21 May 2025 12:32

What is the optimal stent type for drainage of pancreatic pseudocysts?

Presented By

Dr Tomotaka Saito, Tokyo University, Japan

Trial

WONDER-02

Conference

DDW 2025

Type

News article

21 May 2025 11:39

Minor papilla sphincterotomy not better than sham in preventing acute pancreatitis

Presented By

Dr Gregory Coté, Oregon Health and Science University, OR, USA

Trial

SHARP

Conference

DDW 2025

Type

News article

21 May 2025 11:37

MRI-derived liver disease markers linked to liver and cardiovascular events

Presented By

Dr Prashant Pandya, Kansas University Medical Center, KS, USA

Conference

DDW 2025

Type

News article

21 May 2025 11:32

GLP-1 receptor agonists might reverse liver pathology in MASH

Presented By

Dr Noppachai Siranart, Brigham and Women’s Hospital, MA, USA

Conference

DDW 2025

Type

News article

Presented By

Prof. Palle Jeppesen, Rigshospitalet, Copenhagen, Denmark

Conference

DDW 2025

Type

News article

21 May 2025 11:17

Letter from the Editor

Presented By

Dr Marjolijn Duijvestein, Radboudumc, the Netherlands

Conference

ECCO 2025

8 April 2025 13:29

Antibody responses predict IBD onset 10 years before diagnosis

Presented By

Dr Arno Bourgonje, University Medical Center Groningen, the Netherlands

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:48

Therapeutic antibody clearance reliable predictor for endoscopic outcomes in CD

Presented By

Dr Erwin Dreesen, KU Leuven, Belgium

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:46

Higher neoplasia detection rate with virtual chromoendoscopy in real-world IBD study

Presented By

Dr Chandni Radia, King’s College London, UK

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:44

Reducing the carbon footprint of IBD care

Presented By

Dr Marjolijn Duijvestein, Radboud University Medical Center, the Netherlands

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:43

TL1A-LTB axis induces perianal fistulising disease-associated changes in CD

Presented By

Dr Victoria Gudino, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Spain

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:31

Emulsifier-restrictive diet effective in alleviating symptoms in CD

Presented By

Dr Aaron Bancil, King’s College London, UK

Trial

ADDapt

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:26

Could stem cell transplantation be a fruitful solution for refractory CD?

Presented By

Dr Louis Cohen, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:24

First IL-7 inhibitor for UC shows its potential

Presented By

Dr Arnaud Bourreille, CHU Nantes, France

Trial

Phase 2, CoTikiS

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:03

Novel TL1A inhibitor achieves high rates at stringent endpoints in UC

Presented By

Prof. Vipul Jairath, Western University, Canada

Trial

Phase 2, TUSCANY-2

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:57

Positive results for TL1A inhibitor duvakitug in CD

Presented By

Prof. Vipul Jairath, Western University, Canada

Trial

Phase 2, RELIEVE UCCD

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:52

Improving efficacy with longer mirikizumab treatment in CD

Presented By

Prof. Séverine Vermeire, KU Leuven, Belgium

Trial

Phase 3, VIVID-2

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:39

Long-term upadacitinib data reassuring for patients with UC

Presented By

Prof. Remo Panaccione, University of Calgary, Canada

Trial

Phase 3, U-ACTIVATE

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:37

EFFICACI: Infliximab or vedolizumab after TNF failure in UC?

Presented By

Prof. Guillaume Bouguen, CHU Rennes, France

Trial

EFFICACI

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:34

Latest data for subcutaneous guselkumab in CD and UC

Presented By

Prof. Ailsa Hart, London North-West University, UK; Prof. Laurent Peyrin-Biroulet, University of Lorraine, France

Trial

Phase 3, GRAVITI, ASTRO

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:31

Long-term use of etrasimod in UC safe and well-tolerated

Presented By

Prof. Séverine Vermeire, KU Leuven, Belgium

Trial

OASIS, ELEVATE, ES101002

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:22

Sustained efficacy and stable safety profile for risankizumab in UC

Presented By

Prof. Raja Atreya, Friedrich-Alexander University, Germany

Trial

Phase 3, COMMAND

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:08

VEDOKIDS: Long-term outcomes of vedolizumab in paediatric IBD

Presented By

Dr Ohad Atia, Shaare Zedek Medical Centre, Israel

Trial

VEDOKIDS

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:56

PREdiCCT: Role of psychosocial factors in IBD flares unravelled

Presented By

Dr Lauranne Derikx, Erasmus MC, the Netherlands

Trial

PREdiCCT

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:49

Kono-S or side-to-side anastomosis for resection in Crohn’s terminal ileitis?

Presented By

Dr Koianka Trencheva, Cornell University, NY, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:47

Identifying patients at high risk for chronic pouchitis

Presented By

Dr Edward Barnes, University of North Carolina at Chapel Hill, NC, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:34

ECCO consensus on diet and nutrition in IBD

Presented By

Dr Richard Hansen, University of Dundee, UK; Dr Vaios Svolos, University of Thessaly, Greece

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:20

ECCO Topical Review: pouch-related disorders

Presented By

Dr Maia Kayal, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 09:18

ECCO 2025 Highlights Podcast

Presented By

Dr Rachel Giles & Robert van den Heuvel, Medicom

Conference

ECCO 2025

10 March 2025 12:53

Letter from the Editor

Presented By

Dr Marjolijn Duijvestein, Radboudumc, the Netherlands

Conference

UEGW 2024

28 November 2024 11:37

A paradigm shift in CD clinical practice

Presented By

Dr Nuru Noor, University of Cambridge, UK

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:24

LOVE-CD: Vedolizumab yields better outcomes in early than in late CD

Presented By

Prof. Geert D’Haens, Amsterdam UMC, the Netherlands

Trial

LOVE-CD

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:24

Moving towards the prevention of IBD

Presented By

Dr Arno Bourgonje, University Medical Center Groningen, the Netherlands

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:23

New insights into perianal fistulising CD pathogenesis may lead to new therapies

Presented By

Dr Siyan Cao, Washington University, USA

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:23

Risankizumab influences key pathogenic Th17 cells in CD

Presented By

Dr Daniele Noviello, University of Milan, Italy

Trial

SEQUENCE

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:23

Meaningful corticosteroid-sparing effect of mirikizumab in UC

Presented By

Prof. David Laharie, University of Bordeaux, France

Trial

Phase 3, LUCENT-2

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:22

Extending ustekinumab dosing interval does not influence drug survival in IBD

Presented By

Dr Monique Devillers, Erasmus University Medical Center, the Netherlands

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:22

CULTIVATE: Promising signal for etrasimod in Crohn’s disease

Presented By

Prof. Geert D’Haens, Amsterdam UMC, the Netherlands

Trial

Phase 2, CULTIVATE

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:22

Tamuzimod delivers promising long-term data in UC

Presented By

Prof. Silvio Danese, Vito-Salute San Raffaele University, Italy

Trial

Phase 2

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:22

TL1A inhibitor tulisokibart shows potential in UC

Presented By

Dr Christopher Ma, University of Calgary, Canada

Trial

Phase 2, ARTEMIS-UC

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:21

Upadacitinib associated with normalisation of HRQoL in UC

Presented By

Dr Joana Torres, Hospital Beatriz Ângelo, Portugal

Trial

U-ACHIEVE; U-ACCOMPLISH

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:21

Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA

Presented By

Dr Serena Stigliano, University of Rome, Italy

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:21

An accelerated treatment approach may save lives in pancreatic walled-off necrosis

Presented By

Dr Gitte Olsen, Copenhagen University Hospital, Denmark

Trial

ACCELERATE

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:21

Guar gum alleviates IBS-related constipation in a randomised controlled trial

Presented By

Dr Silvia Delgado-Aros, Nestle Health Sciences, Switzerland

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:20

How useful is colonoscopy for constipation in young women?

Presented By

Dr Amani Beshara, Hillel Yaffe Medical Center, Israel

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:20

Tradipitant improves symptoms of motion sickness

Presented By

Dr Vasilios Polymeropoulos

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:19

Encouraging results for L-carnitine in metabolic dysfunction-associated steatotic liver disease

Presented By

Dr Pezhman Alavinejad, Ahvaz Jundishapur University of Medical Sciences, Iran

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:19

Exploring zibotentan plus dapagliflozin for cirrhosis

Presented By

Dr Phil Ambery

Trial

Phase 2, ZENITH-CKD

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:19

TACITO: Does faecal microbiota transplantation improve survival in mRCC?

Presented By

Dr Gianluca Ianiro, Agostino Gemelli University Policlinic, Italy

Trial

Phase 2, TACITO

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:19

Is faecal microbiota transplantation a viable option to treat primary C. difficile infections?

Presented By

Dr Frederik Juul, Oslo University Hospital, Norway

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:18

Cendakimab meets primary endpoints in eosinophilic oesophagitis

Presented By

Prof. Alain Schoepfer, University of Lausanne, Switzerland

Trial

Phase 3

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:18

Neoadjuvant chemoradiation does not improve surgical outcomes or survival in pancreatic cancer

Presented By

Dr Aurélien Lambert, Lorraine Cancer Institute, France

Trial

Phase 2, PANDAS/PRODIGE 44

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:18

Adding lenvatinib plus pembrolizumab to TACE improves PFS in intermediate-stage HCC

Presented By

Prof. Josep Llovet, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, LEAP-012

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:16

Benefit of adjuvant atezolizumab/bevacizumab in HCC not maintained over time

Presented By

Dr Adam Yopp, UT Southwestern Medical Center, TX, USA

Trial

Phase 3, IMbrave050

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:13

Pre-operative chemoradiation does not improve survival in resectable gastric cancer

Presented By

Prof. Trevor Leong, Peter MacCallum Cancer Centre, Australia

Trial

Phase 3, TOPGEAR

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:10

Final results of the IKF-AIO-Moonlight trial

Presented By

Dr Sylvie Lorenzen, Rechts der Isar Hospital, Germany

Trial

Phase 2, IKF-AIO-Moonlight

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:08

Retifanlimab boosts survival in patients with anal cancer

Presented By

Dr Sheela Rao, Royal Marsden, UK

Trial

Phase 3, POD1UM-303/InterAACT 2

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:04

NICHE-2 and NICHE-3 show high efficacy of short neoadjuvant immunotherapy in dMMR colon cancer

Presented By

Dr Myriam Chalabi, Netherlands Cancer Institute, the Netherlands; Dr Peter de Gooyer, Netherlands Cancer Institute, the Netherlands

Trial

Phase 2, NICHE

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 13:00

Organ-preserving regimens in rectal cancer

Presented By

Dr Alessio Amatu, Niguarda Cancer Center, Italy; Dr Syrine Ben Dhia, Antoine Lacassagne Center, France

Trial

NO-CUT, OPERA

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:57

No benefit of high-dose vitamin D3 supplementation in mCRC

Presented By

Dr Kimmie Ng, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 3, SOLARIS

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:51

More highlights in Colorectal Cancer

Trial

POCHI, LEANOX

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:48

UEGW 2024 Highlights Podcast

Presented By

Robert van den Heuvel

Conference

UEGW 2024

Presented By

Dr Arvind Dasari, MD Anderson Cancer Center, TX, USA

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:48

CAPRI 2 GOIM trial navigates biomarker-driven therapy

Presented By

Dr Giulia Martini, University of Campania Luigi Vanvitelli, Italy

Trial

Phase 2, CAPRI 2 GOIM

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:44

Meta-analysis of triplet therapy in BRAFV600E-mutated mCRC

Presented By

Dr Davi Said G. Celso, Federal University of Viçosa, Brazil

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:41

CheckMate 8HW: Nivolumab/ipilimumab in MSI-H/dMMR mCRC

Presented By

Dr Sara Lonardi, Veneto Institute of Oncology, Italy

Trial

Phase 3, CheckMate 8HW

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:39

Sequence effect for third-line treatment of mCRC

Presented By

Prof. Michel Ducreux, Gustave Roussy, France

Trial

Phase 2, SOREGATT

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:36

REGINA meets stage 1 endpoint in rectal cancer and moves to stage 2 with reduced dose regorafenib

Presented By

Dr Francesco Sclafani, Institut Jules Bordet, Belgium

Trial

Phase 2, REGINA

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:34

High efficacy of pembrolizumab combined with standard therapy in patients with MSS/pMMR mCRC and high immune infiltrate

Presented By

Prof. David Tougeron, Poitiers University Hospital, France

Trial

Phase 2, POCHI

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:31

Prognostic value of ctDNA in stage III colon cancer

Presented By

Prof. Julien Taieb, Paris Descartes University, France

Trial

Phase 3, IDEA-France, IDEA-Greece

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:28

Neoadjuvant combined immunotherapy also effective in MSS/pMRR CRC

Presented By

Dr Mehraneh Jafari, Weill Cornell Medical Center, NY, USA

Trial

Phase 2, NEST-1

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:25

Neoadjuvant immunotherapy plus radiation effective in advanced MSI-H rectal cancer

Trial

Phase 2, ECOG-ACRIN EA2201

Type

Peer-reviewed article

21 August 2024 11:19

Peri- or post-operative chemotherapy benefits patients with resectable CRCLM

Presented By

Dr Giacomo Bregni, Brussels University Hospital, Belgium

Trial

Phase 3

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:12

MINOTAUR: Promising phase 1 data for lunresertib plus FOLFIRI

Presented By

Dr Elisa Fontana, Sarah Cannon Research Institute, UK

Trial

Phase 1, MINOTAUR

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:09

TRANSMET meets OS endpoint

Presented By

Dr Maximiliano Gelli, Gustave Roussy, France

Trial

TRANSMET

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:05

No survival benefit of tumour debulking for patients with multi-organ metastatic CRC

Presented By

Dr Elske Gootjes, Radboudumc, the Netherlands

Trial

Phase 3, ORCHESTRA

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:53

Thermal ablation of small-size colorectal liver metastases is non-inferior to resection

Presented By

Prof. Martijn Meijerink, Amsterdam UMC, the Netherlands

Trial

Phase 3, COLLISION

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:48

Benefit of first-line nivolumab/ipilimumab in MSI-H/dMMR metastatic CRC

Presented By

Prof. Heinz-Josef Lenz, University of Southern California Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 3, CheckMate 8HW

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:44

Neoadjuvant checkpoint blockade in MSI-H/dMMR CRC

Trial

Phase 1/2, NICHE-2, NEOPRISM-CRC

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:36

CodeBreaK 300: Promising survival trends in KRAS G12C-mutated mCRC

Presented By

Prof. Marwan Fakih, City of Hope Comprehensive Cancer Center, CA, USA

Trial

Phase 3, CodeBreaK 300

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:26

FLOT outperforms CROSS in resectable oesophageal cancer

Presented By

Prof. Jens Höppner, University of Bielefeld, Germany

Trial

Phase 3, ESOPEC

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:14

Nivolumab/ipilimumab combination outperforms TKIs in unresectable HCC

Presented By

Dr Peter Galle, Universitätsmedizin Mainz, Germany

Trial

Phase 3, CheckMate 9DW

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:10

No advantage of neoadjuvant radiochemotherapy over neoadjuvant chemotherapy in borderline resectable pancreatic cancer

Presented By

Dr Masafumi Ikeda, National Cancer Center Hospital East, Japan

Trial

Phase 3, GABARNANCE

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:06

DEFIFrance: Real-world use of defibrotide for VOD/SOS

17 July 2024 12:27

Peer-reviewed article

11 July 2024 13:38

Quality-of-life assessment in children with eosinophilic oesophagitis

Presented By

Émile L'Heureux-Hubert, University of Montreal, Canada

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 13:36

Gut permeability and neuroinflammation linked in Parkinson’s disease

Presented By

Dr Francesco Rettura, University of Pisa, USA

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 13:26

Promising data for cardiovascular outcomes of bariatric surgery in patients with obesity

Presented By

Dr Soban Maan, West Virginia University, USA

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 13:23

Dr Laura Raffals, Mayo Clinic, USA

Trial

Phase 3, ADMIRE-CD II

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 12:47

PREEMPT CRC: Blood-based screening test for colorectal cancer shows promise

Presented By

Dr Aasma Shaukat, New York University, USA

Trial

PREEMPT CRC

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 12:33

New cable-transmission capsule endoscopy shows high accuracy in detecting upper GI lesions

Presented By

Dr Yuan Tian, Peking University First Hospital, China

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 12:26

Superior OS with atezolizumab plus bevacizumab versus lenvatinib in unresectable HCC

Presented By

Dr Sangdao Boonkaya, King Chulalongkorn Memorial Hospital, Thailand

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 11:46

REGENERATE study: Obeticholic acid shows antifibrotic benefit in NASH

Presented By

Dr Arun J Sanyal, Virginia Commonwealth University, USA

Trial

Phase 3, REGENERATE

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 11:41

Acalculous cholecystitis as a risk factor for gallbladder perforation: insights from a 10-year retrospective study

Presented By

Dr Se Woo Park, Hallym University Dongtan Sacred Heart Hospital, South Korea

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 11:36

STARS: Apraglutide shows efficacy in short bowel syndrome with intestinal failure

Presented By

Prof. Francisca Joly, Hopital Beaujon, France

Trial

Phase 3, STARS

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 11:30

COX-2 inhibitors show promise in reducing severity of acute pancreatitis

Presented By

Dr Lu-Ming Huang, West China Hospital of Sichuan University, China

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 11:23

Hormone-containing therapies may increase the risk of IBS and functional dyspepsia

Presented By

Dr Michael Jones, Macquarie University, Australia

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 11:15

New study validates utility of refined EBMT criteria for VOD

19 June 2024 13:46

Refined diagnostic criteria for SOS/VOD in adult patients: 2023 update by the EBMT

19 June 2024 13:32

DDW 2024 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

DDW 2024

5 June 2024 15:36

Letter from the Editor

Editor

Dr Marjolijn Duijvestein, Radboudumc, the Netherlands

Conference

ECCO 2024

18 April 2024 13:55

VIVID-1: Mirikizumab meets expectations in Crohn’s disease

Presented By

Prof. Marc Ferrante, University Hospitals Leuven, Belgium

Trial

Phase 3, VIVID-1

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:49

COMMAND: Long-term efficacy benefits of risankizumab in ulcerative colitis

Presented By

Prof. Stefan Schreiber, University Hospital Schleswig-Holstein, Germany

Trial

Phase 3, COMMAND

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:47

SEQUENCE: Risankizumab versus ustekinumab across endpoints

Presented By

Prof. Marla Dubinsky, Mount Sinai Hospital, NY, USA

Trial

Phase 3, SEQUENCE

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:45

QUASAR: Guselkumab improves QoL for patients with ulcerative colitis

Presented By

Prof. Julian Panés, Hospital Clinic de Barcelona, Spain

Trial

Phase 3, QUASAR

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:43

Fatigue, urgency, and QoL improvements on mirikizumab in Crohn’s disease

Presented By

Prof. Simon Travis, University of Oxford, UK

Trial

Phase 3, VIVID-1

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:41

Novel agent VTX002 holds promise in ulcerative colitis

Presented By

Prof. Bruce Sands, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 2

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:39

PROFILE: Top-down treatment strategy benefits patients with early Crohn’s disease

Presented By

Dr Nuru Noor, Cambridge University Hospitals, UK

Trial

PROFILE

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:38

Biologicals and JAK inhibitors hold promise in microscopic colitis

Presented By

Dr Bram Verstockt, University Hospitals Leuven, Belgium

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:35

Ustekinumab as alternative for anti-TNFs in HLA-DQA1*05-positive Crohn’s disease

Presented By

Dr Jordi Guardiola, University Hospital Bellvitge, Spain

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:33

How effective is dose escalation of biologicals in IBD?

Presented By

Dr Cristina Rubín de Célix, University Hospital La Princesa, Spain

Trial

RAINBOW-IBD

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:30

Promising data for JAK inhibitors in Crohn’s disease from phase 2 trial

Presented By

Dr Séverine Vermeire, University Hospitals Leuven, Belgium

Trial

Phase 2, PIZZICATO

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:28

U-ENDURE long-term extension: sustained efficacy of upadacitinib in Crohn’s disease

Presented By

Dr Geert D’Haens, Amsterdam University Medical Centers, the Netherlands

Trial

U-ENDURE

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:25

TRIUMPH: Tofacitinib as rescue option for acute severe ulcerative colitis

Presented By

Dr Neeraj Narula, McMaster University, Canada

Trial

Phase 2, TRIUMPH

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:23

Should we screen for metabolic bone disease at IBD diagnosis?

Presented By

Dr Mohamed Attauabi, Copenhagen University Hospital, Denmark

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:20

Predicting relapse in ulcerative colitis with AI-assisted endoscopy

Presented By

Dr Yasuharu Maeda, Showa University Northern Yokohama Hospital, Japan; University College Cork, Ireland

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:19

Clear case for NUDT15 genetic testing in Asian patients with IBD

Presented By

Dr Chris Roberts, University of Exeter, UK

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:14

HELIOS: HD-WLE can yield similar neoplasia detection rates as HD-CE

Presented By

Dr Maarten te Groen, Radboudumc, the Netherlands

Trial

HELIOS

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:12

CURE-CD: Capsule endoscopy-guided proactive treatment leads to fewer relapses in Crohn’s disease

Presented By

Dr Shomron Ben-Horin, Tel-Aviv University, Israel

Trial

CURE-CD

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:10

Extended mesenterectomy or mesenteric-sparing surgery in Crohn’s disease?

Presented By

Dr Eline van der Does de Willebois, Amsterdam University Medical Centers, the Netherlands

Trial

SPICY

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 12:33

Similar outcomes for Kono-S and side-to-side anastomosis in Crohn’s terminal ileitis

Presented By

Dr Koianka Trencheva, Weill Cornell Medicine, NY, USA

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 12:29

Risk factors for re-resection in Crohn’s disease revealed

Presented By

Dr Anja Poulsen, Copenhagen University, Denmark

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 12:26

ADMIRE-CD-II: Darvadstrocel does not meet primary endpoint in complex peri-anal fistula

Presented By

Dr Zuzana Serclova, Hořovice Hospital, Czech Republic

Trial

Phase 3, ADMIRE-CD-II

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 12:23

Determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies

18 March 2024 09:53

Recommendation to screen for colorectal cancer by full colonoscopy in first-degree relatives of patients

18 March 2024 09:42

ECCO 2024 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

ECCO 2024

11 March 2024 04:00

Join the conversation on Rare Disease Awareness Day

Expert

Prof. Rachel Giles

26 February 2024 11:42

Interview: The winding road to curing metastatic colorectal cancer

Expert

Dr Eduard Batlle, Institute for Research in Biomedicine Barcelona, Spain

23 February 2024 15:22

Letter from the Editor

Editor

Dr Marjolijn Duijvestein, Radboudumc, the Netherlands

Conference

UEGW 2023

7 December 2023 15:51

DIVERSITY1: Filgotinib results in Crohn’s disease leave investigators puzzled

Presented By

Prof. Séverine Vermeire, UZ Leuven, Belgium

Trial

Phase 3, DESTINY1

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:48

SEQUENCE: Risankizumab doubles endoscopic remission rates compared with ustekinumab in CD

Presented By

Prof. Laurent Peyrin-Biroulet, University Hospital of Nancy, France

Trial

Phase 3, SEQUENCE

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:44

Guselkumab provides benefits in UC regardless of advanced therapy history

Presented By

Prof. Axel Dignass, Goethe University, Germany

Trial

Phase 3, QUASAR

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:42

INSPIRE: Risankizumab meets all efficacy endpoints in UC

Presented By

Prof. Edouard Louis, Liège University Hospital, Belgium

Trial

Phase 3, INSPIRE

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:39

Risankizumab resolves extraintestinal manifestations in CD

Presented By

Prof. Subrata Ghosh, Cork University College, Ireland

Trial

Phase 3, ADVANCE; MOTIVATE; FORTIFY

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:36

Obefazimod takes the spotlight as promising UC treatment

Presented By

Prof. Séverine Vermeire, UZ Leuven, Belgium

Trial

Phase 2

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:32

Rapid response to upadacitinib boosts outcomes in severe Crohn’s disease

Presented By

Prof. Jean-Frederic Colombel, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, U-EXCEED; U-EXCEL

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:27

LUCENT trials: Mirikizumab works in UC, regardless of targeted therapy history

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, LUCENT-2

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:23

ARTEMIS-UC: New kid in town for UC

Presented By

Prof. Bruce Sands, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 2, ARTEMIS-UC

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:20

Subcutaneous infliximab shows promise in UK IBD study

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:16

Safer removal of large polyps with cold snare technique

Presented By

Dr Ingo Steinbrück, Evangelisches Diakoniekrankenhaus Freiburg, Germany

Trial

CHRONICLE

Conference

UEGW 2-23

Type

Peer-reviewed article

7 December 2023 15:12

Higher recurrence rates with cold snare EMR than with conventional EMR

Presented By

Dr Óscar Nogales, Hospital General Universitario Gregorio Marañón, Spain

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:10

How to deal with at-risk patients above the CRC screening age limit?

Presented By

Dr Esther Toes-Zoutendijk, Erasmus University Medical Center, the Netherlands

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:05

European CRC screening needs to be revised

Presented By

Dr Julian Prosenz, Karl Landsteiner University of Health Sciences, Austria

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:02

Epinephrine boosts efficiency in gastric ESD

Presented By

Dr Hon Chi Yip, The Chinese University of Hong Kong, China

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 14:38

Artificial intelligence-aided colonoscopy did not improve outcomes in Lynch syndrome

Presented By

Mr Oswaldo Ortiz, Hospital Clinic Barcelona, Spain

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 14:34

Ms Linda Weißer, HiDoc Technologies GmbH, Germany

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 14:18

GastroGPT: Successful proof-of-concept study of gastroenterology-specific large language model

Presented By

Dr Cem Şimşek, Hacettepe University, Turkey

Trial

GastroGPT

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 14:14

Primary results from MAESTRO-NASH trial: resmetirom efficacious for NASH

Presented By

Prof. Jörn Schattenberg, University Medical Center Mainz, Germany

Trial

Phase 3, MAESTRO-NASH

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 14:03

Apraglutide: Advancing the treatment of short bowel syndrome

Presented By

Ms Astrid Verbiest, University of Leuven, Belgium

Trial

Phase 2

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 13:58

Endobiliary radiofrequency ablation in pCCA: a pilot study

Presented By

Dr Jeska Fritzsche, Amsterdam UMC, the Netherlands

Trial

RACCOON-P

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 13:55

Raising awareness for microscopic colitis: disease course and predictors

Presented By

Dr Bas Verhaegh, Laurentius Hospital Roermond, the Netherlands

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 13:51

Reprogramming stem cells to heal intestinal mucosa in IBD: fact or fiction?

Expert

Dr Cambrian Liu, University of Chicago, IL, USA

1 November 2023 21:03

UEGW 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

UEGW 2023

30 October 2023 01:46

1-year mortality risk score for GI bleeding with antithrombotics

6 October 2023 11:42

Linking the Black Death with Crohn’s disease predisposition

Expert

Dr Luis Barreiro, University of Chicago, IL, USA

19 July 2023 15:50

Clinics on wheels – Bringing healthcare to patients in underserved communities

Expert

Dr Priya Sarin Gupta, Mass General Brigham, MA, USA

18 July 2023 11:28

EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease

Presented By

Prof. Marc Ferrante, KU Leuven, Belgium

Trial

EVOLVE

Conference

DDW 2023

Type

News article

Presented By

Dr Jose Maria Remes-Troche, Veracruzana University, Mexico

Conference

DDW 2023

Type

News article

13 June 2023 13:45

Daily and seasonal fluctuations in the gut microbiome

Presented By

Dr Carolina Dantas Machado, UC San Diego, CA, USA

Conference

DDW 2023

Type

News article

13 June 2023 13:43

Colorectal cancer: Aspirin and NSAIDs could reduce the risk of early-onset adenomas

Presented By

Dr Cassandra Fritz, Washington University School of Medicine, MO, USA

Conference

DDW 2023

Type

News article

13 June 2023 13:38

PIPAC technique shows promise for unresectable colorectal peritoneal metastases

Presented By

Dr Vincent van de Vlasakker, Catharina Hospital, the Netherlands

Trial

Phase 2, CRC-PIPAC-II

Conference

DDW 2023

Type

News article

13 June 2023 13:36

Effectiveness of B/F/TAF treatment in HIV/HBV co-infection

Trial

Phase 3, Alliance

Conference

DDW 2023

Type

News article

13 June 2023 13:33

Terlipressin shows promise for participants with hepatorenal syndrome and concomitant alcoholic hepatitis

Presented By

Dr Kevin Korenblat, Washington University School of Medicine, MO, USA

Trial

Phase 3, CONFIRM

Conference

DDW 2023

Type

News article

13 June 2023 13:30

Mepolizumab shows potential in eosinophilic oesophagitis treatment

Trial

Phase 2, Mepo for EoE

Conference

DDW 2023

Type

News article

13 June 2023 13:27

Dupilumab improves eosinophilic oesophagitis outcomes, regardless of history of oesophageal dilation

Presented By

Prof. Arjan Bredenoord, University of Amsterdam, the Netherlands

Trial

Phase 3, LIBERTY-EoE-TREET

Conference

DDW 2023

Type

News article

13 June 2023 13:23

Linaprazan glurate in the treatment of erosive oesophagitis

Conference

DDW 2023

Type

News article

13 June 2023 13:21

Novel clinical score for predicting laryngopharyngeal reflux

Conference

DDW 2023

Type

News article

13 June 2023 13:18

Coeliac Disease: “among the top 10 hard-to-diagnose common diseases” – an interview with Dr Cynthia Kelly

4 May 2023 17:05

Diabetes therapy with GLP-1-based drugs does not elevate the risk of IBD

Presented By

Dr Heidi Søgaard Christensen , Aalborg University Hospital, Denmark

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:59

Long-term resection potentially better than anti-TNF treatment in CD

Presented By

Prof. Manasi Agrawal, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

LIR!C

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:58

Early, post-operative complications in CD reduced by pre-operative enteral nutrition, irrespective of biologic exposure

Presented By

Prof. Mathurin Fumery, Amiens University Hospital, France

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:55

Perinatal period is crucial for the risk of developing CD

Presented By

Prof. Sun-Ho Lee, Mount Sinai Hospital, Canada

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:53

Drop in overall IBD procedures during the pandemic

Presented By

Dr M Derks Eduarda Wilhelmina, Radboud University Medical Centre, the Netherlands

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:46

Early-life antibiotic exposure: a risk factor for paediatric-onset IBD

Presented By

Dr Mikkel Malham, Copenhagen University Hospital, Denmark

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:46

Proton pump inhibitors associated with worse outcomes in CD

Presented By

Dr Stéphanie Barrau, Saint Etienne University Hospital, France

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:42

Paediatric patients with immune-mediated inflammatory disease harbour a heightened cancer risk

Presented By

Ms Andrea Ehrström , Hvidovre Hospital, Denmark

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:40

Poor sleep in CD linked to low levels of vitamin D

Presented By

Dr Caroline Walker, Tallaght University Hospital, Ireland

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:38

Novel AI tool assessing mucosal inflammation achieves high correlation with histopathologists

Presented By

Prof. Laurent Peyrin-Biroulet, Nancy University Hospital, France

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:33

Letter from the Editor

Editor

Dr Marjolijn Duijvestein, Radboudumc, the Netherlands

Conference

ECCO 2023

4 May 2023 16:30

Beneficial effect of early, post-operative vedolizumab on endoscopic recurrence in CD

Presented By

Prof. Geert D’Haens , Academic Medical Center University of Amsterdam, the Netherlands

Trial

REPREVIO

Conference

ECCO

Type

Peer-reviewed article

4 May 2023 16:28

Long-term data supports the established efficacy and safety of ustekinumab in UC

Presented By

Prof. Silvio Danese , Vita-Salute San Raffaele University, Italy

Trial

UNIFI LTE UNIFI LTE

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:21

Anti-TNF withdrawal may be a safe option in stable IBD

Presented By

Prof. María Chaparro Sánchez , Hospital Universitario de La Princesa, Spain

Trial

Phase 4, EXIT

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:12

Intensified drug therapy leads to better stricture morphology in CD

Presented By

Dr Julien Schulberg , St Vincent’s Hospital Melbourne, Australia

Trial

STRIDENT

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:03

Continued efficacy of long-term ozanimod as UC treatment

Presented By

Prof. Silvio Danese , Vita-Salute San Raffaele University, Italy

Trial

True North OLE

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 15:51

Upadacitinib successful in the management of both CD and UC

Presented By

Dr Brian Feagan , University of Western Ontario, Canada

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 15:40

Solid results for long-term therapy of UC with filgotinib

Presented By

Dr Brian Feagan, University of Western Ontario, Canada

Trial

Phase 3, SELECTION

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 15:01

ECCO 2023 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ECCO 2023

16 March 2023 08:01

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Top 14 Medical Innovations for 2022

Expert

Dr Alex McDonald (Board member, Physician’s Weekly) and Dr Rachel Giles (Medical Science Officer, Medicom Medical Publishers)

25 January 2023 02:33

Letter from the Editor

Editor

Dr Marjolijn Duijvestein, Radboudumc, the Netherlands

Conference

UEGW 2022

2 December 2022 11:07

Immunotherapy response may be modulated by microbiome

Presented By

Dr Johannes Björk, University Medical Center Groningen, the Netherlands

Trial

PRIMM

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:48

Computer-aided colonoscopies improved adenoma detection rates

Presented By

Dr Michiel Maas, Raboud UMC, the Netherlands

Conference

UEGW 2022

Type

Peer-reviewed article

Presented By

Dr Nosheen Umar, University of Birmingham, UK

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:21

Portal hypertension is associated with poor prognosis in cirrhotic patients

Presented By

Mr Phil Ambery, AstraZeneca, Sweden

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:18

Chances of transplant-free survival in PSC enhanced by colectomy with ileostomy

Presented By

Dr Bregje Mol, Amsterdam UMC, the Netherlands

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:13

SARS-CoV-2: Booster doses of key importance for cirrhotic patients

Presented By

Dr Samer Al-Dury, Sahlgrenska University Hospital, Sweden

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:11

Less ulcer bleeds early after H. pylori eradication in aspirin users

Presented By

Prof. Christopher Hawkey, Nottingham Digestive Diseases Centre, UK

Trial

Phase 4, HEAT

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:08

Dupilumab effective in paediatric patients with eosinophilic oesophagitis

Presented By

Prof. Evan S. Dellon, University of North Carolina School of Medicine in Chapel Hill, NC, USA

Trial

Phase 3, EoE KIDS

Conference

UEGW 2022

Type

Peer-reviewed article

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, ELEVATE UC

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 22:00

Favourable maintenance rates for risankizumab also in delayed responders with CD

Presented By

rof. Geert D’Haens, Amsterdam UMC, the Netherlands

Trial

Phase 3, FORTIFY

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:56

IL-23 inhibition reduces inflammatory biomarkers in pre-treated UC

Presented By

Prof. Julian Panés, Hospital Clínic Barcelona, Spain

Trial

Phase 2, QUASAR

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:53

Maintained symptom control with mirikizumab in UC

Presented By

Prof. Axel Dignass, Agaplesion Markus Hospital, Germany

Trial

Phase 3, LUCENT 2

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:49

Mirikizumab successfully resolves active histologic inflammation in UC

Presented By

Prof. Fernando Magro, CHU de São João, Portugal

Trial

Phase 2, LUCENT 2

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:44

Upadacitinib for CD: remarkable efficacy in induction therapy

Presented By

Prof. Julian Panés, Hospital Clínic Barcelona, Spain

Trial

Phase 3, U-EXCEL

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:42

Sustained maintenance results with upadacitinib in UC

Presented By

Prof. Séverine Vermeire, University Hospital Leuven, Belgium

Trial

U-ACHIEVE Maintenance

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:37

Start low with brepocitinib and ritlecitinib in UC

Presented By

Dr Kenneth Hung, Pfizer, MA, USA

Trial

Phase 2, VIBRATO

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 21:34

Another chance for TYK2 inhibition in UC

Presented By

Prof. Stephan Schreiber, University Hospital Schleswig-Holstein, Germany

Trial

Phase 2, LATTICE-UC

Conference

UEGW 2022

Type

Peer-reviewed article

Presented By

Dr Melek Zahra Sarikaya, Sjællands Universitetshospital, Denmark

Trial

LIR!C

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 17:11

Dose-interval of adalimumab might be prolonged in CD patients in stable remission

Presented By

Dr Reinier van Linschoten , Franciscus Gasthuis en Vlietland, the Netherlands

Trial

Phase 4, LADI

Conference

UEGW 2022

Type

Peer-reviewed article

1 December 2022 17:01

UEGW 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Presented By

Prof. Jessica Allegretti, Brigham and Women’s Hospital, MA, USA

Trial

Phase 2, PRISM-EXT

Conference

DDW 2022

Presented By

Prof. Evan S. Dellon, University of North Carolina School of Medicine, NC, USA

Trial

Phase 3, LIBERTY EOE TREET

Conference

DDW 2022

Type

News article

14 June 2022 22:29

Antibiotic use elevates IBD risks in senior citizens

Presented By

Prof. Adam S. Faye, NYU Langone Health, NY, USA

Conference

DDW 2022

Type

News article

14 June 2022 22:22

Too much hygiene: CD in later life?

Presented By

Dr Williams Turpin, Mount Sinai Hospital and the University of Toronto, Canada

Conference

DDW 2022

Type

News article

Presented By

Dr Yuriko Otake, Osaka University

Type

Peer-reviewed article

12 April 2022 17:32

AI model distinguishes between histologic activity and remission in ulcerative colitis

Presented By

Dr Tommaso Parigi, Humanitas University, Italy

Trial

PICaSSO

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:29

Multi-Omic and dietary analysis of Crohn’s disease identifies pathogenetic factors

Presented By

Dr Yael Haberman, Sheba Medical Center, Israel

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:27

Novel classification system for perianal fistulising Crohn’s disease

Presented By

Dr Philip Tozer, St Mark’s Hospital and Academic Institute, UK

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:26

Vaccination tool associated with improved vaccination coverage in IBD

Presented By

Ms Liselotte Fierens, KU Leuven, Belgium

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:24

Comparable safety profiles of biological therapies in elderly patients with IBD

Presented By

Dr Gustavo Drügg Hahn, McGill University Health Center, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:22

Dr Gianluca Pellino, University of Campania Luigi Vanvitelli, Italy

Trial

SCOTCH

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:11

Modified 2-stage ileal pouch-anal anastomosis versus 3-stage alternative

Presented By

Dr Stefan Holubar, Cleveland Clinic Foundation, OH, USA

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:06

Similar results for different corticosteroid tapering protocols in UC

Presented By

Ms Pernille Ovesen, Herlev University Hospital, Denmark

Trial

SCOTCH

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:04

Ozanimod treatment shows maintained response in ulcerative colitis

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, True North

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:57

Stopping infliximab but not antimetabolites leads to more relapses in Crohn’s disease

Presented By

Prof. Edouard Louis, University Hospital Liège, Belgium

Trial

Phase 4, SPARE

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:55

Vedolizumab first approved therapy for chronic pouchitis

Presented By

Prof. Simon Travis, University of Oxford, UK

Trial

Phase 4, EARNEST

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:53

VEDOKIDS: Vedolizumab seems effective in paediatric IBD

Presented By

Dr Dan Turner, Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Israel

Trial

VEDOKIDS

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:51

Primary endpoint of 5-hydroxytryptophan for fatigue in IBD not met

Presented By

Dr Marie Truyens, Ghent University Hospital, Belgium

Trial

Phase 2, Trp-IBD

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:48

Anti-TNFs versus vedolizumab and ustekinumab in Crohn’s disease

Presented By

Dr Neeraj Narula, McMaster University, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:46

Upadacitinib appears to be an efficacious therapy for moderately-to-severely ulcerative colitis

Presented By

Prof. Remo Panaccione , University of Calgary, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

Presented By

Dr Peter Bossuyt, Imelda General Hospital, Belgium

Trial

Phase 3, ADVANCE, MOTIVATE, FORTIFY

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:15

Guselkumab plus golimumab promising combination for ulcerative colitis

Presented By

Prof. Bruce Sands, Mount Sinai School of Medicine, NY, USA

Trial

Phase 2, VEGA

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:10

Combined endpoint may support personalised medicine in ulcerative colitis

Presented By

Prof. Stefan Schreiber, Christian-Albrecht University, Germany

Trial

Phase 3, SELECTION

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:06

Filgotinib seems promising for perianal fistulising Crohn’s disease

Presented By

Dr Walter Reinisch, Medical University of Vienna, Austria

Trial

Phase 2, DIVERGENCE 2

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:04

Upadacitinib maintenance therapy delivers sustained improvements in active ulcerative colitis

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, U-ACHIEVE

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 15:57

Upadacitinib counters extraintestinal manifestations in ulcerative colitis

Presented By

Prof. Jean-Frédéric Colombel, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, U-ACHIEVE; U-ACCOMPLISH

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 15:53

Upadacitinib effector pathways unravelled

Presented By

Dr Bram Verstockt, KU Leuven, Belgium

Trial

Phase 2, U-ACHIEVE

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 15:49

Deucravacitinib does not meet primary endpoint for ulcerative colitis

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 2, LATTICE-UC

Conference

ECCO 2022

Journal

JAMA Internal Medicine

29 March 2022 18:17

Pfizer’s bowel disease drug succeeds in late-stage study

23 March 2022 16:04

Metastasis rate high after endoscopic resection of high-risk T1a esophageal cancers

Journal

Gastrointestinal Endoscopy

22 March 2022 21:02

Cumulative exposure to tacrolimus tied to post liver transplant cancer risk

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 12:38

ctDNA promising biomarker for recurrence of pancreatic cancer

Presented By

Dr Gregory Botta, UCSD Moores Cancer Center, CA, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 12:32

Letter from the Editor

Editor

Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch

Conference

ASCO GI 2022

21 March 2022 12:29

Head-to-head: Etoposide and irinotecan equally effective in neuroendocrine carcinoma

Presented By

Dr Chigusa Morizane, National Cancer Center Hospital, Japan

Trial

Phase 3, JCOG1213, TOPIC-NEC

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 12:26

EMR versus ESD in oesophageal cancer

Presented By

Dr Vani Konda, Baylor University Medical Center, TX, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:23

Pre-operative chemoradiation versus peri-operative chemotherapy for oesophageal cancer

Presented By

Prof. Karyn Goodman, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:22

AK104 plus chemotherapy promising first-line option for gastric cancer

Presented By

Dr Jiafu Ji, Beijing Cancer Hospital, China

Trial

Phase 1/2, AK104-201

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:19

DESTINY-Gastric01: OS benefit of T-DXd over chemotherapy for HER2-positive gastric cancer

Presented By

Dr Kensei Yamaguchi, Cancer Institute Hospital of JFCR, Japan

Trial

Phase 2, DESTINY-Gastric01

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:17

The emerging role of AI in gastroesophageal cancer

Presented By

Dr Wai Leung, University of Hong Kong, China

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:15

DCF outperforms standard-of-care for locally advanced oesophageal cancer

Presented By

Dr Ken Kato, National Cancer Center Hospital, Japan

Trial

Phase 3, JCOG1109, NExT

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:13

Nivolumab in gastric cancer: Efficacy update and the role of gut microbiome

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan; Dr Yu Sunakawa, St. Marianna University School of Medicine, Japan

Trial

Phase 3, CheckMate 649, DELIVER

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:11

Updates on pembrolizumab for oesophageal and gastric cancer

Presented By

Dr Jean-Philippe Metges, CHU Brest, France; Dr Zev Wainberg, University College Los Angeles, CA, USA

Trial

Phase 3, KEYNOTE-590, KEYNOTE-062

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 11:08

NIPICOL: New data on optimal ICI treatment duration in MSI/dMMR mCRC

Presented By

Dr Romain Cohen, Sorbonne University, France

Trial

Phase 2, NIPICOL

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:30

Dostarlimab may offer an alternative for dMMR rectal cancer

Presented By

Dr Melissa Lumish, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 2

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:28

DESTINY-CRC01: Maintained efficacy of T-DXd in mCRC

Presented By

Dr Takayuki Yoshino, National Cancer Center Hospital East, Japan

Trial

Phase 2, DESTINY-CRC01

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:26

Key updates in colorectal cancer screening

Presented By

Dr Robin Mendelsohn, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

Presented By

Dr Claire Gallois, Université de Paris, France

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:17

Long-course chemoradiation versus short-course radiotherapy in rectal cancer

Presented By

Dr Emma Holliday, MD Anderson Cancer Center, University of Texas, TX, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:15

Adjuvant S-1 therapy superior to observation in resected biliary tract cancer

Presented By

Dr Masafumi Ikeda, Japan Clinical Oncology Group, Japan

Trial

Phase 3, JCOG1202, ASCOT

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:13

Pembrolizumab safe and efficacious in advanced hepatocellular carcinoma

Presented By

Prof. Shukui Qin, Nanjing University of Chinese Medicine, China

Trial

Phase 3, KEYNOTE-394

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:11

TOPAZ-1: Adding durvalumab to chemotherapy effective in advanced biliary tract cancer

Presented By

Dr Do-Youn Oh, Seoul National University College of Medicine, South Korea

Trial

Phase 3, TOPAZ-1

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:09

HIMALAYA: Durvalumab ± tremelimumab new first-line option for unresectable HCC

Presented By

Prof. Ghassan Abou-Alfa, Memorial Sloan Kettering Center, NY, USA

Trial

Phase 3, HIMALAYA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:05

LAUNCH: TACE plus lenvatinib efficacious in advanced HCC

Presented By

Prof. Ming Kuang, Sun Yat-sen University, China

Trial

Phase 3, LAUNCH

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:03

Modest activity of atezolizumab plus bevacizumab in Child-Pugh B HCC

Presented By

Dr Hyeyeong Kim, Ulsan University Hospital, South Korea

Trial

Phase 3, IMbrave150

Conference

ASCO GI 2022

Journal

JAMA Network Open

10 March 2022 15:44

ECCO 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

UEGW 2021

Type

News article

27 October 2021 09:50

Serious adverse events put a stop to ASTIClite trial for CD

Presented By

Prof. James Lindsay, Barts and The London School of Medicine, UK

Trial

Phase 3, ASTIClite

Conference

UEGW 2021

Type

News article

27 October 2021 09:48

Motorised spiral enteroscopy safe in real-life and in patients with altered anatomy

Presented By

Dr Torsten Beyna, Evangelic Hospital Düsseldorf, Germany

Trial

SAMISEN

Conference

UEGW 2021

Type

News article

27 October 2021 09:46

Novel tool can reliably exclude submucosal invasion in colorectal polyps

Presented By

Dr Lynn Debels, University Hospital Ghent, Belgium

Conference

UEGW 2021

Type

News article

27 October 2021 09:44

Home infusion safe for IBD patients receiving infliximab and vedolizumab

Journal

Crohn's & Colitis 360

26 October 2021 18:57

Surgery needed in nearly half of appendicitis patients treated with antibiotics

Journal

The New England Journal of Medicine

25 October 2021 23:02

Certain CDH1 variants tied to gastric cancer risk in hereditary lobular breast cancer

Journal

JAMA Surgery

22 October 2021 23:59

Acquired mutations linked to fat metabolism, insulin sensitivity in chronic liver disease

Journal

Nature

20 October 2021 22:32

UEGW 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

FORTIFY, VIBRATO umbrella, SELECTION, LIBERTY EoE TREET

11 August 2021 14:08

ECCO 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Presented By

Dr Bram Verstockt , University Hospital Leuven, Belgium

Conference

ECCO 2021

Type

News article

2 July 2021 22:51

Ustekinumab safe and effective in elderly CD patients

Presented By

Dr Diego Casas Deza, Hospital Universitario Miguel Servet

Trial

ENEIDA registry

Conference

ECCO 2021

Type

News article

2 July 2021 22:50

Promising safety and pharmacokinetic data on BT051 for UC

Presented By

Dr Chris Stevens, Bacainn Therapeutics, Clinical Development, Concord, United States

Trial

Phase 1

Conference

ECCO 2021

Type

News article

Presented By

Dr Elena Akimenko, Gentofte Hospital, Denmark

Conference

ECCO 2021

Type

News article

2 July 2021 20:58

Risk of hospitalisation and surgery linked to IBD biological

Presented By

Dr Camilla Bjørn Jensen, Frederiksberg Hospital

Conference

ECCO 2021

Type

News article

2 July 2021 20:20

Risk of colorectal cancer is detected by low-pass whole genome sequencing

Presented By

Dr Ibrahim Al Bakir, Queen Mary University of London, UK

Conference

ECCO 2021

Type

News article

2 July 2021 19:03

Large variability in IBD care and education across Europe

Presented By

Dr Jan Král, Institute for Clinical and Experimental Medicine, Czech Republic

Conference

ECCO 2021

Type

News article

2 July 2021 18:07

Ultra-processed food intake associated with IBD

Presented By

Dr Neeraj Narula , McMaster University, UK

Conference

ECCO 2021

Type

News article

2 July 2021 17:09

Factors of coping difficulties in IBD revealed

Presented By

Mr J. Marshall, University of Sheffield, Academic Unit of Primary Medical Care, Sheffield, United Kingdom

Conference

ECCO 2021

Type

News article

2 July 2021 15:12

Obesity increases the risk of immunogenicity to adalimumab in IBD

Presented By

Dr Remi Mahmoud, University Medical Centre Utrecht, the Netherlands

Conference

ECCO 2021

Journal

Gastrointestinal Endoscopy

Presented By

Dr Kai-Keen Shiu, University College London Hospitals NHS Foundation Trust, UK

Trial

Phase 3, KEYNOTE-177

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:52

Short-course radiotherapy with delayed surgery better for elderly rectal cancer patients

Presented By

Dr Eric Francois, Centre Antoine-Lacassagne, France

Trial

PRODIGE 42-GERICO 12 NACRE

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:50

Bemarituzumab response for gastric/GEJ cancers correlates with FGFR2b levels

Presented By

Prof. Zev Wainberg, UCLA, USA

Trial

Phase 2, FIGHT

Conference

ASCO GI 2021

Type

Peer-reviewed article

Presented By

Prof. Josep Tabernero, Vall d'Hebron Institute of Oncology, Spain

Trial

Prognostic value of tumour deposits in stage 3 colon cancer patients

Presented By

Dr Romain Cohen, Mayo Clinic, USA

Trial

Phase 3, CALGB/SWOG 80702

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:43

Final phase 2 results of second-line infigratinib for advanced cholangiocarcinoma

Presented By

Prof. Milind Javle, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 2

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:42

Neoadjuvant chemotherapy does not increase perioperative complications in thoracic oesophageal cancer

Presented By

Prof. Kazuo Koyanagi, National Cancer Center, Japan

Trial

Phase 3, JCOG 1109

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:42

Ipilimumab/nivolumab plus panitumumab in patients with microsatellite-stable mCRC

Presented By

Dr Michael Lee, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 2

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:41

Adjuvant nivolumab: good quality-of-life

Presented By

Prof. Eric Van Cutsem, University of Leuven, Belgium

Trial

Phase 3, CheckMate 577

Conference

ASCO GI 2021

Type

Peer-reviewed article

Presented By

Prof. Robert Lewandowski, Northwestern University, Chicago, USA

Trial

LEGACY

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:33

Maintenance treatment with cetuximab versus observation in RAS wildtype mCRC

Presented By

Dr Valérie Boige, Institut Gustave Roussy, France

Trial

Phase 2, PRODIGE 28-time UNICANCER

Conference

ASCO GI 2021

Type

Peer-reviewed article

Featured articles

CONTENTS

Online First

Immunology

General

Cardiology